04/13/2021 | Press release | Distributed by Public on 04/13/2021 12:30

SEC Filing (N-VPFS)

John Hancock Life Insurance Company of New York

AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS

John Hancock Life Insurance Company of New York

For the Years Ended December 31, 2020, 2019 and 2018

With Report of Independent Auditors

AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

YEARS ENDED DECEMBER 31, 2020, 2019 and 2018

Contents

Report of Independent Auditors			1
Statutory-Basis Financial Statements:
Balance Sheets-Statutory-Basis			3
Statements of Operations-Statutory-Basis			5
Statements of Changes in Capital and Surplus-Statutory-Basis			6
Statements of Cash Flow-Statutory-Basis			7
Notes to Statutory-Basis Financial Statements			8

Report of Independent Auditors

The Board of Directors and Stockholder

John Hancock Life Insurance Company of New York

We have audited the accompanying statutory-basis financial statements of John Hancock Life Insurance Company of New York (the Company), which comprise the balance sheets as of December 31, 2020 and 2019 and the related statements of operations, changes in capital and surplus and cash flow for each of the three years in the period ended December 31, 2020, and the related notes to the financial statements.

Management's Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with accounting practices prescribed or permitted by the New York State Department of Financial Services. Management also is responsible for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

Auditor's Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity's internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the statutory-basis financial statements, the Company prepared these financial statements using accounting practices prescribed or permitted by the New York State Department of Financial Services, which is a basis of accounting other than U.S. generally accepted accounting principles. The effects on the financial statements of the variances between these statutory accounting practices and U.S. generally accepted accounting principles, although not reasonably determinable, are presumed to be material.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the significance of the matter described in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles paragraph, the statutory-basis financial statements referred to above do not present fairly, in conformity with U.S. generally accepted accounting principles, the financial position of the Company at December 31, 2020 and 2019, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2020.

1

Opinion on Statutory-Basis of Accounting

In our opinion, the statutory-basis financial statements referred to above present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, on the basis of accounting described in Note 2.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 31, 2021

2

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

BALANCE SHEETS-STATUTORY-BASIS

		December 31,
		2020			2019
(in millions)
Admitted assets
Cash and invested assets:
Bonds			$ 5,451				$ 4,787
Stocks:
Preferred stocks			13				8
Common stocks			104				125
Mortgage loans on real estate			692				617
Real estate:
Investment properties			238				241
Cash, cash equivalents and short-term investments			7				13
Policy loans			128				122
Derivatives			1,480				967
Receivable for collateral on derivatives			-				1
Receivable for securities			1				-
Other invested assets			856				954
Total cash and invested assets			8,970				7,835
Investment income due and accrued			81				72
Premiums due			5				5
Amounts recoverable from reinsurers			28				16
Funds held by or deposited with reinsured companies			806				837
Net deferred tax asset			107				79
Other reinsurance receivable			37				24
Amounts due from affiliates			396				523
Other assets			6				18
Assets held in separate accounts			8,903				8,254
Total admitted assets			$ 19,339				$ 17,663

The accompanying notes are an integral part of the statutory-basis financial statements.

3

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

BALANCE SHEETS-STATUTORY-BASIS

		December 31,
		2020			2019
(in millions)
Liabilities and capital and surplus
Liabilities:
Policy and contract obligations:
Policy reserves			$ 6,376				$ 5,808
Policyholders' and beneficiaries' funds			225				232
Dividends payable to policyholders			8				12
Policy benefits in process of payment			12				48
Other amount payable on reinsurance			71				56
Other policy obligations			2				1
Total policy and contract obligations			6,694				6,157
Payable to parent and affiliates			3				9
Transfers to (from) separate account, net			(20	)			(21	)
Asset valuation reserve			234				239
Reinsurance in unauthorized companies			15				10
Funds withheld from unauthorized reinsurers			379				372
Interest maintenance reserve			716				353
Current federal income taxes payable			122				-
Derivatives			967				596
Payables for collateral on derivatives			47				32
Payables for securities			-				190
Other general account obligations			66				48
Obligations related to separate accounts			8,903				8,254
Total liabilities			18,126				16,239
Capital and surplus:
Common stock (par value $1; 3,000,000 shares authorized; 2,000,003 shares issued and outstanding at December 31, 2020 and 2019)			2				2
Paid-in surplus			913				913
Unassigned surplus			298				509
Total capital and surplus			1,213				1,424
Total liabilities and capital and surplus			$ 19,339				$ 17,663

The accompanying notes are an integral part of the statutory-basis financial statements.

4

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF OPERATIONS-STATUTORY-BASIS

		Years Ended December 31,
		2020			2019			2018
(in millions)
Premiums and other revenues:
Life and annuity premiums, net		$	962			$	516			$	1,052
Consideration for supplementary contracts with life contingencies			12				10				11
Net investment income			328				319				334
Amortization of interest maintenance reserve			21				12				14
Commissions and expense allowance on reinsurance ceded			22				8				32
Reserve adjustment on reinsurance ceded			-				2				(3	)
Separate account administrative and contract fees			99				101				105
Other revenue			34				35				36
Total premiums and other revenues			1,478				1,003				1,581
Benefits paid or provided:
Death, surrender and other contract benefits, net			1,372				1,399				1,357
Annuity benefits			121				141				198
Disability benefits			2				2				2
Interest and adjustments on policy or deposit-type funds			7				4				8
Payments on supplementary contracts with life contingencies			12				11				10
Increase (decrease) in life reserves			530				(70	)			(64	)
Total benefits paid or provided			2,044				1,487				1,511
Insurance expenses and other deductions:
Commissions and expense allowance on reinsurance assumed			69				84				86
General expenses			41				49				49
Insurance taxes, licenses and fees			9				13				20
Net transfers to (from) separate accounts			(375	)			(389	)			(391	)
Investment income ceded			39				35				22
Other (income) deductions			(66	)			(114	)			(65	)
Total insurance expenses and other deductions			(283	)			(322	)			(279	)
Income (loss) from operations before dividends to policyholders, federal income taxes and net realized capital gains (losses)			(283	)			(162	)			349
Dividends to policyholders			12				16				21
Income (loss) from operations before federal income taxes and net realized capital gains (losses)			(295	)			(178	)			328
Federal income tax expense (benefit)			(15	)			(41	)			(36	)
Income (loss) from operations before net realized capital gains (losses)			(280	)			(137	)			364
Net realized capital gains (losses)			(7	)			(60	)			11
Net income (loss)		$	(287	)		$	(197	)		$	375

The accompanying notes are an integral part of the statutory-basis financial statements.

5

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF CHANGES IN CAPITAL AND SURPLUS-STATUTORY-BASIS

		Common Stock			Paid-in Surplus			Unassigned Surplus (Deficit)			Total Capital and Surplus
(in millions)
Balances at January 1, 2018			$ 2				$ 913				$ 568				$ 1,483
Net income (loss)					375				375
Change in net unrealized capital gains (losses)					(25	)			(25	)
Change in net deferred income tax					(70	)			(70	)
Decrease (increase) in non-admitted assets					51				51
Change in liability for reinsurance in unauthorized reinsurance					(3	)			(3	)
Decrease (increase) in asset valuation reserves					(35	)			(35	)
Dividend paid to Parent					(100	)			(100	)
Change in surplus as a result of reinsurance					(18	)			(18	)
Other adjustments, net											5				5
Balances at December 31, 2018			2				913				748				1,663
Net income (loss)					(197	)			(197	)
Change in net unrealized capital gains (losses)					87				87
Change in net deferred income tax					53				53
Decrease (increase) in non-admitted assets					(25	)			(25	)
Decrease (increase) in asset valuation reserves					(40	)			(40	)
Dividend paid to Parent					(100	)			(100	)
Change in surplus as a result of reinsurance											(17	)			(17	)
Balances at December 31, 2019			2				913				509				1,424
Net income (loss)					(287	)			(287	)
Change in net unrealized capital gains (losses)					73				73
Change in net deferred income tax					87				87
Decrease (increase) in non-admitted assets					(41	)			(41	)
Change in liability for reinsurance in unauthorized reinsurance					(6	)			(6	)
Change in reserve due to change in valuation basis					(36	)			(36	)
Decrease (increase) in asset valuation reserves					5				5
Change in surplus as a result of reinsurance					(4	)			(4	)
Other adjustments, net											(2	)			(2	)
Balances at December 31, 2020			$ 2				$ 913				$ 298				$ 1,213

The accompanying notes are an integral part of the statutory-basis financial statements.

6

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

STATEMENTS OF CASH FLOW-STATUTORY-BASIS

		Years Ended December 31,
		2020			2019			2018
(in millions)
Operations
Premiums and other considerations collected, net of reinsurance		$	975			$	1,059			$	1,062
Net investment income received			329				321				357
Separate account fees			99				101				105
Commissions and expenses allowance on reinsurance ceded			18				(9)				14
Miscellaneous income			64				55				63
Benefits and losses paid			(1,543)				(1,544)				(1,570)
Net transfers from (to) separate accounts			376				389				396
Commissions and expenses (paid) recovered			(109)				(105)				(101)
Dividends paid to policyholders			(16)				(18)				(19)
Federal and foreign income and capital gain taxes (paid) recovered			15				(10)				(19)
Net cash provided by operating activities			208				239				288
Investment activities
Proceeds from sales, maturities, or repayments of investments:
Bonds			3,176				844				2,188
Stocks			38				44				3
Mortgage loans on real estate			58				31				168
Other invested assets			165				281				85
Derivatives			-				-				18
Total investment proceeds			3,437				1,200				2,462
Cost of investments acquired:
Bonds			3,364				1,104				2,152
Stocks			4				5				1
Mortgage loans on real estate			133				25				22
Real estate			2				11				11
Other invested assets			55				138				243
Derivatives			63				70				-
Total cost of investments acquired			3,621				1,353				2,429
Net increase (decrease) in receivable/payable for securities and collateral on derivatives			(175)				201				(8)
Net (increase) decrease in policy loans			(6)				-				(9)
Net cash provided by (used in) investment activities			(365)				48				16
Financing and miscellaneous activities
Net deposits (withdrawals) on deposit-type contracts			(7)				(11)				(8)
Dividend paid to parent			-				(100)				(100)
Other cash provided (applied)			158				(198)				(172)
Net cash provided by (used in) financing and miscellaneous activities			151				(309)				(280)
Net increase (decrease) in cash, cash equivalents and short-term investments			(6)				(22)				24
Cash, cash equivalents and short-term investments at beginning of year			13				35				11
Cash, cash equivalents and short-term investments at end of year		$	7			$	13			$	35
Non-cash activities during the year:
Premium and other operating activity related to reinsurance transactions, net		$	-			$	525			$	-
Investing activities related to reinsurance transactions, net			-				(525)				-

The accompanying notes are an integral part of the statutory-basis financial statements.

7

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

1. Organization and Nature of Operations

John Hancock Life Insurance Company of New York (the 'Company') is a life insurance company organized on February 10, 1992 under the laws of the State of New York. The New York State Department of Financial Services (the 'Insurance Department') granted the Company a license to operate on July 22, 1992. The Company is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.) ('JHUSA'). JHUSA is a wholly-owned subsidiary of The Manufacturers Investment Corporation ('MIC'). MIC is a wholly-owned subsidiary of John Hancock Financial Corporation ('JHFC'), which is an indirect, wholly-owned subsidiary of The Manufacturers Life Insurance Company ('MLI'). MLI, in turn, is a wholly-owned subsidiary of Manulife Financial Corporation ('MFC'), a Canadian-based, publicly traded financial services holding company.

The Company provides a wide range of financial protection and wealth management products and services to both individual and institutional customers. Through its insurance operations, the Company offers a variety of individual life insurance products that are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing. The Company also offers a variety of retirement products to retirement plans. The Company distributes these products through multiple distribution channels, including insurance agents and affiliated brokers, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks.

Pursuant to a distribution agreement with the Company, John Hancock Distributors LLC ('JHD'), a registered broker-dealer and a wholly-owned subsidiary of JHUSA, acts as the principal underwriter of variable life contracts and other products issued by the Company.

The Company's results and operations have been and may continue to be adversely impacted by the COVID-19 pandemic and the recent economic downturn. The adverse effects include but are not limited to significant volatility in equity markets and decline in interest rates, increase in credit risk, strain on commodity markets, foreign currency exchange rate volatility, increases in insurance claims, persistency and redemptions, and disruption of business operations. The breadth and depth of these events and how long they will continue have introduced additional uncertainty around estimates used in determining the carrying value of certain assets and liabilities included in these financial statements.

2. Significant Accounting Policies

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes known and may impact the amounts reported and disclosed herein.

Basis of Presentation

These financial statements have been prepared in conformity with accounting practices prescribed or permitted by the Insurance Department. The National Association of Insurance Commissioners' ('NAIC') Accounting Practices and Procedures Manual ('NAIC SAP') has been adopted as a component of practices prescribed or permitted by the State of New York. The New York Superintendent of the Insurance Department (the 'Superintendent') has the authority to prescribe or permit other specific practices that deviate from prescribed practices. NAIC SAP practices differ from accounting principles generally accepted in the United States ('GAAP') as described below.

Investments: Investments in bonds not backed by other loans are principally stated at amortized cost using the constant yield (interest) method. Bonds can also be stated at the lesser of amortized cost or fair value based on their NAIC designated rating. Non-redeemable preferred stocks, which have characteristics of equity securities, are reported at cost or lower of cost or market value as determined by the Securities Valuation Office of the NAIC ('SVO') rating, and the related net unrealized capital gains (losses) are reported in unassigned surplus along with any adjustment for federal income taxes. Redeemable preferred stocks, which have characteristics of debt securities and are rated as medium quality or better, are reported at cost or amortized cost. All other redeemable preferred stocks are reported at the lower of cost, amortized cost, or fair value.

For bonds other than loan-backed and structured securities, the Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. The Company recognizes other-than-temporary

8

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

impairment losses on bonds with unrealized losses when the entity does not have the intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. Declines in value due to credit difficulties are also considered to be other-than-temporarily impaired when the Company does not have the intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. The entire difference between amortized cost and fair value on such bonds with credit difficulties is recognized as an impairment loss in income.

Loan-backed and structured securities (i.e., collateralized mortgage obligations) are adjusted for the effects of changes in prepayment assumptions on the related accretion of discounts or amortization of premiums of such securities using either the retrospective or prospective methods. The retrospective adjustment method is used to value all such securities, except principal-only and interest-only securities and such securities with NAIC designations of 3-6, which are valued using the prospective method. If it is determined that a decline in fair value is other-than-temporary, the cost basis of the security is written down to the present value of estimated future cash flows using the original effective interest rate inherent in the security.

Common stocks are primarily reported at fair value based on quoted market prices and the related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustment for federal income taxes. There are no restrictions on common and preferred stocks.

Non-insurance subsidiaries, which have significant ongoing operations other than for the benefit of the Company and its affiliates, are reported based on the underlying audited GAAP equity. Non-insurance subsidiaries, which have no significant ongoing operations other than for the benefit of the Company and its affiliates, are reported based on the underlying audited GAAP equity, including the admitted portion of goodwill. Dividends from subsidiaries are included in net investment income. The remaining net change in the subsidiaries' equity is included in the change in net unrealized capital gains (losses).

Realized capital gains (losses) on sales of securities are recognized using the first in, first out ('FIFO') method. The cost basis of bonds, common and preferred stocks, and other invested assets is adjusted for impairments in value deemed to be other-than-temporary and such adjustments are reported as a component of net realized capital gains (losses).

Mortgage loans on real estate are reported at unpaid principal balances, less an allowance for impairments. Valuation allowances, if necessary, are established for mortgage loans on real estate based on the difference between the net value of the collateral, determined as the fair value of the collateral less estimated costs to obtain and sell, and the recorded investment in the mortgage loan. The initial valuation allowance and subsequent changes in the allowance for mortgage loans are charged or credited directly to unassigned surplus. A mortgage loan is considered to be impaired when, based on current information and events, it is probable that the Company will be unable to collect all principal and interest amounts due according to the contractual terms of the mortgage agreement. When management determines foreclosure is probable and the impairment is other-than-temporary, the mortgage loan is written down and a realized loss is recognized.

Real estate held for the production of income is reported at depreciated cost, net of related obligations. Real estate that the Company has the intent to sell is reported at the lower of depreciated cost or fair value, net of related obligations. Depreciation is calculated on a straight-line basis over the estimated useful lives of the properties.

Cash equivalents are short-term highly liquid investments with original maturities of three months or less and are principally stated at amortized cost. Short-term investments include investments with maturities of one year or less and greater than three months at the date of acquisition and are principally stated at amortized cost.

Policy loans are reported at unpaid principal balances.

Derivative instruments that meet the criteria to qualify for hedge accounting are accounted for in a manner consistent with the item hedged (i.e., amortized cost or fair value with the related net unrealized capital gains (losses) reported in unassigned surplus along with any adjustment for federal income taxes). Derivative instruments that are entered into for other hedging purposes, also known as economic hedges, do not meet the criteria to qualify for hedge accounting. These derivative instruments are accounted for at fair value, and the related changes in fair value are recognized as net unrealized capital gains (losses) reported in unassigned surplus, net of any adjustments for federal income taxes. Embedded derivatives are not accounted for separately from the host contract.

9

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Other invested assets consist of ownership interests in partnerships and limited liability companies ('LLCs') which are carried based on the underlying audited GAAP equity, with the exception of affordable housing tax credit properties, which are carried at amortized cost. The related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustments for federal income taxes. The Company records its share of income using the most recent financial information available, which is generally on a three month lag. Depending on the timing of receipt of the audited financial statements of these other invested assets, the investee level financial data may be up to one year in arrears.

Interest Maintenance and Asset Valuation Reserves: Under a formula prescribed by the NAIC, the Company defers the portion of realized capital gains (losses) on sales of fixed income investments, principally bonds and mortgage loans, and interest-related hedging activities that are attributable to changes in the general level of interest rates and amortizes those deferrals over the remaining period to maturity based on groupings of individual securities sold in five-year bands. That net deferral is reported as the interest maintenance reserve ('IMR') in the accompanying Balance Sheets. Realized capital gains (losses) are reported in income, net of federal income tax and transferred to the IMR. The asset valuation reserve ('AVR') provides a valuation allowance for invested assets. The AVR is determined by an NAIC prescribed formula with changes reflected directly in unassigned surplus.

Subsidiaries: The accounts and operations of the Company's subsidiaries are not consolidated with the accounts and operations of the Company.

Goodwill: Goodwill is admitted subject to an aggregate limitation of 10% of the capital and surplus in the most recently filed quarterly statement, excluding electronic data processing ('EDP') equipment, operating system software, net deferred tax assets, and net positive goodwill. Goodwill is amortized over the period the Company benefits economically, not to exceed 10 years. Goodwill is reported in other invested assets in the Balance Sheets.

Separate Accounts: Separate account assets and liabilities reported in the accompanying Balance Sheets represent funds that are separately administered, principally for annuity contracts and variable life insurance policies, and for which the contract holder, rather than the Company, bears the investment risk. Separate account obligations are intended to be satisfied from separate account assets and not from assets of the general account. Separate accounts are generally reported at fair value. The operations of the separate accounts are not included in the Statements of Operations; however, income earned on amounts initially invested by the Company in the formation of new separate accounts is included in other revenue. Fees charged to contract holders, principally mortality, policy administration, and surrender charges are included in separate account administrative and contract fees. The assets in the separate accounts are not pledged to others as collateral or otherwise restricted. For the years ended December 31, 2020, 2019 and 2018, there were no gains (losses) on transfers of assets from the general account to the separate account.

Nonadmitted Assets: Certain assets designated as nonadmitted, principally deferred income taxes, the Company's investment in John Hancock Variable Trust Advisers LLC ('JHVTA') (formerly John Hancock Investment Management Services, LLC), an affiliated company, other invested assets, furniture and equipment, prepaid expenses, and other assets not specifically identified as admitted assets within the NAIC SAP are excluded from the accompanying Balance Sheets and are charged directly to unassigned surplus.

Policy Acquisition Costs: The costs of acquiring and renewing business are expensed when incurred.

Policy Reserves: Reserves for life, annuity, and deposit-type contracts are developed by actuarial methods and are determined based on interest rates, mortality tables and valuation methods prescribed by the NAIC that will provide, in the aggregate, reserves that are greater than or equal to the maximum of guaranteed policy cash values or the amounts required by the Superintendent.

·

The Company waives deduction of deferred fractional premiums on the death of lives insured and annuity contract holders and returns any premium beyond the date of death. Surrender values on policies do not exceed the corresponding benefit reserves. At December 31, 2020 and 2019, the Company held reserves of $ 458 million and $ 476 million, respectively, on insurance in-force amounts for which gross premiums were less than net premiums according to the standard of valuation set by the State of New York.

10

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

·

At December 31, 2020 and 2019, the Company held reserves of $700 million and $325 million, respectively, as a result of asset adequacy testing ('AAT').

·

Reserves for individual life insurance policies are maintained using the 1941, 1958, 1980, 2001 and 2017 Commissioner's Standard Ordinary Mortality Tables and using principally the Commissioner's Reserve Valuation Method. In 2020, the New York State Department of Financial Services ('NY DFS') adopted Insurance Regulation 213 ('Reg 213') amendments, introducing the NY DFS's version of principle-based reserving ('PBR') for companies filing in New York. PBR has been implemented for Term Life and Annuity policies. The Company received approval for a 1-year deferral on PBR implementation for Permanent Life policies.

·

Annuity and supplementary contracts with life contingency reserves are based principally on the 1937 Standard Annuity Table, the Group Annuity Mortality Tables for 1951, 1971, 1983 and 1994, the 1971 and 1983 Individual Annuity Mortality Tables, the A-2000 Individual Annuity Mortality Table, and the 2012 Individual Annuity Reserving Mortality Table.

·

Liabilities related to policyholder funds left on deposit with the Company are generally equal to fund balances.

·

For life insurance, the calendar year exact method is used to calculate the reserve at December 31, 2020 and 2019. Reserves at December 31, 2020 and 2019 are calculated based on the rated age. For certain policies with substandard table ratings, substandard multiple extras are applied via the Lotter method.

·

Tabular interest, tabular less actual reserve released, and tabular costs have been determined by formula. Tabular interest on funds not involving life contingencies is calculated as one percent of the product of such valuation rate of interest times the mean of the amount of funds subject to such valuation rate of interest held at the beginning and end of the valuation year.

·

From time to time, the Company finds it appropriate to modify certain required policy reserves because of changes in actuarial assumptions. Reserve modifications resulting from such determinations are recorded directly to unassigned surplus.

·

Reserves for variable deferred annuity contracts are calculated in accordance with NY DFS Reg 213 §103.6. The reserve is calculated using stochastic scenarios and assumptions set by the Company, subject to two reserve floors, one based on a standardized calculation using prescribed stochastic scenarios and assumptions, the other using a prescribed, standard scenario.

Reinsurance: Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders. The Company remains liable to its policyholders for the portion reinsured to the extent that any reinsurer does not meet its obligations for reinsurance ceded to it under the reinsurance agreements. Failure of the reinsurers to honor their obligations could result in losses to the Company; consequently, estimates are established for amounts deemed or estimated to be uncollectible. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics of the insurer.

Premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured business are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums ceded to other companies have been reported as a reduction of premium income. Amounts applicable to reinsurance ceded for future policy benefits, unearned premium reserves, and claim liabilities have been reported as reductions of these items.

The Company records a liability for unsecured policy reserves ceded to reinsurers not authorized in the State of New York to assume such business. Changes to those amounts are credited or charged directly to unassigned surplus. Policy and contract liabilities ceded to reinsurers have been reported as reductions of the related reserves. Commissions and expense allowances allowed by reinsurers on business ceded are reported as income when received. Investment income ceded includes separate account fee income, net investment income and realized investment and other gains (losses), which was ceded to the affiliated reinsurers. NAIC SAP prescribes that no gain be recognized upon inception of a reinsurance treaty. The initial gain is recorded directly to unassigned surplus and released into income over the life of the treaty.

11

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Federal Income Taxes: Total federal income taxes are based upon the Company's best estimate of its current and deferred tax assets or liabilities. Current tax expense is reported in the Statements of Operations as federal income tax expense if resulting from operations and within net realized capital gains (losses) if resulting from capital transactions. Changes in the balances of deferred taxes, which provide for book versus tax temporary differences, are subject to limitations and are reported within various lines within surplus. The provision for federal and foreign income taxes incurred in the Statements of Operations is different from that which would be obtained by applying the statutory federal income tax rate to income before income tax (including realized capital gains). For additional information, see the Federal Income Taxes Note for reconciliation of effective tax rate.

Participating Insurance and Policyholder Dividends: Participating business which is assumed from JHUSA, represented approximately 15% and 16% of the Company's aggregate reserve for group fixed annuity and life contracts at December 31, 2020 and 2019, respectively. The amount of policyholders' dividends to be paid is approved annually by JHUSA's Board of Directors. Policyholder dividends are recognized when declared rather than over the term of the related policies. The determination of the amount of policyholders' dividends is complex and varies by policy type. In general, the aggregate amount of policyholders' dividends is calculated based upon actual interest, mortality, morbidity, persistency, and expense experience for the year, as well as management's judgment as to the appropriate level of statutory surplus to be retained by the Company.

Statements of Cash Flow: Cash, cash equivalents and short-term investments in the Statements of Cash Flow represent movements of cash and highly liquid debt investments with initial maturities of one year or less.

Premiums and Benefits: Premiums for whole, term, and universal life, annuity policies, and group annuity contracts with any mortality and morbidity risk are recognized as revenue when due. Revenues for universal life and annuity policies with mortality or morbidity risk consist of the entire premium received. Premiums received for variable universal life, as well as annuity policies and group annuity contracts without mortality or morbidity risk are recorded using deposit accounting and are credited directly to an appropriate policy reserve account, without recognizing premium revenue. Benefits incurred represent the total of death benefits paid, annuity benefits paid and the change in policy reserves.

Policy and Contract Claims: Policy and contract claims are determined on an individual-case basis for reported losses. Estimates of incurred but not reported losses are developed on the basis of past experience.

Guaranty Fund Assessments: Guaranty fund assessments are accrued when the Company receives knowledge of an insurance insolvency.

Variances Between NAIC SAP and GAAP: The more significant variances from GAAP are: (a) bonds would generally be reported at fair value; (b) changes in the fair value of derivative financial instruments would generally be reported as revenue unless deemed an effective hedge; (c) embedded derivatives would be bifurcated from the underlying contract or security and accounted for separately at fair value; (d) income recognition on partnerships and LLCs, which are accounted for under the equity method, would not be limited to the amount of cash distribution; (e) majority-owned noninsurance subsidiaries, variable interest entities where the Company is the primary beneficiary, and certain other controlled entities would be consolidated; (f) changes in the balances of deferred income taxes would generally be included in net income; (g) market value adjusted ('MVA') annuity products would be reported in the general account of the Company; (h) all assets, subject to valuation allowances, would be recognized; (i) reserves would generally be based upon the net level premium method or the estimated gross margin method with estimates of future mortality, morbidity, persistency and interest; (j) reinsurance ceded, unearned ceded premium and unpaid ceded claims would be reported as an asset; (k) AVR and the IMR would not be recorded; (l) changes to the mortgage loan valuation allowance would be reported in income; (m) surplus notes would be reported as liabilities; (n) premiums received in excess of policy charges for universal life and annuity policies would not be recognized as premium revenue and benefits would represent the excess of benefits paid over the policy account value and interest credited to the account values; (o) certain acquisition costs, such as commissions and other variable costs, directly related to acquiring new business are charged to current operations as incurred, would generally be capitalized and amortized based on profit emergence over the expected life of the policies or over the premium payment period; and (p) changes in unrealized capital gains (losses) and foreign currency translations would be presented as other comprehensive income.

The effects of the foregoing variances from GAAP on the accompanying statutory-basis financial statements have not been determined, but are presumed to be material.

12

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

3. Permitted or Prescribed Statutory Accounting Practices

The financial statements of the Company are presented in conformity with accounting practices prescribed or permitted by the Insurance Department.

For determining the Company's solvency under the State of New York's insurance laws and regulations, the Insurance Department recognizes only statutory accounting practices prescribed or permitted by the State of New York for determining and reporting the financial condition and results of operations of the Company. NAIC SAP has been adopted as a component of practices prescribed or permitted by the State of New York. The Superintendent has the authority to prescribe or permit other specific practices that deviate from prescribed practices. As of December 31, 2020 and 2019, the Superintendent had not prescribed or permitted the Company to use any accounting practices that would result in the Company's income or financial position to deviate from NAIC SAP.

13

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

4. Accounting Changes

Accounting changes adopted to conform to the provisions of NAIC SAP are reported as changes in accounting principles. The cumulative effect of changes in accounting principles is reported as an adjustment to unassigned surplus in the period of the change in accounting principle. The cumulative effect is the difference between the amount of unassigned surplus at the beginning of the year and the amount of unassigned surplus that would have been reported at that date if the new accounting principle had been applied retrospectively.

Adoption of New Accounting Standards

Effective January 1, 2020, NY DFS adopted Reg 213 §103.6. The requirement is applicable to all variable annuity business in force. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

Effective December 31, 2019, the NAIC made non-substantive revisions to Statement of Statutory Accounting Principles ('SSAP') No. 100R, Fair Value Measurements to adopt with modification the disclosure amendments reflected in Accounting Standards Update ('ASU') 2018-13Changes to the Disclosure Requirements for Fair Value Measurement. The revisions included elimination of certain fair value disclosures. The Company adopted the amendment in 2019. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

Effective January 1, 2018, the NAIC made substantive revisions to SSAP No. 100, Fair Value Measurements. The revised guidance allows the use of net asset value as a practical expedient for fair value when 1) specifically allowed in a SSAP or 2) when specific conditions exist. The Company adopted the amendment in 2018. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

Effective January 1, 2018, the NAIC made substantive revisions to SSAP No. 86, Accounting for Derivative Instruments and Hedging, Income Generation, and Replication (Synthetic Asset)Transactions to adopt ASU 2017-04 Settlement of Valuation Margin. The revised guidance requires the recognition of changes in variation margin as unrealized gains/losses until the derivative contract has matured, terminated and/or expired. The guidance applies to both over-the-counter ('OTC') derivatives and ('ETF') exchange-traded futures, regardless of whether the counterparty or exchange considers the variation margin payment to be collateral or a legal settlement. The Company adopted the amendment in 2018. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

In November 2018, the NAIC adopted SSAP No. 108 - Derivatives Hedging Variable Annuity Guarantees as a substantive guidance which permits and specifies the requirements for applying a special accounting treatment for derivative contracts hedging variable annuity guarantee benefits that are subject to fluctuations as a result of interest rate sensitivity. The provisions of SSAP No. 108 are separate and distinct from the statutory guidance in SSAP No. 86 - Derivatives. Application of the adopted guidance is limited to the derivative transactions specified in SSAP No. 108 and permitted only if all of the requirements for the special accounting treatment are met. The guidance is effective beginning January 1, 2020. The Company has not elected hedge accounting under SSAP 108.

In November 2018, the NAIC made non-substantive revisions to SSAP No. 51R - Life Contracts to adopt ASU 2018-28Updates to Liquidity Disclosures. The revisions included enhancements to the existing disclosures on annuity actuarial reserves and deposit type liabilities by withdrawal characteristics and added life liquidity disclosures. The Company adopted the amendment in 2019. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

In November 2018, the NAIC made non-substantive revisions to SSAP No. 86 - Derivatives to incorporate hedge documentation and assessment efficiencies from ASU 2017-12Targeted Improvements to Accounting for Hedging Activities as issued by Financial Accounting Standards Board ('FASB'). The revisions will allow companies to perform subsequent assessments of hedge effectiveness qualitatively if certain conditions are met, allow companies more time to perform the initial quantitative hedge effectiveness assessment and clarify that companies may apply the 'criterial terms match' method for a group of forecasted transactions if they meet the requirements. The revisions were effective beginning January 1, 2019 and the Company adopted the amendment in 2019. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

14

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

In March 2017, the NAIC made substantive revisions to SSAP No. 69 - Statement of Cash Flow to adopt ASU 2016-15Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments as issued by the FASB, without modifications. The revisions clarified the classification of eight specific cash flow issues with the objective of reducing diversity in practice. The amendment is to be applied retrospectively, effective for fiscal years beginning after December 15, 2018 and interim periods within those years. The Company adopted the amendment in 2019. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

In June 2017, the NAIC adopted revisions to SSAP No. 37, Mortgage Loans. The revision requires an age analysis of mortgage loans disclosure, aggregated by type, with identification of mortgage loans in which the entity is a participant or co-lender in a mortgage loan agreement, capturing: 1) recorded investment of current mortgage loans, 2) recorded investment of mortgage loans classified as 30-59 days, 60-89 days, 90-179 days, and 180 days and greater past due; 3) recorded investment of mortgage loans 90 days and 180 days past due still accruing interest; 4) interest accrued for mortgage loans 90 days and 180 days past due; and 5) recorded investment and number of mortgage loans where interest has been reduced, by percent reduced. The Company adopted the amendment in 2018. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

In August 2017, the NAIC adopted non-substantive revisions to SSAP No. 69 - Statement of Cash Flow to adopt ASU 2016-18Statement of Cash Flows: Restricted Cash as issued by the FASB. The revision clarifies that restricted cash and cash equivalents shall not be reported as operating, investing or financing activities, but shall be reported with cash and cash equivalents when reconciling beginning and ending amounts on the cash flow statement. A consequential change was incorporated in SSAP No. 1 - Accounting Policies, Risks & Uncertainties and Other Disclosures to ensure information on restricted cash, cash equivalents and short-term investments is reported in the restricted asset disclosure. The revision was effective December 31, 2019, to be adopted retrospectively to allow for comparative cash flow statements. The Company adopted the amendment in 2019. The guidance did not have a material impact on the Company's financial position, results of operations, and financial statement disclosures.

Future Adoption of New Accounting Standards

In April 2020, the NAIC adopted INT 20-1Reference Rate Reform as an interpretation of statutory accounting guidance to incorporate the US GAAP guidance from ASU 2020-04, Reference Rate Reform (Topic 848) 'Facilitation of the Effects of Reference Rate Reform on Financial Reporting'. The effective date of this guidance begins on March 12, 2020 and sunsets on Dec 31, 2022. The guidance provides limited period elective application of accounting relief (expedients) to address the direct effects from the reference rate reform on affected contracts and hedging relationships. The Company is currently assessing which expedients to adopt and the impact of this guidance on its financial statements.

On September 22, 2017, The Bilateral Agreement Between the United States of America and the European Union (EU) on Prudential Measures Regarding Insurance and Reinsurance, known as the Covered Agreement, was signed by the United States Department of the Treasury and the US Trade Representative. The Covered Agreement includes provisions that serve to reduce reinsurance collateral requirements for certified reinsurers that are licensed and domiciled in Qualified Jurisdictions. On June 25, 2019, the NAIC Executive Committee adopted revisions to the Credit for Reinsurance Model Law (#785) and Credit for Reinsurance Model Regulation (#786), which implement the reinsurance collateral provisions of the Covered Agreements with the European Union (EU) and the United Kingdom (UK). These revisions create a new type of jurisdiction, which is called a Reciprocal Jurisdiction and eliminate reinsurance collateral requirements and local presence requirements for EU and UK reinsurers that maintain a minimum amount of own-funds equivalent to $250 million and a solvency capital requirement (SCR) of 100% under Solvency II. The revisions also provide Reciprocal Jurisdiction status for accredited U.S. jurisdictions and Qualified Jurisdictions if they meet certain requirements in the credit for reinsurance models. U.S. states must adopt these revisions prior to September 1, 2022 or face potential federal preemption by the Federal Insurance Office. To avoid preemption, the laws must be enacted prior to September 1, 2022, and must adhere exactly to the models as they have been adopted by the NAIC. On December 7, 2019, the Statutory Accounting Principles (E) Working Group adopted revisions to Appendix A-785 to incorporate the updates from the adopted Credit for Reinsurance Model Law (#785) and the Credit for Reinsurance Model Regulation (#786) that include the relevant provisions from the Covered Agreement. The Company is assessing the impact on the Company's financial position, results of operations, and financial statement disclosures.

15

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

In August 2016, the NAIC adopted substantive revisions to SSAP No. 51 - Life Contracts in order to allow PBR for life insurance contracts as specified in the Valuation Manual. Current statutory accounting guidance refers to existing model laws for reserving guidance which are primarily based on formulaic methodology. Also, in June 2016, the NAIC adopted updates to Appendix A-820: Minimum Life and Annuity Reserve Standards as part of the PBR project, which incorporate relevant aspects of the 2009 revisions to the Standard Valuation Law (Model #820) into Appendix A-820. The effective date is January 1, 2017 and companies are allowed to defer adoption for three years until January 1, 2020. NY DFS adopted Reg 213 amendments in 2020. PBR has now been implemented for Term Life policies (new policies written after adoption) and Annuity policies (all in-force). The Company received approval from NY DFS to defer this adoption until January 1, 2021 for Permanent Life policies. Adoption will be on a prospective basis, therefore, there is no impact to surplus upon adoption.

Reconciliation Between Audited Financial Statements and NAIC Annual Statements

There were no differences in net income (loss) or capital and surplus between the audited financial statements and the NAIC statements as filed as of and for the years ended December 31, 2020, 2019 and 2018.

5. Investments

Bonds

The carrying value and fair value of the Company's investments in bonds are summarized as follows:

		Carrying Value			Gross Unrealized Gains			Gross Unrealized Losses			Fair Value
(in millions)
December 31, 2020:
U.S. government and agencies		$	3,073			$	217			$	(42	)		$	3,248
States and political subdivisions			62				7				-				69
Foreign governments			34				5				-				39
Corporate bonds			1,970				375				(1	)			2,344
Mortgage-backed and asset-backed securities			312				43				-				355
Total bonds		$	5,451			$	647			$	(43	)		$	6,055
December 31, 2019:
U.S. government and agencies		$	2,885			$	199			$	(24	)		$	3,060
States and political subdivisions			34				6				-				40
Foreign governments			38				3				-				41
Corporate bonds			1,540				191				(2	)			1,729
Mortgage-backed and asset-backed securities			290				25				-				315
Total bonds		$	4,787			$	424			$	(26	)		$	5,185

16

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

A summary of the carrying value and fair value of the Company's investments in bonds at December 31, 2020, by contractual maturity, is as follows:

		Carrying Value			Fair Value
(in millions)
Due in one year or less		$	72			$	72
Due after one year through five years			675				701
Due after five years through ten years			623				692
Due after ten years			3,769				4,235
Mortgage-backed and asset-backed securities			312				355
Total		$	5,451			$	6,055

The expected maturities in the foregoing table may differ from the contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties.

The Company maintains assets which are pledged as collateral in connection with various agreements and transactions. Additionally, the Company holds assets on deposit with government authorities as required by state law. The following table summarizes the carrying value or fair value, as applicable, of the pledged or deposited assets:

		December 31,
		2020			2019
(in millions)
At fair value:
Bonds and cash pledged in support of over-the-counter derivative instruments		$	143			$	71
Bonds and cash pledged in support of exchange-traded futures			35				12
Bonds and cash pledged in support of cleared interest rate swaps			35				13
Total fair value		$	213			$	96
At carrying value:
Bonds on deposit with government authorities		$	-			$	-
Mortgage loans pledged in support of real estate			-				-
Bonds held in trust			-				-
Pledged collateral under reinsurance agreements			-				-
Total carrying value		$	-			$	-

At December 31, 2020 and 2019, the Company held below investment grade corporate bonds of $75 million and $54 million, with an aggregate fair value of $81 million and $55 million, respectively. The Company performs periodic evaluations of the relative credit standing of the issuers of these bonds.

The Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. This process involves monitoring market events that could impact issuers' credit ratings, business climate, management changes, litigation and government actions, and other similar factors. This process also involves monitoring late payments, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts, and cash flow projections as indicators of credit issues.

At the end of each quarter, the MFC Loan Review Committee reviews all securities where there is evidence of impairment or a significant unrealized loss at the Balance Sheet date. Impairment is considered to have occurred, based on management's judgment, when it is deemed probable that the Company will not be able to collect all amounts due according to the debt security's contractual terms. The analysis focuses on each company's or project's ability to service its debts in a timely fashion and the length of time the security has been trading below amortized cost. The results of this analysis are reviewed by the Transaction and Portfolio Review Committee at MFC. This committee includes MFC's Chief Financial Officer, Chief

17

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Investment Officer, Chief Risk Officer, Chief Credit Officer, and other senior management. This quarterly process includes a fresh assessment of the credit quality of each investment in the entire fixed maturity security portfolio.

The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances considered include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer, including the current and future impact of any specific events; and (3) the Company's ability and intent to hold the security to maturity or until it recovers in value. To the extent the Company determines that a security is deemed to be other-than-temporarily impaired, the difference between book value and fair value would be charged to income. For loan-backed and structured securities in an unrealized loss position, where the Company does not intend to sell or is not likely to be required to sell the security, the Company calculates an other-than-temporary impairment loss by subtracting the net present value of the projected future cash flows of the security from the amortized cost of the security. The net present value is calculated by discounting the Company's best estimate of projected future cash flows at the effective interest rate implicit in the debt security prior to impairment. The projection of future cash flows is subject to the same analysis the Company applies to its overall impairment evaluation process, as noted above, which incorporates security specific information such as late payments, downgrades by rating agencies, key financial ratios, financial statements, and fundamentals of the industry and geographic area in which the issuer operates, as well as overall macroeconomic conditions. The cash flow estimates, including prepayment assumptions, are based on data from third-party data sources or internal estimates, and are driven by assumptions regarding the underlying collateral, including default rates, recoveries, and changes in value.

There are a number of significant risks and uncertainties inherent in the process of monitoring impairments and determining if impairment is other-than-temporary. These risks and uncertainties include (1) the risk that the Company's assessment of an issuer's ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer; (2) the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated; (3) the risk that fraudulent information could be provided to the Company's investment professionals who determine the fair value estimates and other-than-temporary impairments; and (4) the risk that new information obtained by the Company or changes in other facts and circumstances lead the Company to change its intent to hold the security to maturity or until it recovers in value. Any of these situations could result in a charge to income in a future period.

At December 31, 2020 and 2019, the Company had no Other-Than-Temporary Impairments (OTTI) for loan-backed and structured securities.

18

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The following table shows gross unrealized losses and fair values of bonds, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

		Less than 12 months						12 months or more						Total
		Fair Value			Gross Unrealized Losses					Fair Value			Gross Unrealized Losses					Fair Value			Gross Unrealized Losses
(in millions)
December 31, 2020:
U.S. government and agencies		$	1,356			$	(42	)			$	-			$	-				$	1,356			$	(42	)
States and political subdivisions			3				-					-				-					3				-
Foreign governments			-				-					-				-					-				-
Corporate bonds			67				(1	)				1				-					68				(1	)
Mortgage-backed and asset-backed securities			6				-					-				-					6				-
Total		$	1,432			$	(43	)			$	1			$	-				$	1,433			$	(43	)
		Less than 12 months					12 months or more					Total
		Fair Value				Gross Unrealized Losses					Fair Value				Gross Unrealized Losses					Fair Value				Gross Unrealized Losses
(in millions)
December 31, 2019:
U.S. government and agencies		$	1,121			$	(24	)			$	29			$	-				$	1,150			$	(24	)
States and political subdivisions			4				-					-				-					4				-
Foreign governments			-				-					-				-					-				-
Corporate bonds			35				-					14				(2	)				49				(2	)
Mortgage-backed and asset-backed securities			-				-					8				-					8				-
Total		$	1,160			$	(24	)			$	51			$	(2	)			$	1,211			$	(26	)

At December 31, 2020 and 2019, there were 34 and 45 bonds that had a gross unrealized loss of which the single largest unrealized loss was $42 million and $23 million, respectively. The Company anticipates that these bonds will perform in accordance with their contractual terms and the Company currently has the ability and intent to hold these bonds until they recover or mature. Unrealized losses can be created by rising interest rates or by rising credit concerns and therefore widening credit spreads. Credit concerns are apt to play a larger role in the unrealized loss on below investment grade securities. Unrealized losses on investment grade securities principally relate to changes in interest rates or changes in credit spreads since the securities were acquired. Credit rating agencies' statistics indicate that investment grade securities have been found to be less likely to develop credit concerns.

The sales of investments in bonds, including non-cash sales from reinsurance transactions, resulted in the following:

		Years Ended December 31,
		2020			2019			2018
(in millions)
Proceeds		$	3,035			$	1,153			$	1,389
Realized gross gains			493				41				6
Realized gross losses			(5	)			(5	)			(28	)

19

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

For the years ended December 31, 2020 and 2019, realized capital losses include $3 million and $0 million related to bonds that had experienced an other-than-temporary decline in value and were comprised of 5 and 0 securities, respectively.

The Company had no nonadmitted accrued investment income from bonds (unaffiliated) at December 31, 2020 and 2019.

Affiliate Transactions

In 2020, the Company sold certain bonds to its parent, JHUSA. These bonds had a book value of $59 million and fair value of $65 million. The Company recognized $6 million in pre-tax realized gains before transfer to the IMR.

In 2019, the Company sold certain bonds to its parent, JHUSA. These bonds had a book value of $121 million and fair value of $123 million. The Company recognized $2 million in pre-tax realized gains before transfer to the IMR.

In 2019, the Company acquired, at fair value, certain bonds from its parent, JHUSA, for $130 million.

In 2018, the Company sold certain bonds to its parent, JHUSA. These bonds had a book value of $637 million and fair value of $647 million. The Company recognized $10 million in pre-tax realized gains before transfer to the IMR.

In 2018, the Company acquired, at fair value, certain bonds from its parent, JHUSA, for $313 million.

20

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Preferred and Common Stocks

Cost and fair value of the Company's investments in preferred and common stocks are summarized as follow:

		Cost			Gross Unrealized Gains			Gross Unrealized Losses			Fair Value
(in millions)
December 31, 2020:
Preferred stocks:
Nonaffiliated		$	9			$	4			$	-			$	13
Affiliates			-				-				-				-
Common stocks:
Nonaffiliated			75				32				(3	)			104
Affiliates*			-				-				-				-
Total stocks		$	84			$	36			$	(3	)		$	117
		Cost				Gross Unrealized Gains				Gross Unrealized Losses				Fair Value
(in millions)
December 31, 2019:
Preferred stocks:
Nonaffiliated		$	8			$	3			$	-			$	11
Affiliates			-				-				-				-
Common stocks:
Nonaffiliated			102				26				(3	)			125
Affiliates*			-				-				-				-
Total stocks		$	110			$	29			$	(3	)		$	136

*Affiliates - fair value represents the carrying value

At December 31, 2020 and 2019, there were 2 and 15 nonaffiliated equity securities that had a gross unrealized loss excluding securities that have been written down to zero. The single largest unrealized loss was $3 million and $2 million at December 31, 2020 and 2019, respectively. The Company anticipates that these equity securities will recover in value in the near term.

The Company has a process in place to identify equity securities that could potentially have an impairment that is other-than-temporary. The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer; and (3) the Company's ability and intent to hold the security until it recovers. To the extent the Company determines that a security is deemed to be other-than-temporarily impaired, the difference between book value and fair value would be charged to income.

For the years ended December 31, 2020, 2019 and 2018, realized capital losses include $3 million, $0 million, and $0 million related to preferred and common stocks that have experienced an other-than-temporary decline in value and were comprised of 14, 0, and 0 securities, respectively.

21

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Mortgage Loans on Real Estate

At December 31, 2020 and 2019, the mortgage loan portfolio was diversified by geographic region and specific collateral property type as displayed below. The Company controls credit risk through credit approvals, limits, and monitoring procedures.

December 31, 2020:
Property Type		Carrying Value						Geographic Concentration		Carrying Value
(in millions)								(in millions)
Apartments		$	241				East North Central		$	55
Industrial			83				East South Central			5
Office buildings			169				Middle Atlantic			154
Retail			129				Mountain			40
Agricultural			-				New England			14
Agribusiness			1				Pacific			249
Mixed use			-				South Atlantic			91
Other			69				West North Central			34
Allowance			-				West South Central			50
			Canada / Other			-
						Allowance			-
Total mortgage loans on real estate		$	692				Total mortgage loans on real estate		$	692
December 31, 2019:
Property Type			Carrying Value				Geographic Concentration			Carrying Value
(in millions)				(in millions)
Apartments		$	208				East North Central		$	59
Industrial			39				East South Central			10
Office buildings			180				Middle Atlantic			95
Retail			130				Mountain			43
Agricultural			-				New England			13
Agribusiness			11				Pacific			232
Mixed use			-				South Atlantic			99
Other			49				West North Central			34
Allowance			-				West South Central			32
			Canada / Other			-
						Allowance			-
Total mortgage loans on real estate		$	617				Total mortgage loans on real estate		$	617

The aggregate mortgages outstanding to any one borrower do not exceed $33 million.

During 2020, the respective maximum and minimum lending rates for mortgage loans issued were 4.52% and 2.37% for commercial loans. The Company issued no agricultural loans during 2020 or 2019. The Company issued no purchase money mortgages in 2020 or 2019. At the issuance of a loan, the percentage of any one loan to value of security, exclusive of insured, guaranteed or purchase money mortgages does not exceed 75%. The average recorded investment in impaired loans was $0 million and $0 million at December 31, 2020 and 2019, respectively. The Company recognized $0 million, $0 million, and $0 million of interest income during the period the loans were impaired for the years ended December 31, 2020, 2019 and 2018, respectively.

22

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The following table shows the age analysis of mortgage loans aggregated by type:

		Farm			Residential			Commercial			Mezzanine			Total
(in millions)
December 31, 2020:
Recorded Investment
Current		$	1			$	-			$	690			$	1			$	692
30 - 59 Days Past Due			-				-				-				-				-
60 - 89 Days Past Due			-				-				-				-				-
90 - 179 Days Past Due			-				-				-				-				-
180 + Days Past Due			-				-				-				-				-
December 31, 2019:
Recorded Investment
Current		$	11			$	-			$	605			$	1			$	617
30 - 59 Days Past Due			-				-				-				-				-
60 - 89 Days Past Due			-				-				-				-				-
90 - 179 Days Past Due			-				-				-				-				-
180 + Days Past Due			-				-				-				-				-

The Company had no recorded investment of mortgage loans 90 to 179 days or 180 days or greater past due still accruing interest or where interest has been reduced in 2020 and 2019. The Company was not a participant or co-lender in a mortgage loan agreement in 2020 and 2019.

Generally, the terms of the restructured mortgage loans call for the Company to receive some form or combination of an equity participation in the underlying collateral, excess cash flows or an effective yield at the maturity of the loans sufficient to meet the original terms of the loans. There are no contractual commitments made to extend credit to debtors owning receivables whose terms have been modified in troubled debt restructurings. The Company accrues interest income on impaired loans to the extent deemed collectible and the loan continues to perform under its original or restructured contractual terms. Interest income on non-performing loans generally is recognized on a cash basis.

For mortgage loans, the Company evaluates credit quality through regular monitoring of credit related exposures, considering both qualitative and quantitative factors in assigning an internal risk rating ('IRR'). These ratings are updated at least annually.

The carrying value of mortgage loans by IRR was as follows:

		December 31,
		2020			2019
(in millions)
AAA		$	41			$	45
AA			241				231
A			294				223
BBB			93				117
BB			23				1
B and lower and unrated			-				-
Total		$	692			$	617

Affiliated Transactions

In 2019, the Company acquired at fair value, certain mortgages from an affiliate, Hancock Mortgage REIT Inc., ('HMREIT'), for $5 million.

In 2018, the Company sold certain mortgages to its parent, JHUSA. These mortgages had a book value of $98 million and fair value of $105 million at the date of the transaction. The Company recognized $7 million in pre-tax realized gains before transfer to the IMR.

23

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Real Estate

The composition of the Company's investment in real estate is summarized as follows:

		December 31,
		2020			2019
(in millions)
Properties occupied by the company		$	-			$	-
Properties held for the production of income			277				276
Properties held for sale			-				-
Less accumulated depreciation			(39	)			(35	)
Total		$	238			$	241

The Company recorded $0 million, $0 million, and $0 million of impairments on real estate investments during the years ended December 31, 2020, 2019 and 2018, respectively.

Other Invested Assets

The Company had no investments in partnerships or LLCs that exceed 10% of its admitted assets at December 31, 2020 and 2019.

Other invested assets primarily consist of investments in partnerships and LLCs. The Company recorded $9 million, $0 million, and $1 million of impairments on partnerships and LLCs in 2020, 2019, or 2018. Any impairment is based on significant judgement by the Company in determining whether the objective evidence of other-than-temporary impairment exists. The Company considers relevant facts and circumstances in evaluating whether the impairment of another invested asset is other-than-temporary. Relevant facts and circumstances include (1) the length of time the fair value has been below cost; (2) the financial position of the investee; (3) the Company's ability and intent to hold the other invested asset until it recovers. To the extent the Company determines that an other invested asset is deemed to be other-than-temporarily impaired, the difference between book and fair value would be charged to income.

Affiliate Transactions

In 2019, Manulife Private Capital and Manulife Investment Management Private Markets launched a closed-end pooled fund that offers third-party investors the opportunity to invest alongside JHUSA's and MLI's general account and/or their affiliates (collectively the 'General Account') in private equity funds and private equity co-investments in the US and in Canada. The fund was seeded with a pool of private equity fund investments and direct private equity co-investments from the Company. The assets sold by the Company, to seed the fund, had a book value of $173 million and fair value of $180 million which resulted in a gain to operations of $7 million.

In 2018, the Company sold certain other invested assets to its parent, JHUSA. These other invested assets had a book value of $3 million and fair value of $4 million. The Company recognized $1 million in pre-tax realized gains.

Other

The Company had no exposure to the subprime mortgage related risk at December 31, 2020 or 2019.

24

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Net Investment Income and Net Realized and Other Gains (Losses)

Major categories of the Company's net investment income are summarized as follows:

		2020			2019			2018
(in millions)
Income:
Bonds		$	161			$	165			$	178
Preferred stocks			-				-				-
Common stocks			1				2				1
Mortgage loans on real estate			29				29				35
Real estate			46				39				39
Policy loans			5				5				5
Cash, cash equivalents and short-term investments			2				7				6
Other invested assets			92				92				84
Derivatives			36				19				23
Other income			-				-				-
Total investment income			372				358				371
Expenses
Investment expenses			(35	)			(30	)			(28	)
Investment taxes, licenses and fees, excluding federal income taxes			(4	)			(4	)			(4	)
Investment interest expense			-				-				-
Depreciation on real estate and other invested assets			(5	)			(5	)			(5	)
Total investment expenses			(44	)			(39	)			(37	)
Net investment income		$	328			$	319			$	334

Other invested assets above represent income earned from the Company's investment in JHVTA.

Realized capital gains (losses) and amounts transferred to the IMR are as follows:

		Years Ended December 31,
		2020			2019			2018
(in millions)
Realized capital gains (losses)		$	500			$	7			$	12
Less amount transferred to the IMR (net of related tax benefit (expense) of $(102) in 2020, $(9) in 2019, and $2 in 2018)			384				33				(6	)
Realized capital gains (losses) before tax			116				(26	)			18
Less federal income taxes on realized capital gains (losses) before effect of transfer to the IMR			123				34				7
Net realized capital gains (losses)		$	(7	)		$	(60	)		$	11

6. Derivatives

Derivatives are financial contracts, the value of which is derived from underlying interest rates, foreign exchange rates, credit, equity price movements, indices or other market risks arising from on-balance sheet financial instruments and selected anticipated transactions. The Company uses derivatives including swaps and futures agreements to manage current and anticipated exposures to changes in interest rates and equity market prices.

25

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Over-the-counter ('OTC') bilateral swaps are contractual agreements between the Company and a counterparty to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency.

Cleared OTC interest rate swaps are contractual agreements between the Company and a counterparty whereby the transaction must be cleared through a central clearing house, and subject to mandatory margin and reporting requirements.

Futures agreements are contractual obligations to buy or sell a financial instrument or foreign currency on a predetermined future date at a specified price. Futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.

Options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) a security, exchange rate, interest rate, or other financial instrument at a predetermined price/rate within a specified time.

Types of Derivatives and Derivative Strategies

Interest Rate Contracts. The Company uses interest rate futures contracts, OTC interest rate swap agreements and cleared interest rate swap agreements as part of its overall strategies of managing the duration of assets and liabilities or the average life of certain asset portfolios to specified targets. Interest rate swap agreements are contracts with counterparties to exchange interest rate payments of a differing character (i.e., fixed-rate payments exchanged for variable-rate payments) based on an underlying principal balance (notional principal). The net differential to be paid or received on interest rate swap agreements is accrued and recognized as a component of net investment income.

The Company uses interest rate swap agreements in effective cash flow and fair value hedge accounting relationships. These derivatives hedge the variable cash flows associated with certain floating-rate bonds, as well as, future fixed income asset acquisitions, which will support the Company's life insurance businesses. These derivatives reduce the impact of future interest rate changes on the cost of acquiring adequate assets to support the investment income assumptions used in pricing these products. For its fair value hedging relationships, the Company uses interest rate swap agreements to hedge the risk of changes in fair value of existing fixed rate assets and liabilities arising from changes in benchmark interest rates.

The Company uses exchange-traded interest rate futures primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating U.S. Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in other hedging relationships.

Equity Market Contracts. Equity index futures contracts are contractual obligations to buy or sell a specified amount of an underlying equity index at an agreed contract price on a specified date. Equity index futures are contracts with standard amounts and settlement dates that are traded on regulated exchanges. The Company utilizes equity index futures in other hedging relationships.

Equity index options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) an underlying equity market index on or before a specified future date at a specified price. The Company utilizes equity index options in other hedging relationships.

26

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The table below provides a summary of the gross notional amount and fair value of derivatives contracts for all derivatives in effective hedge accounting relationships and other hedging relationships:

				December 31, 2020
(in millions)				Notional Amount			Carrying Value Assets			Carrying Value Liabilities			Fair Value Assets			Fair Value Liabilities
Effective Hedge Accounting Relationships
Fair value hedges		Interest rate swaps		$	172			$	3			$	-			$	18			$	26
Cash flow hedges		Interest rate swaps			-				-				-				-				-
Total Derivatives in Effective Hedge Accounting Relationships		$	172			$	3			$	-			$	18			$	26
Other Hedging Relationships
	Interest rate swaps		$	8,074			$	1,475			$	967			$	1,475			$	967
	Interest rate futures			126				-				-				-				-
	Equity index options			99				2				-				2				-
	Equity index futures			186				-				-				-				-
Total Derivatives in Other Hedging Relationships		$	8,485			$	1,477			$	967			$	1,477			$	967
Total Derivatives			$	8,657			$	1,480			$	967			$	1,495			$	993
				December 31, 2019
(in millions)				Notional Amount			Carrying Value Assets			Carrying Value Liabilities			Fair Value Assets			Fair Value Liabilities
Effective Hedge Accounting Relationships
Fair value hedges		Interest rate swaps		$	173			$	4			$	-			$	16			$	9
Cash flow hedges		Interest rate swaps			13				-				-				4				-
Total Derivatives in Effective Hedge Accounting Relationships		$	186			$	4			$	-			$	20			$	9
Other Hedging Relationships
	Interest rate swaps		$	8,288			$	960			$	596			$	960			$	596
	Interest rate futures			144				-				-				-				-
	Equity index options			89				3				-				3				-
	Equity index futures			205				-				-				-				-
Total Derivatives in Other Hedging Relationships		$	8,726			$	963			$	596			$	963			$	596
Total Derivatives			$	8,912			$	967			$	596			$	983			$	605

Hedging Relationships

The Company generally does not enter into derivative contracts for speculative purposes. In certain circumstances, these hedges also meet the requirements for hedge accounting and are reported in a manner consistent with the hedged asset or liability. For the years ended December 31, 2020, 2019 and 2018, the Company recorded net unrealized gains of $7 million, $4 million, and $2 million, respectively related to derivatives that no longer qualify for hedge accounting.

Fair Value Hedges. The Company uses interest rate swaps to manage its exposure to changes in fair value of fixed-rate financial instruments caused by changes in interest rates.

27

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Cash Flow Hedges. The Company uses interest rate swaps to hedge the variability in cash flows from variable rate financial instruments and forecasted transactions.

For the year ended December 31, 2020, all of the Company's hedged forecast transactions qualified as cash flow hedges and no cash flow hedges were discontinued because it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship.

The maximum time frame for which variable cash flows are hedged is 0 years.

Derivatives Not Designated as Hedging Instruments (Economic Hedges). The Company enters into interest rate swap agreements and interest rate futures contracts to manage exposure to interest rates without designating the derivatives as hedging instruments.

The Company offers certain variable annuity products with a guaranteed minimum withdrawal benefit ('GMWB') and guaranteed minimum death benefit ('GMDB'). These guarantees are effectively an embedded option on the basket of mutual funds offered to contract holders. The Company manages a hedging program to reduce its exposure to certain contracts with the GMWB and GMDB guarantees. This dynamic hedging program uses interest rate swap agreements, equity index futures (including but not limited to the Dow Jones Industrial, Standard & Poor's 500 ('S&P'), Russell 2000, and Dow Jones Euro Stoxx 50 indices), currency futures, total return swaps, equity index options, swaptions and U.S. Treasury futures to match the sensitivities of the GMWB and GMDB liabilities to the market risk factors.

The Company deferred net realized gains (losses) of $1 million, $0 million, and $0 million (including $1 million, $0 million, and $0 million of gains (losses) for derivatives in other hedging relationships) related to interest rates for the years ended December 31, 2020, 2019 and 2018, respectively. Deferred net realized gains (losses) are reported in the IMR and amortized over the remaining period to expiration date.

For the years ended December 31, 2020, 2019 and 2018 net gains and losses related to derivatives in other hedging relationships were recognized by the Company, and the components were recorded in net unrealized and net realized gains (losses) as follows:

		Years ended December 31,
		2020		2019		2018
(in millions)
Other Hedging Relationships
Net unrealized capital gain (loss):
Interest rate swaps		$	144			$	124			$	(61)
Interest rate futures			(1	)			6				(5)
Equity index options			-				5				(3)
Equity index futures			(2	)			(8	)			6
Total net unrealized capital gain (loss)		$	141			$	127			$	(63)
Net realized capital gain (loss):
Interest rate swaps		$	1			$	-			$	-
Interest rate futures			(11	)			(13	)			5
Equity index options			3				-				1
Equity index futures			(54	)			(56	)			10
Total net realized capital gain (loss)		$	(61	)		$	(69	)		$	16
Total gain (loss) from derivatives in other hedging relationships		$	80			$	58			$	(47)

28

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Credit Risk

The Company's exposure to loss on derivatives is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in negative positions and the impact of collateral on hand. The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to the derivative financial instruments. The current credit exposure of the Company's derivative contracts is limited to the fair value in excess of the collateral held at the reporting date.

The Company manages its credit risk by entering into transactions with creditworthy counterparties, obtaining collateral where appropriate, and entering into master netting agreements that provide for a netting of payments and receipts with a single counterparty. The Company enters into credit support annexes with its OTC derivative dealers in order to manage its credit exposure to those counterparties. As part of the terms and conditions of those agreements, the pledging and accepting of collateral in connection with the Company's derivative usage is required. As of December 31, 2020 and 2019, the Company had accepted collateral consisting of cash of $47 million and $32 million and various securities with a fair value of $642 million and $452 million, respectively, which are held in separate custodial accounts. In addition, the Company has pledged collateral to support both the OTC derivative instruments, exchange traded futures and cleared interest rate swap transactions. For further details regarding pledged collateral see the Investments Note.

Under U.S. regulations, certain interest rate swap agreements are required to be cleared through central clearing houses. These transactions are contractual agreements that require initial and variation margin collateral postings and are settled on a daily basis through a clearing house. As such, they reduce the credit risk exposure in the event of default by a counterparty.

Financing Premiums

The following table presents the Company's aggregate, non-discounted total premium cost for derivative contracts with financing premiums and the premium cost due in each of the following years, and thereafter.

Fiscal Year		Derivative Premium Payments Due
(in millions)
2021		$ 5
2022		-
2023		-
2024		-
Thereafter		-
Total Future Settled Premiums		$ 5

		Undiscounted Future Premium Commitments		Derivative Fair Value With Premium Commitments			Derivative Fair Value Excluding Impact of Future Settled Premiums
(in millions)
Prior Year		$ 4		$	3			$	7
Current Year		$ 5		$	2			$	7

29

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

7. Fair Value

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

·

Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition - This category includes assets and liabilities measured at fair value. Financial instruments in this category include common stocks, derivatives, and separate account assets and liabilities.

·

Other Financial Instruments Not Reported at Fair Value After Initial Recognition - This category includes assets and liabilities as follows:

Bonds - For bonds, including corporate debt, U.S. Treasury, commercial and residential mortgage-backed securities, asset-backed securities, collateralized debt obligations, issuances by foreign governments, and obligations of state and political subdivisions, fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). The significant inputs into these models include, but are not limited to, yield curves, credit risks and spreads, measures of volatility, and prepayment speeds.

Mortgage Loans on Real Estate -The fair value of unimpaired mortgage loans is estimated using discounted cash flows and takes into account the contractual maturities and discount rates, which were based on current market rates for similar maturity ranges and adjusted for risk due to the property type. The fair value of impaired mortgage loans is based on the net of the collateral less estimated cost to obtain and sell. Fair value of commercial mortgages is derived through an internal valuation methodology using both observable and unobservable inputs. Unobservable inputs include credit assumptions and liquidity spread adjustments. Fair value of fixed-rate residential mortgages is determined using the discounted cash flow method. Inputs used for valuation are primarily comprised of prevailing interest rates and prepayment rates, if applicable. Fair value of variable-rate residential mortgages is assumed to be their carrying value.

Cash, Cash Equivalents and Short-Term Investments - The carrying values for cash, cash equivalents, and short-term investments approximate their fair value due to the short-term maturities of these instruments.

Policy Loans - These loans are carried at unpaid principal balances, which approximate their fair values.

Policy Reserves - Policy reserves consist of guaranteed investment contracts. The fair values associated with these financial instruments are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC's corporate spread. The fair value attributable to credit risk represents the present value of the spread.

Policyholders' and Beneficiaries' Funds - Includes term certain contracts and supplementary contracts without life contingencies. The fair values associated with the term certain contracts and supplementary contracts without life contingencies are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC's corporate spread. The fair value attributable to credit risk represents the present value of the spread. Fair value disclosure is not required for those balances that can be withdrawn by the policyholder at any time without prior notice or penalty. The fair value is the amount estimated to be payable to the policyholder as of the reporting date which is generally the carrying value and provides no additional disclosure value.

Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition

Valuation Hierarchy

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

30

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

·

Level 1 - Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date reflecting market transactions. Level 1 assets primarily include exchange traded equity securities and certain separate account assets.

·

Level 2 - Fair value measurements using inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.), and inputs that are derived from or corroborated by observable market data. Most bonds are classified within Level 2. Also, included in the Level 2 category are certain separate account assets and liabilities and derivative assets and liabilities.

·

Level 3 - Fair value measurements using significant nonmarket observable inputs. These include valuations for assets and liabilities that are derived using data, some or all of which is not market observable data, including assumptions about risk. Level 3 securities include less liquid securities such as securities that have little or no price transparency.

Determination of Fair Value

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction (not a forced liquidation or distress sale) between market participants at the measurement date, that is, an exit value.

When available, quoted market prices are used to determine fair value. If quoted market prices are not available, fair value is typically based upon alternative valuation techniques such as discounted cash flows, matrix pricing, consensus pricing services and other techniques. Broker quotes are generally used when external public vendor prices are not available.

The Company has a process in place that includes a review of price movements relative to the market, a comparison of prices between vendors, and a comparison to internal matrix pricing which uses predominately external observable data. Judgement is applied in adjusting external observable data for items including liquidity and credit factors.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

Bonds

Refer to the previous page for the determination of fair value of bonds. Generally, impaired bonds with a NAIC designation rating of 6 whose cost is greater than its fair value are reported at fair value and are classified within Level 3.

Preferred Stocks

Preferred stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Preferred stocks not traded in active markets are classified within Level 3.

Common Stocks

Common stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Common stocks not traded in active markets are classified within Level 3.

31

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Derivatives

The fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC derivatives. The pricing models used are based on market standard valuation methodologies, and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, currency exchange rates, financial indices, credit spreads, default risk (including the counterparties to the contract), and volatility. The Company's derivatives are generally classified within Level 2 given the significant inputs to the pricing models for most OTC derivatives are observable or can be corroborated by observable market data. Inputs that are observable generally include interest rates, foreign currency exchange rates, and interest rate curves; however, certain OTC derivatives may rely on inputs that are significant to the fair value, but are unobservable in the market or cannot be derived principally from or corroborated by observable market data and would be classified within Level 3. Inputs that are unobservable generally include broker quotes, volatilities, and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation.

Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all OTC derivatives after taking into account the effects of netting agreements and collateral arrangements.

Separate Account Assets and Liabilities

For separate accounts structured as a unitized fund, the fair value of the separate account assets is based on the fair value of the underlying funds owned by the separate account. Assets owned by the Company's separate accounts consist of investments in mutual funds with values that are based upon quoted market prices or reported net asset values ('NAV'). Open-ended mutual fund investments that are traded in an active market and have a publicly available price are included in Level 1. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose interest in the separate account assets is recorded by the Company as separate account liabilities. Separate account liabilities are set equal to the fair value of separate account assets.

The fair value of fund investments is based upon quoted market prices or reported net asset value ('NAV'). Fund investments that are traded in an active market and have a NAV that the Company can access at the measurement date are classified within Level 1. Level 2 assets consist primarily of bonds which are valued using matrix pricing with independent pricing data.

32

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The following table presents the Company's assets and liabilities that are measured and reported at fair value in the Balance Sheets after initial recognition by fair value hierarchy level:

		December 31, 2020
		Carrying Value			Total Fair Value			Level 1			Level 2			Level 3			Net Asset Value (NAV)
(in millions)
Assets:
Bond with NAIC 6 rating:
Industrial and misc		$	-			$	-			$	-			$	-			$	-			$	-
Loan-backed and structured securities			-				-				-				-				-				-
Total bonds with NAIC 6 rating			-				-				-				-				-				-
Preferred stocks:
Industrial and misc			-				-				-				-				-				-
Total preferred stocks			-				-				-				-				-				-
Common stocks:
Industrial and misc			104				104				95				-				9				-
Total common stocks			104				104				95				-				9				-
Derivatives:
Interest rate swaps			1,475				1,475				-				1,475				-				-
Interest rate treasury locks			-				-				-				-				-				-
Interest rate options			-				-				-				-				-				-
Interest rate futures			-				-				-				-				-				-
Foreign currency swaps			-				-				-				-				-				-
Foreign currency forwards			-				-				-				-				-				-
Foreign currency futures			-				-				-				-				-				-
Equity total return swaps			-				-				-				-				-				-
Equity index options			2				2				-				2				-				-
Equity index futures			-				-				-				-				-				-
Credit default swaps			-				-				-				-				-				-
Total derivatives			1,477				1,477				-				1,477				-				-
Assets held in separate accounts			8,903				8,903				8,903				-				-				-
Total assets		$	10,484			$	10,484			$	8,998			$	1,477			$	9			$	-
Liabilities:
Derivatives:
Interest rate swaps		$	967			$	967			$	-			$	967			$	-			$	-
Interest rate treasury locks			-				-				-				-				-				-
Interest rate options			-				-				-				-				-				-
Interest rate futures			-				-				-				-				-				-
Foreign currency swaps			-				-				-				-				-				-
Foreign currency forwards			-				-				-				-				-				-
Foreign currency futures			-				-				-				-				-				-
Equity total return swaps			-				-				-				-				-				-
Equity index options			-				-				-				-				-				-
Equity index futures			-				-				-				-				-				-
Credit default swaps			-				-				-				-				-				-
Total derivatives			967				967				-				967				-				-
Liabilities held in separate accounts			8,903				8,903				8,903				-				-				-
Total liabilities		$	9,870			$	9,870			$	8,903			$	967			$	-			$	-

33

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

		December 31, 2019
		Carrying Value			Total Fair Value			Level 1			Level 2			Level 3			Net Asset Value (NAV)
(in millions)
Assets:
Bond with NAIC 6 rating:
Industrial and misc		$	-			$	-			$	-			$	-			$	-			$	-
Loan-backed and structured securities			-				-				-				-				-				-
Total bonds with NAIC 6 rating			-				-				-				-				-				-
Preferred stocks:
Industrial and misc			-				-				-				-				-				-
Total preferred stocks			-				-				-				-				-				-
Common stocks:
Industrial and misc			125				125				114				-				11				-
Total common stocks			125				125				114				-				11				-
Derivatives:
Interest rate swaps			960				960				-				960				-				-
Interest rate treasury locks			-				-				-				-				-				-
Interest rate options			-				-				-				-				-				-
Interest rate futures			-				-				-				-				-				-
Foreign currency swaps			-				-				-				-				-				-
Foreign currency forwards			-				-				-				-				-				-
Foreign currency futures			-				-				-				-				-				-
Equity total return swaps			-				-				-				-				-				-
Equity index options			3				3				-				3				-				-
Equity index futures			-				-				-				-				-				-
Credit default swaps			-				-				-				-				-				-
Total derivatives			963				963				-				963				-				-
Assets held in separate accounts			8,254				8,254				8,254				-				-				-
Total assets		$	9,342			$	9,342			$	8,368			$	963			$	11			$	-
Liabilities:
Derivatives:
Interest rate swaps		$	596			$	596			$	-			$	596			$	-			$	-
Interest rate treasury locks			-				-				-				-				-				-
Interest rate options			-				-				-				-				-				-
Interest rate futures			-				-				-				-				-				-
Foreign currency swaps			-				-				-				-				-				-
Foreign currency forwards			-				-				-				-				-				-
Foreign currency futures			-				-				-				-				-				-
Equity total return swaps			-				-				-				-				-				-
Equity index options			-				-				-				-				-				-
Equity index futures			-				-				-				-				-				-
Credit default swaps			-				-				-				-				-				-
Total derivatives			596				596				-				596				-				-
Liabilities held in separate accounts			8,254				8,254				8,254				-				-				-
Total liabilities		$	8,850			$	8,850			$	8,254			$	596			$	-			$	-

34

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Fair Value of Financial Instruments Not Reported at Fair Value in the Balance Sheet

The table below presents the carrying amounts and fair value by fair value hierarchy level for certain assets and liabilities that are not reported at fair value in the Balance Sheets:

		December 31, 2020
		Carrying Value			Total Fair Value			Level 1			Level 2			Level 3
(in millions)
Assets:
Bonds (1)		$	5,451			$	6,055			$	-			$	5,834			$	221
Preferred stocks			13				13				-				-				13
Mortgage loans on real estate			692				790				-				-				790
Cash, cash equivalents and short term investments			7				7				7				-				-
Policy loans			128				128				-				128				-
Derivatives in effective hedge accounting relationships			3				18				-				18				-
Total assets		$	6,294			$	7,011			$	7			$	5,980			$	1,024
Liabilities:
Consumer notes		$	-			$	-			$	-			$	-			$	-
Borrowed money			-				-				-				-				-
Policy reserves			72				70				-				-				70
Policyholders' and beneficiaries' funds			124				129				-				129				-
Derivatives in effective hedge accounting relationships			-				26				-				26				-
Total liabilities		$	196			$	225			$	-			$	155			$	70
		December 31, 2019
		Carrying Value			Total Fair Value			Level 1			Level 2			Level 3
(in millions)
Assets:
Bonds (1)		$	4,787			$	5,185			$	-			$	5,005			$	180
Preferred stocks			8				11				-				-				11
Mortgage loans on real estate			617				681				-				-				681
Cash, cash equivalents and short term investments			13				13				11				2				-
Policy loans			122				122				-				122				-
Derivatives in effective hedge accounting relationships			4				20				-				20				-
Total assets		$	5,551			$	6,032			$	11			$	5,149			$	872
Liabilities:
Consumer notes		$	-			$	-			$	-			$	-			$	-
Borrowed money			-				-				-				-				-
Policy reserves			75				71				-				-				71
Policyholders' and beneficiaries' funds			125				130				-				130				-
Derivatives in effective hedge accounting relationships			-				9				-				9				-
Total liabilities		$	200			$	210			$	-			$	139			$	71

(1)

Bonds are carried at amortized cost unless they have NAIC designation rating of 6.

35

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Level 3 Financial Instruments

The changes in Level 3 financial instruments measured and reported at fair value for the years ended December 31, 2020, 2019 and 2018, are summarized as follows:

					Net realized/unrealized gains (losses) included in:																		Transfers
		Balance at January 1, 2020			Net income (1)			Surplus			Amounts credited to separate account liabilities (2)			Purchases			Issuances			Sales			Settlements			Into Level 3 (3)			Out of Level 3 (3)			Balance at December 31, 2020
(in millions)
Bonds with NAIC 6 rating:
Impaired corporate bonds		$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-
Impaired mortgage-backed and asset-backed securities			-				-				-				-				-				-				-				-				-				-				-
Total bonds with NAIC 6 rating			-				-				-				-				-				-				-				-				-				-				-
Preferred stocks:
Industrial and misc			-				-				-				-				-				-				-				-				-				-				-
Total preferred stocks			-				-				-				-				-				-				-				-				-				-				-
Common stocks:
Industrial and misc			11				5				(1	)			-				-				-				(6	)			-				-				-				9
Total common stocks			11				5				(1	)			-				-				-				(6	)			-				-				-				9
Net derivatives			-				-				-				-				-				-				-				-				-				-				-
Separate account assets/liabilities			-				-				-				-				-				-				-				-				-				-				-
Total		$	11			$	5			$		(1)		$	-			$	-			$	-			$	(6	)		$	-			$	-			$	-			$	9

36

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

					Net realized/unrealized gains (losses) included in:																		Transfers
		Balance at January 1, 2019			Net income (1)			Surplus			Amounts credited to separate account liabilities (2)			Purchases			Issuances			Sales			Settlements			Into Level 3 (3)			Out of Level 3 (3)			Balance at December 31, 2019
(in millions)
Bonds with NAIC 6 rating:
Impaired corporate bonds		$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-
Impaired mortgage-backed and asset-backed securities			-				-				-				-				-				-				-				-				-				-				-
Total bonds with NAIC 6 rating			-				-				-				-				-				-				-				-				-				-				-
Preferred stocks:
Industrial and misc			-				-				-				-				-				-				-				-				-				-				-
Total preferred stocks			-				-				-				-				-				-				-				-				-				-				-
Common stocks:
Industrial and misc			33				4				(8	)			-				-				-				(18	)			-				-				-				11
Total common stocks			33				4				(8	)			-				-				-				(18	)			-				-				-				11
Net derivatives			-				-				-				-				-				-				-				-				-				-				-
Separate account assets/liabilities			-				-				-				-				-				-				-				-				-				-				-
Total		$	33			$	4			$		(8)		$	-			$	-			$	-			$	(18	)		$	-			$	-			$	-			$	11

37

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

					Net realized/unrealized gains (losses) included in:																		Transfers
		Balance at January 1, 2018			Net income (1)			Surplus			Amounts credited to separate account liabilities (2)			Purchases			Issuances			Sales			Settlements			Into Level 3 (3)			Out of Level 3 (3)			Balance at December 31, 2018
(in millions)
Bonds with NAIC 6 rating:
Impaired corporate bonds		$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	-
Impaired mortgage-backed and asset-backed securities			-				-				-				-				-				-				-				-				-				-				-
Total bonds with NAIC 6 rating			-				-				-				-				-				-				-				-				-				-				-
Preferred stocks:
Industrial and misc			-				-				-				-				-				-				-				-				-				-				-
Total preferred stocks			-				-				-				-				-				-				-				-				-				-				-
Common stocks:
Industrial and misc			32				-				1				-				-				-				-				-				-				-				33
Total common stocks			32				-				1				-				-				-				-				-				-				-				33
Net derivatives			-				-				-				-				-				-				-				-				-				-				-
Separate account assets/liabilities			-				-				-				-				-				-				-				-				-				-				-
Total		$	32			$	-			$	1			$	-			$	-			$	-			$	-			$	-			$	-			$	-			$	33

(1)

This amount is included in net realized capital gains (losses) on the Statements of Operations.

(2)

Changes in the fair value of separate account assets are credited directly to separate account liabilities in accordance with NAIC SAP and are not reflected in income.

(3)

For financial instruments that are transferred into and/or out of Level 3, the Company uses the fair value of the instruments at the beginning of the period.

38

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The transfers into Level 3 primarily result from securities that were impaired during the year or securities where a lack of observable market data (versus the previous year) resulted in reclassifying instruments into Level 3. The transfers out of Level 3 primarily result from observable market data becoming available for that instrument, thus eliminating the need to extrapolate market data beyond observable points. Additionally, securities carried at fair value at the beginning of the period but carried at amortized cost at the end of the period due to rating change or change in fair value relative to amortized cost, are included in transfers out of Level 3. Conversely, any securities carried at amortized cost at the beginning of the period and carried at fair value at the end of the year due to SVO rating change or change in fair value relative to amortized cost, are included into transfers into Level 3.

8. Reinsurance

Certain premiums and benefits are assumed from or ceded to affiliate and other insurance companies under various reinsurance agreements. The Company entered into these reinsurance agreements to shift underlying risk on certain of its products, and to improve cash flow and statutory capital. The ceded reinsurance agreements provide the Company with increased capacity to write larger risks and maintain its exposure to loss within its capital resources.

Total reinsurance amounts included in the Company's accompanying statutory-basis financial statements were as follows:

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums earned
Direct		$	1,034			$	1,113			$	1,078
Assumed			163				186				196
Ceded			(235	)			(783	)			(222	)
Net		$	962			$	516			$	1,052
Benefits to policyholders ceded		$	(553	)		$	(443	)		$	(427	)

Reserve amounts ceded to reinsurers not authorized in the State of New York are mostly covered by funds withheld assets, letters of credit or trust agreements. Amounts payable or recoverable for reinsurance on policy and contract liabilities are not subject to periodic or maximum limits. At December 31, 2020, any material recoveries were collateralized or settled by the assuming company.

Neither the Company nor any of its related parties control, directly or indirectly, any external reinsurers with whom the Company conducts business. No policies issued by the Company have been reinsured with a foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company does not have any reinsurance agreements in effect under which the reinsurer may unilaterally cancel the agreement. At December 31, 2020, there were no reinsurance agreements in effect such that the amount of losses paid or accrued through the statement date may result in a payment to the reinsurer of amounts which, in aggregate and allowing for offset of mutual credits from other reinsurance agreements with the same reinsurer, exceed the total direct premium collected under the reinsured policies.

As of December 31, 2020, if all reinsurance agreements were cancelled the estimated aggregate reduction in unassigned surplus is $621 million.

The Company has not entered into any reinsurance transactions within the scope of Actuarial Guideline 48, the NAIC Term Life and Universal Life with Secondary Guarantees (XXX/AXXX) Credit for Reinsurance Model Regulation.

39

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The following tables and commentary disclose the reinsurance treaty transactions considered material to the Company.

Non-Affiliated Reinsurance

The table and commentary below consist of the impact of the New York Life ('NYL') Agreements:

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums ceded		$	(62	)		$	(66	)		$	(71	)
Premiums assumed			25				26				28
Benefits ceded			(157	)			(144	)			(166	)
Benefits assumed			63				58				66
Other reinsurance receivable (payable)			-				(4	)			(5	)
Funds held by or deposited with reinsured companies			806				837				859

Effective July 1, 2015, the Company entered into coinsurance reinsurance agreements with NYL to cede 100% quota share ('QS') of the Company's John Hancock Life Insurance ('JHLICO') Closed Block policies ('NYL 100% Coinsurance'). In addition, NYL agreed to retrocede 40% QS of the same policy risks back to the Company under a coinsurance funds withheld ('FWH') agreement ('NYL 40% FWH Retrocession'). Collectively, these agreements are known as the NYL Agreements. The NYL 100% Coinsurance keeps the assets supporting the JHLICO Closed Block together in NYL, and the NYL 40% FWH Retrocession adjusts the net reinsurance to NYL to 60% of the JHLICO Closed Block policies at risk.

The table and commentary below consist of the impact of the Reinsurance Group of America ('RGA') Agreement:

		Year ended December 31,
		2020			2019
(in millions)
Premiums ceded, net		$	-			$	(99	)
Benefits ceded, net			(10	)			(11	)
Other reinsurance receivable			1				1
Other amounts payable on reinsurance			-				-

Effective January 1, 2019, the Company entered into a coinsurance agreement with RGA to cede 90% quota share ('QS') of a significant block of individual pay-out annuities. The transaction was structured such that the Company transferred the policy liabilities of $92 million and related invested assets of $98 million. The Company recognized a pre-tax gain of $3 million net of realized capital gains, including a ceding commission received of $1 million, and an increase of $3 million to statutory surplus. Under the terms of the agreement, the Company will maintain responsibility for servicing the policies. The transaction closed on February 7, 2019.

40

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The table and commentary below consist of the impact of the Jackson National Life Insurance Company ('Jackson') Agreement:

		Year ended December 31,
		2020			2019
(in millions)
Premiums ceded, net		$	-			$	(444	)
Benefits ceded, net			(34	)			(35	)
Funds held by or deposited with reinsured companies			-				-
Other reinsurance receivable			4				3
Other amounts payable on reinsurance			-				-

Effective January 1, 2019, the Company entered into a coinsurance agreement with Jackson, a wholly-owned subsidiary of Prudential plc, to cede 90% QS of a block of legacy group pay-out annuities. The transaction was structured such that the Company transferred the policy liabilities of $352 million and related invested assets of $437 million. The Company incurred a pre-tax loss of $80 million net of realized capital gains, including a ceding commission paid of $26 million, and a decrease of $60 million to statutory surplus. Under the terms of the agreement, the Company will maintain responsibility for servicing the policies. The transaction closed on March 15, 2019.

The table and commentary below consist of the impact of the Global Atlantic Financial Group ('GAFG') Agreement:

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums ceded, net		$	(2	)		$	(1	)		$	(1	)
Benefits ceded, net			(79	)			(100	)			(112	)
Other reinsurance receivable			7				16				21
Other amounts payable on reinsurance			-				-				-

Effective July 1, 2012, the Company entered into a coinsurance agreement with GAFG, formerly named Commonwealth Annuity ('CWA'), to cede its fixed deferred annuities at 90% quota share ('QS'). The transaction was structured such that the Company transferred the actuarial liabilities and related invested assets. Under the terms of the agreement, the Company will maintain responsibility for servicing the policies.

At the beginning of 2020, the Company had a number of reinsurance agreements with Scottish Re (U.S.), Inc. ('SRUS'). On March 6, 2019, SRUS was declared impaired and placed into rehabilitation by the Delaware Chancery Court. The Company reached a settlement agreement with the Receiver of SRUS, which was approved by the Delaware Chancery Court on February 28, 2020. Under the terms of the settlement, the yearly renewable term reinsurance agreements between the Company and SRUS were terminated effective as of January 1, 2020; certain term coinsurance agreements were novated to Hannover Life Reassurance Company of America ('Hannover Life') effective January 1, 2019; and the arbitration between the Company and SRUS was dismissed with prejudice. The Company is expected to receive approximately $2 million from Hannover Life as settlement for the 2020 net claims recoverable balance. As of December 31, 2020, the Company has a provision against the net reinsurance receivable not novated to Hannover Life. As of December 31, 2020, SRUS is still listed as an accredited reinsurer with the State of New York Department of Financial Services. The Company recorded a reserve credit of $8 million and $22 million as of December 31, 2020 and 2019 respectively related to the various agreements with SRUS.

41

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Affiliated Reinsurance

The table and commentary below consist of the impact of the reinsurance agreements with its parent, JHUSA:

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums assumed, net		$	138			$	159			$	167
Benefits assumed, net			439				396				408
Other reinsurance receivable			6				3				5
Other amounts payable on reinsurance			59				42				39
Funds withheld from unauthorized reinsurers			-				-				-
Treaty settlement received (paid)			(171	)			(207	)			(208	)

On January 1, 2010, the assets supporting the policyholders who reside in the state of New York ('NY business') were transferred from JHUSA to the Company. The transfer included participating traditional life insurance, universal life insurance, fixed deferred and immediate annuities, participating pension contracts where assets were held in separate accounts, and variable annuities. The NY business was transferred using assumption reinsurance, modified coinsurance and coinsurance with cut-through provisions.

The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, JHRECO:

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums ceded		$	-			$	(7	)		$	-
Benefits ceded			(28	)			(6	)			(2	)
Other reinsurance receivable (payable)			19				-				-
Funds withheld from unauthorized reinsurers			-				5				2
Treaty Settlement received (paid)			23				2				-

The Company reinsures a portion of the risk related to certain life policies with JHRECO.

The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, Manulife Reinsurance Limited ('MRL'):

		Years ended December 31,
		2020			2019			2018
(in millions)
Premiums ceded		$	4			$	2			$	(1	)
Benefits ceded			(19	)			(17	)			(9	)
Other reinsurance receivable			-				-				-
Other amounts payable on reinsurance			1				1				1
Funds withheld from unauthorized reinsurers			379				367				359
Treaty Settlement received (paid)			(3	)			(3	)			(3	)

42

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Effective July 1, 2005, the Company entered into a reinsurance agreement with MRL to reinsure 90% of all risks not already reinsured to third parties on selected single and joint survivorship guaranteed universal life contracts. The agreement is written on a coinsurance FWH basis.

In 2020 and 2019, the Company did not commute any ceded reinsurance.

43

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

9. Federal Income Taxes

The components of the net deferred tax asset/(liability) are as follows:

44

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The Company has not recorded a valuation allowance with respect to the realizability of its deferred tax assets. In assessing the need for a valuation allowance, management considered the future reversal of taxable temporary differences, future taxable income exclusive of reversing temporary differences, taxable income in the carry back period, as well as tax planning strategies. Tax planning strategies were considered to the extent they were both prudent and feasible and if implemented, would result in the realization of deferred tax assets. Based on management's assessment of all available information, management believes that it is more likely than not the Company will realize the full benefit of its deferred tax assets.

The amount of adjusted gross deferred tax assets admitted under each component and the resulting increase in deferred tax assets by character are as follows:

		December 31, 2020
		(1)		(2)			(3)
							(Col 1 + 2)
		Ordinary		Capital			Total
(in millions)
2. Admission calculation components SSAP No. 101
(a) Federal income taxes paid in prior years recoverable through loss carrybacks.		$	-			$	1			$	1
(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.
(The lesser of 2(b)1 and 2(b)2 below)			106				-				106
1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.			106				-				106
2. Adjusted gross deferred tax assets allowed per limitation threshold.			166				-				166
(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.			159				-				159
(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))		$	265			$	1			$	266

45

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

		December 31, 2019
		(4)		(5)			(6)
							(Col 4 + 5)
		Ordinary		Capital			Total
(in millions)
2. Admission calculation components SSAP No. 101
(a) Federal income taxes paid in prior years recoverable through loss carrybacks.		$	-			$	-			$	-
(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.
(The lesser of 2(b)1 and 2(b)2 below)			79				-				79
1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.			79				-				79
2. Adjusted gross deferred tax assets allowed per limitation threshold.			202				-				202
(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.			141				-				141
(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))		$	220			$	-			$	220
		Change
		(7)		(8)			(9)
		(Col 1 - 4)		(Col 2 - 5)			(Col 7 + 8)
		Ordinary		Capital			Total
(in millions)
2. Admission calculation components SSAP No. 101
(a) Federal income taxes paid in prior years recoverable through loss carrybacks.		$	-			$	1			$	1
(b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation.
(The lesser of 2(b)1 and 2(b)2 below)			27				-				27
1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date.			27				-				27
2. Adjusted gross deferred tax assets allowed per limitation threshold.			(36	)			-				(36	)
(c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities.			18				-				18
(d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c))		$	45			$	1			$	46

46

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

		2020			2019
(in millions)
(a)  Ratio percentage used to determine recovery period and threshold limitation amount			920	%		1055%
(b)  Amount of adjusted capital and surplus used to determine recovery period and threshold limitation in 2(b)2 above		$	1,106			$ 1,345

Impact of tax planning strategies is as follows:

		December 31, 2020
		(1)		(2)
		Ordinary		Capital
(in millions)
(a)  Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.
1. Adjusted Gross DTAs Amount From Note 9A1(c)		$	325			$	1
2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0	%
3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)		$	265			$	1
4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0	%
		December 31, 2019
		(3)		(4)
		Ordinary		Capital
(in millions)
(a)  Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.
1. Adjusted Gross DTAs Amount From Note 9A1(c)		$	240			$	-
2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0	%
3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)		$	220			$	-
4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0	%

47

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

		Change
		(5)		(6)
		(Col 1 - 3)		(Col 2 - 4)
		Ordinary		Capital
(in millions)
(a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage.
1. Adjusted Gross DTAs Amount From Note 9A1(c)		$	85			$	1
2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0%
3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e)		$	45			$	1
4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies			0	%			0%

The Company's tax planning strategies do not include the use of reinsurance.

There are no unrecognized deferred tax liabilities for amounts described in ASC 740-10-25-3.

Current income taxes incurred consist of the following major components:

		Years Ended December 31,
		(1)		(2)			(3)
							(Col 1 - 2)
		2020		2019			Change
(in millions)
1. Current income tax
(a)  Federal		$	(15	)		$	(41	)		$	26
(b)  Foreign			-				-				-
(c)  Subtotal			(15	)			(41	)			26
(d)  Federal income tax on net capital gains			123				34				89
(e)  Utilization of capital loss carryforwards			-				-				-
(f)  Other			-				-				-
(g)  Federal and foreign income taxes incurred		$	108			$	(7	)		$	115

48

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows:

		December 31,
		(1)			(2)			(3)
								(Col 1 - 2)
		2020			2019			Change
(in millions)
2. Deferred tax assets:
(a) Ordinary:
(1) Discounting of unpaid losses		$	-			$	-			$	-
(2) Unearned premium reserve			-				-				-
(3) Policyholder reserves			285				206				79
(4) Investments			4				4				-
(5) Deferred acquisition costs			27				22				5
(6) Policyholder dividends accrual			2				2				-
(7) Fixed assets			-				-				-
(8) Compensation and benefits accrual			-				-				-
(9) Pension accrual			-				-				-
(10) Receivables - nonadmitted			-				-				-
(11) Net operating loss carryforward			-				-				-
(12) Tax credit carry-forward			-				-				-
(13) Other (including items <5% of total ordinary tax assets)			7				6				1
(99) Subtotal		$	325			$	240			$	85
(b) Statutory valuation allowance adjustment			-				-				-
(c) Nonadmitted			60				20				40
(d) Admitted ordinary deferred tax assets (2(a)(99) - 2(b) - 2(c))		$	265			$	220			$	45
(e) Capital:
(1) Investments		$	1			$	-			$	1
(2) Net capital loss carryforward			-				-				-
(3) Real estate			-				-				-
(4) Other (including items <5% of total capital tax assets)			-				-				-
(99) Subtotal		$	1			$	-			$	1
(f) Statutory valuation allowance adjustment			-				-				-
(g) Nonadmitted			-				-				-
(h) Admitted capital deferred tax assets (2(e)(99) - 2(f) - 2(g))		$	1			$	-			$	1
(i) Admitted deferred tax assets (2(d)+2(h))		$	266			$	220			$	46
3. Deferred tax liabilities:
(a) Ordinary:
(1) Investments		$	128			$	108			$	20
(2) Fixed assets			-				-				-
(3) Deferred and uncollected premium			1				1				-
(4) Policyholder reserves			10				12				(2	)
(5) Other (including items <5% of total ordinary tax liabilities)			1				3				(2	)
(99) Subtotal		$	140			$	124			$	16
(b) Capital:
(1) Investments		$	19			$	17			$	2
(2) Real estate			-				-				-
(3) Other (including items <5% of total capital tax liabilities)			-				-				-
(99) Subtotal		$	19			$	17			$	2
(c) Deferred tax liabilities (3(a)(99) + 3(b)(99))		$	159			$	141			$	18
4. Net deferred tax assets/liabilities (2(i) - 3(c))		$	107			$	79			$	28

49

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

The change in net deferred income taxes is comprised of the following:

		December 31,
		2020			2019		Change
(in millions)
Total deferred tax assets		$	326			$	240			$	86
Total deferred tax liabilities			159				141				18
Net deferred tax assets (liabilities)		$	167			$	99			$	68
Tax effect of unrealized gains and losses					(19	)
Tax effect of unrealized foreign exchange gains (losses)					-
Other					-
Change in net deferred income taxes				$	87

The provision for federal and foreign income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate of 21% to income before income tax (including realized capital gains). The significant items causing this difference are as follows:

		Years Ended December 31,
		2020			2019		2018
(in millions)
Ordinary provisions computed at statutory rate		$	(75	)		$	(52	)		$	69
Net realized capital gains (losses) before IMR at statutory rate			117				16				3
Change in nonadmitted assets			-				-				-
Reinsurance			(2	)			(4	)			(5	)
Valuation allowance			-				-				-
Tax-exempt income			-				-				-
Nondeductible expenses			-				-				-
Foreign tax expense gross up			-				-				-
Amortization of IMR			(4	)			(11	)			(3	)
Tax recorded in surplus			(8	)			(2	)			(1	)
Dividend received deduction			(3	)			(4	)			(3	)
Investment in subsidiaries			(3	)			(2	)			(2	)
Prior year adjustment			(1	)			(2	)			-
Tax credits			(1	)			(1	)			(1	)
Change in tax reserve			-				1				1
Pension			-				-				-
Tax rate change			-				-				(16	)
Other			1				1				(1	)
Total		$	21			$	(60	)		$	41
Federal and foreign income taxes incurred		$	(15	)		$	(41	)		$	(36	)
Capital gains tax			123				34				7
Change in net deferred income taxes			(87	)			(53	)			70
Total statutory income tax expense (benefit)		$	21			$	(60	)		$	41

50

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

At December 31, 2020 the Company did not have any net operating losses, net capital losses, or credit carry forwards.

Federal income taxes incurred on capital gains available for recoupment in the event of future net capital losses were $121 million, $0 million and $6 million for 2020, 2019 and 2018, respectively.

The Company has no deposits under Section 6603 of the Internal Revenue Code.

The Company is included in the consolidated federal income tax return of JHFC with the following entities:

Essex Corporation		John Hancock Insurance Agency Inc.
Farmland Management Services, Inc.		John Hancock Leasing Corp.
Guide Financial, Inc.		John Hancock Life & Health Insurance Company
Hancock Farmland Services, Inc.		John Hancock Life Insurance Company (USA)
Hancock Forest Management Inc.		John Hancock Realty Advisors Inc.
Hancock Natural Resource Group Inc.		John Hancock Realty Mgt. Inc.
JH 575 Rengstorff LLC		John Hancock Signature Services Inc.
JH Hostetler LLC		John Hancock Natural Resource Corp.
JH Kearny Mesa 5 LLC		Manulife (Michigan) Reassurance Company
JH Kearny Mesa 7 LLC		Manulife Reinsurance (Bermuda) Limited
JH Kearny Mesa 9 LLC		Manulife Reinsurance Limited
JH Networking Insurance Agency Inc.		Manulife Service Corporation
JH Ott LLC		MCC Asset Management Inc.
JH Tulare 8 LLC		PT Timber Inc.
John Hancock Assignment Company		JH Signature Insurance Agency, Inc. (formerly Signator Insurance Agency Inc.)
John Hancock Financial Corporation		The Manufacturers Investment Corporation
John Hancock Financial Network Inc.
John Hancock Funding Company LLC

In accordance with the income tax sharing agreements in effect for the applicable tax years, the Company's income tax expense (benefit) is computed as if the Company filed separate federal income tax returns with tax benefits provided for operating losses and tax credits when utilized by the consolidated group. Intercompany settlements of income taxes are made through an increase or reduction to amounts due to or from affiliates. Such settlements occur on a periodic basis in accordance with the tax sharing agreements.

Taxes receivable from (payable to) JHUSA, are ($125) million and $0 million at December 31, 2020 and 2019, respectively, and are included in other assets or current federal income taxes payable on the Balance Sheets.

The Company files income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions. The Company is under continuous examination by the Internal Revenue Service ('IRS'). The IRS completed the audit of tax years 2014-2015 with the exception of one issue that is currently in appeals. The audit of tax years 2016-2018 is currently in process.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

		2020		2019
(in millions)
Balance at beginning of year		$	3			$	13
Additions based on tax positions related to the current year			-				-
Payments			-				-
Additions for tax positions of prior years			-				-
Reductions for tax positions of prior years			-				(10	)
Balance at end of year		$	3			$	3

51

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Included in the balances as of December 31, 2020 and 2019, are $3 million and $3 million, respectively, of unrecognized benefits that, if recognized, would affect the Company's effective tax rate. Included in the balances as of December 31, 2020 and 2019 are $0 million and $0 million, respectively, of tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.

The Company has no unrecognized tax benefits that will significantly increase or decrease in the next twelve months.

The Company recognizes interest accrued related to unrecognized tax benefits and penalties in income tax expense in the Statements of Operations. The Company recognized approximately $0 million, $0 million and $1 million of interest expense / (benefit) in each of the years ended December 31, 2020, 2019, and 2018, respectively. The Company had approximately $0 million and $7 million accrued for interest as of December 31, 2020 and 2019, respectively. The Company did not recognize any material penalties for the years ended December 31, 2020, 2019 and 2018.

The Company filed a refund claim with the IRS for the AMT credit carryforward balance that remained as of December 31, 2017. The Company is awaiting the refund and has recorded a current tax recoverable for the full amount of the refundable credit of $2 million.

On March 27, 2020, Congress signed into law the Coronavirus Aid, Relief, and Economic Security Act, ('CARES Act') in response to the economic fallout of the COVID-19 pandemic in the United States. The CARES Act provided a 5-year carryback for net operating losses arising in tax years 2018, 2019 and 2020 to provide relief to businesses. In 2020, the Company filed a claim with the IRS to carry back 2018 net operating losses to recoup taxes paid in 2017, in lieu of carrying forward to 2019. There was no material impact to the Company in 2020.

In 2018, the Company updated policy level tax reserves in accordance with the Tax Cuts and Jobs Act and reflected impacts of $24 million in its temporary differences for Actuarial Liabilities in both deferred tax assets and deferred tax liabilities. The transitional deferred tax asset is being amortized into taxable income over 8 years, in the amount of $3 million per year.

10. Capital and Surplus

There are no restrictions placed on the Company's unassigned surplus other than restrictions on dividend payments described below.

Under New York State insurance laws ('NYSIL'), no insurer without the prior approval of the Superintendent, may pay any shareholder dividend in the calendar year immediately following a calendar year for which the insurer's net gain from operations, after tax, not including realized capital gains, was negative. NYSIL also limits the aggregate amount of dividends a life insurer may pay in any calendar year out of positive earned surplus, to the greater of (i) 10% of its statutory policyholders' surplus as of the immediately preceding calendar year or (ii) the Company's statutory net gain from operations, after tax, not including realized capital gains and (losses) for the immediately preceding calendar year, not to exceed 30% of its statutory policyholders' surplus as of the immediately preceding calendar year.

In addition, NYSIL allows for a shareholder dividend even if the company does not have sufficient positive earned surplus, limited to the lesser of (i) 10% of its statutory policyholders' surplus as of the immediately preceding calendar year or (ii) the Company's statutory net gain from operations, after tax, not including realized capital gains and (losses) for the immediately preceding calendar year. The Company paid shareholder dividends of $0 million, $100 million, and $100 million to its parent, JHUSA, in 2020, 2019 and 2018, respectively.

Life/health insurance companies are subject to certain Risk-Based Capital ('RBC') requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life/health insurance company is to be determined based on the various risk factors related to it. As of December 31, 2020 and 2019, based on calculations pursuant to those requirements, the Company's total adjusted capital exceeds the company action level RBC.

52

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

11. Related Party Transactions

Service Agreements

The Company has formal service agreements with JHUSA whereby the Company will pay a fee for services received under the agreements which include legal, personnel, marketing, investment accounting, and certain other administrative services and are billed based on intercompany cost allocations or total average daily net assets. Costs incurred under the agreements were $55 million, $62 million, and $62 million at December 31, 2020, 2019 and 2018, respectively. As of December 31, 2020 and 2019, the Company had amounts payable of $11 million and $15 million, respectively.

The Company has an Administrative Service Agreement with JHVTA and John Hancock Investment Management LLC ('JHIM') (formerly John Hancock Advisers, LLC) pursuant to which the Company will provide certain administrative and related functional support services as required by JHVTA and JHIM in connection with variable contracts issued by the Company which provide for investment in selected portfolios of JHVTA and JHIM. For such services, JHVTA and JHIM will pay the Company a quarterly fee equal to a percentage of the average daily net assets of the funds attributable to the contracts issued by the Company. The amount earned under the agreement was $14 million, $15 million and $15 million for the years ended December 31, 2020, 2019 and 2018 respectively.

The Company has an Underwriting and Distribution Agreement with JHD pursuant to which JHD is appointed as the principal underwriter and exclusive distributor of the variable life and other products issued by the Company. For the years ended December 31, 2020, 2019 and 2018, the Company was billed by JHD for underwriting commissions of $48 million, $62 million, and $64 million, respectively. The Company had amounts payable for services provided of $3 million and $6 million at December 31, 2020 and 2019, respectively.

Management believes the allocation methods used are reasonable and appropriate in the circumstances; however, the Company's Balance Sheets and Statements of Operations may not necessarily be indicative of the financial condition that would have existed if the Company operated as an unaffiliated entity.

Other

During 2020, 2019 and 2018, respectively, the Company received dividends of $14 million, $15 million, and $19 million from JHVTA. These dividends are included in the Company's net investment income.

The Company did not own any shares of the stock of its parent, JHUSA, or its ultimate parent, MFC, at December 31, 2020 and 2019.

The Company is party to the Second Restated and Amended Liquidity Pool and Loan Facility Agreement effective January 1, 2010 with JHUSA. Pursuant to the agreement, participating affiliates are permitted to invest their excess cash in the liquidity pool and earn interest calculated at a rate that is reset daily to the one-month U.S. Dollar London Inter-Bank Bid Rate ('LIBID'), subject to an aggregate limit of $5 billion and an amount not to exceed 10% of the Company's admitted assets as shown in the last financial statement filed with the Insurance Division. As of December 31, 2020 and 2019, the Company had a receivable from JHUSA in the amount of $377 million and $520 million, respectively, which is included in amounts due from affiliates in the Balance Sheets.

The Company had receivables from JHVTA relating to distributions of $0 million and $1 million, which were included in investment income due and accrued at December 31, 2020 and 2019, respectively.

The Company did not recognize any impairment write-down for its investment in subsidiaries, controlled or affiliated companies for the years ended December 31, 2020, 2019 and 2018, respectively.

The Company also enters into reinsurance transactions with its affiliates. Refer to the Reinsurance Note for further details.

53

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

12. Commitments, Contingencies and Legal Proceedings

Commitments: The Company has extended commitments to purchase long-term bonds of $33 million, to purchase other invested assets of $127 million, and issue agricultural and commercial mortgages of $11 million at December 31, 2020. Approximately 40% of these commitments expire in 2021.

Contingencies: As of December 31, 2020, the Company does not have any material contingencies.

Legal Proceedings: The Company is regularly involved in litigation, both as a defendant and as a plaintiff. The litigation naming the Company as a defendant ordinarily involves its activities as a provider of insurance protection and wealth management products, and a taxpayer. In addition, the Insurance Department, the New York Attorney General, the Securities and Exchange Commission ('SEC'), the Financial Regulatory Authority, and other government and regulatory bodies regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company's compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers. An estimation of the range of potential outcomes in any given matter is often unavailable until such matters have developed and sufficient information emerges to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals and estimates of reasonably possible losses or ranges of loss based on such reviews.

In June 2018, a class action was initiated against the Company in the U.S. District Court for the Southern District of New York (the 'Southern District of NY') on behalf of owners of performance universal life policies first issued between 2003 and 2009 whose policies are subject to a cost of insurance ('COI') increase announced in 2018. This case has been consolidated with an almost identical related class action that was initiated in October 2018 against the Company in the Southern District of NY and was assigned to the same judge. Discovery has commenced. No hearings on substantive matters have been scheduled. It is too early to assess the range of potential outcomes for these lawsuits.

54

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

13. Annuity Actuarial Reserves

The Company's annuity actuarial reserves and deposit fund liabilities and related separate account liabilities that are subject to discretionary withdrawal (with adjustment), subject to discretionary withdrawal (without adjustment), and not subject to discretionary withdrawal provisions are summarized as follows:

		December 31, 2020
		General Account			Separate Account with Guarantees		Separate Account Nonguaranteed		Total		Percent of Total
(in millions)
Subject to discretionary withdrawal:
With fair value adjustment		$	38			$	-			$	-			$	38				0	%
At book value less current surrender charge of 5% or more			1				-				-				1				0	%
At fair value			-				-				8,527				8,527				77	%
Total with adjustment or at fair value			39				-				8,527				8,566				77	%
At book value without adjustment (minimal or no charge or adjustment)			1,169				-				-				1,169				11	%
Not subject to discretionary withdrawal			1,339				-				3				1,342				12	%
Total (gross)			2,547				-				8,530				11,077				100	%
Reinsurance ceded			1,288				-				-				1,288
Total (net)		$	1,259			$	-			$	8,530			$	9,789
Amount included in book value less current surrender charge above that will move to book value without adjustment in the year after the statement date		$	-			$	-			$	-			$	-
		December 31, 2019
		General Account				Separate Account with Guarantees				Separate Account Nonguaranteed				Total				Percent of Total
(in millions)
Subject to discretionary withdrawal:
With fair value adjustment		$	77			$	-			$	-			$	77				1	%
At book value less current surrender charge of 5% or more			1				-				-				1				0	%
At fair value			-				-				7,917				7,917				75	%
Total with adjustment or at fair value			78				-				7,917				7,995				76	%
At book value without adjustment (minimal or no charge or adjustment)			1,233				-				-				1,233				12	%
Not subject to discretionary withdrawal			1,332				-				3				1,335				12	%
Total (gross)			2,643				-				7,920				10,563				100	%
Reinsurance ceded			1,361				-				-				1,361
Total (net)		$	1,282			$	-			$	7,920			$	9,202
Amount included in book value less current surrender charge above that will move to book value without adjustment in the year after the statement date		$	1			$	-			$	-			$	1

55

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

14.	Life Actuarial Reserves

The Company's life actuarial reserves and related separate account liabilities that are subject to discretionary withdrawal and not subject to discretionary withdrawal provisions are summarized as follows:

		December 31, 2020
		Account Value			Cash Value			Reserve
A. General Account
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
a. Term Policies with Cash Value		$	-			$	-			$	-
b. Universal Life			111				110				119
c. Universal Life with Secondary Guarantees			1,487				1,317				3,095
d. Indexed Universal Life			27				22				29
e. Indexed Universal Life with Secondary Guarantees			79				71				68
f. Indexed Life			-				-				-
g. Other Permanent Cash Value Life Insurance			2,647				2,647				2,640
h. Variable Life			5				2				4
i. Variable Universal Life			121				118				131
j. Miscellaneous Reserves			-				-				1,397
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				422
b. Accidental Death Benefits			-				-				2
c. Disability - Active Lives			-				-				8
d. Disability - Disabled Lives			-				-				33
e. Miscellaneous Reserves			-				-				26
(3) Total (gross: direct + assumed)		$	4,477			$	4,287			$	7,974
(4) Reinsurance Ceded			1,876				1,837				2,966
(5) Total (net) (3) - (4)		$	2,601			$	2,450			$	5,008
B. Separate Account with Guarantees
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
h. Variable Life		$	-			$	-			$	-
i. Variable Universal Life			-				-				-
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				-
b. Accidental Death Benefits			-				-				-
c. Disability - Active Lives			-				-				-
d. Disability - Disabled Lives			-				-				-
e. Miscellaneous Reserves			-				-				-
(3) Total (gross: direct + assumed)		$	-			$	-			$	-
(4) Reinsurance Ceded			-				-				-
(5) Total (net) (3) - (4)		$	-			$	-			$	-
C. Separate Account Nonguaranteed
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
h. Variable Life		$	5			$	-			$	-
i. Variable Universal Life			385				366				353
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				-
b. Accidental Death Benefits			-				-				-
c. Disability - Active Lives			-				-				-
d. Disability - Disabled Lives			-				-				-
e. Miscellaneous Reserves			-				-				-
(3) Total (gross: direct + assumed)		$	390			$	366			$	353
(4) Reinsurance Ceded			-				-				-
(5) Total (net) (3) - (4)		$	390			$	366			$	353

56

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

		December 31, 2019
		Account Value			Cash Value			Reserve
A. General Account
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
a. Term Policies with Cash Value		$	-			$	-			$	-
b. Universal Life			355				353				362
c. Universal Life with Secondary Guarantees			1,188				1,015				2,780
d. Indexed Universal Life			33				25				34
e. Indexed Universal Life with Secondary Guarantees			51				46				47
f. Indexed Life			-				-				-
g. Other Permanent Cash Value Life Insurance			2,705				2,705				2,806
h. Variable Life			-				-				3
i. Variable Universal Life			137				183				155
j. Miscellaneous Reserves			-				-				857
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				414
b. Accidental Death Benefits			-				-				2
c. Disability - Active Lives			-				-				9
d. Disability - Disabled Lives			-				-				36
e. Miscellaneous Reserves			-				-				33
(3) Total (gross: direct + assumed)		$	4,469			$	4,327			$	7,538
(4) Reinsurance Ceded			1,939				1,935				3,049
(5) Total (net) (3) - (4)		$	2,530			$	2,392			$	4,489
B. Separate Account with Guarantees
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
h. Variable Life		$	-			$	-			$	-
i. Variable Universal Life			-				-				-
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				-
b. Accidental Death Benefits			-				-				-
c. Disability - Active Lives			-				-				-
d. Disability - Disabled Lives			-				-				-
e. Miscellaneous Reserves			-				-				-
(3) Total (gross: direct + assumed)		$	-			$	-			$	-
(4) Reinsurance Ceded			-				-				-
(5) Total (net) (3) - (4)		$	-			$	-			$	-
C. Separate Account Nonguaranteed
(1) Subject to discretionary withdrawal, surrender values, or policy loans:
h. Variable Life		$	-			$	-			$	-
i. Variable Universal Life			331				308				313
(2) Not subject to discretionary withdrawal or no cash values
a. Term Policies without Cash Value			-				-				-
b. Accidental Death Benefits			-				-				-
c. Disability - Active Lives			-				-				-
d. Disability - Disabled Lives			-				-				-
e. Miscellaneous Reserves			-				-				-
(3) Total (gross: direct + assumed)		$	331			$	308			$	313
(4) Reinsurance Ceded			-				-				-
(5) Total (net) (3) - (4)		$	331			$	308			$	313

57

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

15. Separate Accounts

Separate accounts held by the Company include individual and group variable annuity and variable life products that offer guaranteed and non-guaranteed returns. The net investment experience of the separate account is credited directly to the policyholder and can be positive or negative.

For guarantees of amounts in the event of death, the net amount at risk is defined as the excess of the initial sum insured over the current sum insured for fixed premium variable life insurance contracts, and, for other variable life insurance contracts, is equal to the sum insured when the account value is zero and the policy is still in force.

The deposits related to variable annuities generally provide a GMDB. For annuity products, this can take the form of either (a) return of no less than total deposits made to the contract less any partial withdrawals; (b) total deposits made to the contract less any partial withdrawals plus a minimum return; (c) the highest contract value on a specified anniversary date minus any withdrawals following the contract anniversary; or (d) a combination benefit of (b) and (c) above. The assets and liabilities of these accounts are carried at fair value. The GMDB reserve is held in the Company's general account policy reserves.

Contracts with guaranteed minimum income benefit ('GMIB') rider provides a guaranteed lifetime annuity which may be elected by the contract holder after a stipulated waiting period (ten years), and which may be larger than what the contract account balance could purchase at then-current annuity purchase rates.

Multiple variations of an optional GMWB rider have also been offered by the Company. The GMWB rider provides contract holders a guaranteed annual withdrawal amount over a specified time period or in some cases for as long as they live. In general, guaranteed annual withdrawal amounts are based on deposits and may be reduced if withdrawals exceed allowed amounts. Guaranteed amounts may also be increased as a result of 'step-up' provisions which increase the benefit base to higher account values at specified intervals. Guaranteed amounts may also be increased if withdrawals are deferred over a specified period. In addition, certain versions of the GMWB rider extend lifetime guarantees to spouses.

Unaffiliated reinsurance has been utilized to mitigate risk related to some of the guarantee benefit riders. Hedging has also been utilized to mitigate risk related to some of the GMWB riders.

For GMDB, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For GMIB, the net amount at risk is defined as the excess of the current annuitization income base over the current account value. For GMWB, the net amount at risk is defined as the current guaranteed withdrawal amount minus the current account value. For all the guarantees, the net amount at risk is floored at zero at the single contract level.

The deposits related to the variable life insurance contracts are invested in separate accounts and the Company guarantees a specified death benefit if certain specified premiums are paid by the policyholder, regardless of separate account performance.

All of the Company's separate account assets were legally insulated at December 31, 2020 and 2019. The assets legally insulated from the general account are attributed to the following products/transactions:

Product/Transaction
		December 31,
(in millions)		2020		2019
Group Annuity Contracts (401K)		$	6,026			$	5,405
Variable and Fixed Annuities			2,508				2,518
Life Insurance			369				331
Total		$	8,903			$	8,254

58

To compensate the general account for the risk taken, the separate account paid risk charges and amounts toward separate account guarantees as follows:

		Risk Charges Paid to General Account		Amounts toward Separate Account Guarantees
(in millions)
2020		$	12			$	4
2019		$	14			$	5
2018		$	15			$	3
2017		$	16			$	3
2016		$	17			$	4

The Company had the following variable annuities with guaranteed benefits:

		December 31,
		2020		2019
(in millions, except for ages)
Account value		$	2,554			$	2,564
Amount of reserve held			234				194
Net amount at risk - gross			192				215
Weighted average attained age			70				70

The following assumptions and methodology were used to determine the amounts above at December 31, 2020 and 2019:

·

Reg 213 is used in 2020 to determine the aggregate reserve for products falling under the scope. For 2019, assumptions used in the standard scenario are prescribed by regulations. For 2020, the liability is evaluated using a standard scenario; a stochastic reserve using industry prescribed assumptions (Standard Projection) and a stochastic reserve using Company specific assumptions. The Company holds the highest of the three values. Actuarial Guideline 43 ('AG 43') is used in the 2019 reserve calculation.

·

For 2020, the Company used the prescribed Economic Scenario Generator ('ESG') for Reg 213, so there are no calibration criteria requirement. The stochastically generated projection scenarios have met the scenario calibration criteria prescribed in AG 43 for 2019.

·

In 2020 and 2019, annuity mortality is based on the Ruark Variable Annuity Table, which is based on an industry study of variable annuity deaths. The table is further adjusted by factors varied by rider types (living benefit/GMDB only) and qualified and non-qualified business.

·

In 2020 and 2019, annuity base lapse rates vary by product, policy year, and rider type, where the lapse rates range from 0.5% to 40% for GMDB, GMIB and GMWB. These rates are dynamically reduced for guarantees that are in-the-money and rates are also dynamically increased for GMWBs that are out-of-the-money.

·

For variable annuities, the applicable swap curve at December 31 is used for discounting in each year.

59

Account balances of variable contracts with guarantees were invested in separate accounts with the following characteristics:

		December 31,
		2020		2019
(in millions)
Type of Fund
Equity		$	1,641			$	1,609
Balanced			768				781
Bonds			349				347
Money Market			13				21
Total		$	2,771			$	2,758

Information regarding the nonguaranteed separate accounts of the Company is as follows:

		December 31,
		2020		2019
(in millions)
Premiums, deposits and other considerations		$	735			$	782
Reserves for accounts with assets at:
Fair value			8,883				8,233
Amortized cost			-				-
Total		$	8,883			$	8,233
		December 31,
		2020		2019
(in millions)
Reserves for separate accounts by withdrawal characteristics:
Subject to discretionary withdrawal:
With fair value adjustment		$	-			$	-
At book value without fair value adjustments and with current surrender charge of 5% or more			90				100
At fair value			8,716				8,052
At book value without fair value adjustments and with current surrender charge of less than 5%			74				78
Subtotal			8,880				8,230
Not subject to discretionary withdrawal			3				3
Total		$	8,883			$	8,233

60

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK

NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS

Amounts transferred to and from separate accounts are as follows:

16. Employee Benefits

Retirement Plans: The Company participates in the John Hancock Pension Plan, a qualified defined benefit plan sponsored by MIC. The Company also participates in the John Hancock Non-Qualified Pension Plan, a non-qualified defined benefit plan for employees whose qualified cash balance benefit is restricted by the Internal Revenue Code. The non-qualified defined benefit plan was frozen except for grandfathered participants as of January 1, 2008, and the benefits accrued under this plan continue to be subject to the plan's provisions. The expense for these plans was charged to the Company and was not material for the years ended December 31, 2020, 2019 and 2018.

During 2018, the Company implemented its North American voluntary early retirement program. The program resulted in the voluntary separation of 229 employees in the U.S. by the end of 2019. A curtailment loss of $7 million resulting from the program was recorded by MIC in earnings during the 4th quarter of 2018. This loss represents the change in net defined benefit and retiree welfare liabilities due to employees separating sooner and with different post-retirement benefits than had previously been assumed. The Company will recognize its allocation of the curtailment loss in earnings as payments to participants are made.

401(k) Plan: The Company participates in The Investment-Incentive Plan for John Hancock Employees, a qualified defined contribution plan for its employees who meet certain eligibility requirements. The plan is sponsored by JHUSA. The expense for the defined contribution plan was charged to the Company and was not material for the years ended December 31, 2020, 2019 and 2018.

Other Postretirement Benefit Plan: The Company participates in the John Hancock Employee Welfare Plan ('the Welfare Plan'), a postretirement and postemployment medical and life insurance benefit plan for its retired employees and their spouses. The Welfare Plan is sponsored by MIC. The expense for other postretirement benefits was charged to the Company and was not material for the years ended December 31, 2020, 2019 and 2018.

17. Subsequent Events

The Company evaluated the recognition and disclosure of subsequent events for its December 31, 2020 financial statements through March 31, 2021, the date the financial statements were issued. The Company did not have any subsequent events requiring disclosure.

61

A u d i t e d F i n a n c i a l S t a t e m e n t s

John Hancock Life Insurance Company of New York Separate Account B
December 31, 2020

John Hancock Life Insurance Company of New York
Separate Account B

Audited Financial Statements

December 31, 2020

Contents
Report of Independent Registered Public Accounting Firm	3
Statements of Assets and Liabilities	6
Statements of Operations and Changes in Contract Owners' Equity	22
Notes to Financial Statements	54

Report of Independent Registered Public Accounting Firm

To the Board of Directors of John Hancock Life Insurance Company of New York and Contract Owners of
John Hancock Life Insurance Company of New York Separate Account B

Opinion on the Financial Statements

We have audited the accompanying statements of assets and liabilities of each of the subaccounts listed in the Appendix that comprise John Hancock Life Insurance Company of New York Separate Account B (the 'Separate Account') as of December 31, 2020, and the related statements of operations and changes in contract owners' equity for the two years in the period then ended, and the related notes (collectively referred to as the 'financial statements'). In our opinion, the financial statements present fairly, in all material respects, the financial position of each subaccount as of December 31, 2020 and the results of its operations and changes in contract owners' equity for each of the two years then ended, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on each of the subaccounts' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ('PCAOB') and are required to be independent with respect to the Separate Account in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2020 by correspondence with the fund companies or their transfer agents, as applicable. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

We have served as the auditor of the Separate Account since 1999.
Boston, Massachusetts
March 31, 2021

Appendix

Subaccounts comprising John Hancock Life

Insurance Company of New York Separate Account B

500 Index Fund Series NAV	Lifestyle Conservative Portfolio Series NAV
Active Bond Trust Series I	Lifestyle Growth Portfolio Series NAV
Active Bond Trust Series NAV	Lifestyle Moderate Portfolio Series NAV
American Asset Allocation Trust Series I	M Capital Appreciation
American Global Growth Trust Series I	M International Equity
American Growth Trust Series I	M Large Cap Growth
American Growth-Income Trust Series I	M Large Cap Value
American International Trust Series I	Managed Volatility Aggressive Portfolio Series I
Blue Chip Growth Trust Series I	Managed Volatility Aggressive Portfolio Series NAV
Blue Chip Growth Trust Series NAV	Managed Volatility Balanced Portfolio Series I
Capital Appreciation Trust Series I	Managed Volatility Balanced Portfolio Series NAV
Capital Appreciation Trust Series NAV	Managed Volatility Conservative Portfolio Series I
Capital Appreciation Value Trust Series NAV	Managed Volatility Conservative Portfolio Series NAV
Core Bond Trust Series I	Managed Volatility Growth Portfolio Series I
Core Bond Trust Series NAV	Managed Volatility Growth Portfolio Series NAV
Disciplined Value International Trust Series I	Managed Volatility Moderate Portfolio Series I
Disciplined Value International Trust Series NAV	Managed Volatility Moderate Portfolio Series NAV
Emerging Markets Value Trust Series I	Mid Cap Index Trust Series I
Emerging Markets Value Trust Series NAV	Mid Cap Index Trust Series NAV
Equity Income Trust Series I	Mid Cap Stock Trust Series I
Equity Income Trust Series NAV	Mid Cap Stock Trust Series NAV
Financial Industries Trust Series I	Mid Value Trust Series I
Financial Industries Trust Series NAV	Mid Value Trust Series NAV
Fundamental All Cap Core Trust Series I	Money Market Trust Series I
Fundamental All Cap Core Trust Series NAV	Money-Market Trust Series NAV
Fundamental Large Cap Value Trust Series I	Opportunistic Fixed Income Trust Series I
Fundamental Large Cap Value Trust Series NAV	Opportunistic Fixed Income Trust Series NAV
Global Trust Series I	PIMCO All Asset
Global Trust Series NAV	Real Estate Securities Trust Series I
Health Sciences Trust Series I	Real Estate Securities Trust Series NAV
Health Sciences Trust Series NAV	Science & Technology Trust Series I
High Yield Trust Series I	Science & Technology Trust Series NAV
High Yield Trust Series NAV	Select Bond Trust Series I
International Equity Index Series I	Select Bond Trust Series NAV
International Equity Index Series NAV	Short Term Government Income Trust Series I
International Small Company Trust Series I	Short Term Government Income Trust Series NAV
International Small Company Trust Series NAV	Small Cap Index Trust Series I
Investment Quality Bond Trust Series I	Small Cap Index Trust Series NAV
Investment Quality Bond Trust Series NAV	Small Cap Opportunities Trust Series I
Lifestyle Aggressive Portfolio Series NAV	Small Cap Opportunities Trust Series NAV
Lifestyle Balanced Portfolio Series NAV	Small Cap Stock Trust Series I

Appendix

Subaccounts comprising John Hancock Life
Insurance Company of New York Separate Account B

Small Cap Stock Trust Series NAV	Strategic Income Opportunities Trust Series NAV
Small Cap Value Trust Series I	Total Bond Market Series Trust NAV
Small Cap Value Trust Series NAV	Total Stock Market Index Trust Series I
Small Company Value Trust Series I	Total Stock Market Index Trust Series NAV
Small Company Value Trust Series NAV	Ultra Short Term Bond Trust Series I
Strategic Income Opportunities Trust Series I	Ultra Short Term Bond Trust Series NAV

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		500 Index Fund Series NAV			Active Bond Trust Series I			Active Bond Trust Series NAV			American Asset Allocation Trust Series I			American Global Growth Trust Series I			American Growth Trust Series I
Total Assets
Investments at fair value		$	36,399,489			$	473,598			$	2,012,009			$	8,048,783			$	983,902			$	6,851,998
Units outstanding			428,542				16,783				21,828				322,344				30,172				103,615
Unit value		$	84.94			$	28.22			$	92.18			$	24.97			$	32.61			$	66.13
Shares			845,124				45,803				194,585				656,507				49,818				293,951
Cost		$	25,491,792			$	445,964			$	1,901,813			$	8,487,030			$	791,206			$	5,496,185

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		American Growth- Income Trust Series I			American International Trust Series I			Blue Chip Growth Trust Series I			Blue Chip Growth Trust Series NAV			Capital Appreciation Trust Series I			Capital Appreciation Trust Series NAV
Total Assets
Investments at fair value		$	4,508,549			$	3,453,299			$	1,475,156			$	18,636,108			$	830,489			$	3,877,456
Units outstanding			107,362				116,627				22,820				56,023				10,825				51,315
Unit value		$	41.99			$	29.61			$	64.64			$	332.65			$	76.72			$	75.56
Shares			284,093				161,294				36,686				462,779				109,275				506,195
Cost		$	4,751,893			$	3,084,431			$	1,201,584			$	15,904,482			$	742,389			$	3,581,006

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Capital Appreciation Value Trust Series NAV			Core Bond Trust Series I			Core Bond Trust Series NAV			Disciplined Value International Trust Series I			Disciplined Value International Trust Series NAV			Emerging Markets Value Trust Series I
Total Assets
Investments at fair value		$	10,511,436			$	555,235			$	4,918,293			$	349,764			$	2,128,342			$	89,455
Units outstanding			311,486				21,997				241,884				12,224				115,007				5,042
Unit value		$	33.75			$	25.24			$	20.33			$	28.61			$	18.51			$	17.74
Shares			787,373				39,019				347,092				26,802				164,478				9,251
Cost		$	9,430,625			$	521,899			$	4,604,408			$	337,262			$	2,049,541			$	89,178

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Emerging Markets Value Trust Series NAV			Equity Income Trust Series I			Equity Income Trust Series NAV			Financial Industries Trust Series I			Financial Industries Trust Series NAV			Fundamental All Cap Core Trust Series I
Total Assets
Investments at fair value		$	1,604,151			$	751,556			$	5,512,275			$	150,302			$	1,026,410			$	3,213
Units outstanding			112,220				18,163				80,418				4,120				23,293				41
Unit value		$	14.29			$	41.38			$	68.55			$	36.48			$	44.07			$	78.37
Shares			166,061				54,500				402,356				11,752				80,503				107
Cost		$	1,521,555			$	817,368			$	6,051,516			$	153,640			$	1,027,789			$	2,585

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Fundamental All Cap Core Trust Series NAV			Fundamental Large Cap Value Trust Series I			Fundamental Large Cap Value Trust Series NAV			Global Trust Series I			Global Trust Series NAV			Health Sciences Trust Series I
Total Assets
Investments at fair value		$	1,291,275			$	931,220			$	3,373,771			$	89,418			$	1,309,395			$	347,534
Units outstanding			27,464				20,338				104,329				3,674				58,715				2,377
Unit value		$	47.02			$	45.79			$	32.34			$	24.34			$	22.30			$	146.21
Shares			42,546				37,100				134,360				4,280				62,741				11,185
Cost		$	957,880			$	690,084			$	2,461,468			$	84,449			$	1,218,856			$	273,821

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Health Sciences Trust Series NAV			High Yield Trust Series I			High Yield Trust Series NAV			International Equity Index Series I			International Equity Index Series NAV			International Small Company Trust Series I
Total Assets
Investments at fair value		$	4,550,225			$	322,375			$	3,637,003			$	238,291			$	6,814,782			$	29,308
Units outstanding			39,814				10,610				126,048				14,255				103,590				1,347
Unit value		$	114.29			$	30.38			$	28.85			$	16.72			$	65.79			$	21.76
Shares			143,631				61,172				702,124				12,189				348,582				1,990
Cost		$	3,848,147			$	322,603			$	3,701,268			$	199,053			$	5,754,698			$	25,947

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		International Small Company Trust Series NAV			Investment Quality Bond Trust Series I			Investment Quality Bond Trust Series NAV			Lifestyle Aggressive Portfolio Series NAV			Lifestyle Balanced Portfolio Series NAV			Lifestyle Conservative Portfolio Series NAV
Total Assets
Investments at fair value		$	1,689,634			$	180,796			$	630,792			$	1,925,732			$	3,976,684			$	214,413
Units outstanding			77,190				6,104				30,629				102,560				244,607				14,799
Unit value		$	21.89			$	29.62			$	20.59			$	18.78			$	16.26			$	14.49
Shares			114,629				14,856				52,003				119,167				242,777				14,869
Cost		$	1,469,451			$	168,220			$	590,835			$	1,780,334			$	3,600,602			$	199,114

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Lifestyle Growth Portfolio Series NAV			Lifestyle Moderate Portfolio Series NAV			M Capital Appreciation			M International Equity			M Large Cap Growth			M Large Cap Value
Total Assets
Investments at fair value		$	25,093,141			$	1,794,023			$	700,482			$	953,653			$	1,182,473			$	1,147,479
Units outstanding			1,437,043				114,542				4,697				23,280				9,662				37,123
Unit value		$	17.46			$	15.66			$	149.13			$	40.96			$	122.38			$	30.91
Shares			1,411,313				113,979				24,348				71,542				35,319				95,464
Cost		$	22,719,421			$	1,630,633			$	612,458			$	852,723			$	953,340			$	1,197,108

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Managed Volatility Aggressive Portfolio Series I			Managed Volatility Aggressive Portfolio Series NAV			Managed Volatility Balanced Portfolio Series I			Managed Volatility Balanced Portfolio Series NAV			Managed Volatility Conservative Portfolio Series I			Managed Volatility Conservative Portfolio Series NAV
Total Assets
Investments at fair value		$	681,755			$	17,987,869			$	969,445			$	45,778,016			$	80,839			$	8,152,114
Units outstanding			26,886				774,376				31,083				1,946,054				2,708				383,041
Unit value		$	25.36			$	23.23			$	31.19			$	23.52			$	29.85			$	21.28
Shares			68,795				1,815,123				83,143				3,915,998				6,957				699,752
Cost		$	679,218			$	18,536,420			$	1,010,445			$	49,212,594			$	82,288			$	8,239,126

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Managed Volatility Growth Portfolio Series I			Managed Volatility Growth Portfolio Series NAV			Managed Volatility Moderate Portfolio Series I			Managed Volatility Moderate Portfolio Series NAV			Mid Cap Index Trust Series I			Mid Cap Index Trust Series NAV
Total Assets
Investments at fair value		$	1,538,909			$	41,367,207			$	506,603			$	12,495,666			$	566,058			$	4,537,583
Units outstanding			54,647				1,776,643				16,080				533,812				7,886				96,105
Unit value		$	28.16			$	23.28			$	31.51			$	23.41			$	71.78			$	47.21
Shares			127,923				3,432,963				44,283				1,091,325				26,526				212,633
Cost		$	1,656,398			$	45,061,646			$	539,141			$	13,382,446			$	559,509			$	4,333,435

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Mid Cap Stock Trust Series I			Mid Cap Stock Trust Series NAV			Mid Value Trust Series I			Mid Value Trust Series NAV			Money Market Trust Series I			Money-Market Trust Series NAV
Total Assets
Investments at fair value		$	806,869			$	3,705,290			$	296,922			$	1,406,557			$	2,084,208			$	4,660,304
Units outstanding			8,168				17,184				7,330				22,527				148,137				444,888
Unit value		$	98.78			$	215.62			$	40.51			$	62.44			$	14.07			$	10.48
Shares			30,785				138,671				29,167				139,125				2,084,208				4,660,304
Cost		$	555,079			$	2,544,449			$	308,047			$	1,437,481			$	2,084,208			$	4,660,304

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Opportunistic Fixed Income Trust Series I			Opportunistic Fixed Income Trust Series NAV			PIMCO All Asset			Real Estate Securities Trust Series I			Real Estate Securities Trust Series NAV			Science & Technology Trust Series I
Total Assets
Investments at fair value		$	176,808			$	1,273,630			$	588,701			$	165,572			$	1,866,278			$	558,423
Units outstanding			6,384				32,095				28,366				2,400				9,740				9,833
Unit value		$	27.70			$	39.68			$	20.75			$	68.99			$	191.61			$	56.79
Shares			13,136				94,976				52,143				8,728				99,059				13,337
Cost		$	164,890			$	1,197,503			$	558,044			$	162,188			$	1,750,618			$	357,115

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Science & Technology Trust Series NAV			Select Bond Trust Series I			Select Bond Trust Series NAV			Short Term Government Income Trust Series I			Short Term Government Income Trust Series NAV			Small Cap Index Trust Series I
Total Assets
Investments at fair value		$	7,240,387			$	41,031			$	1,417,416			$	146,342			$	719,580			$	215,029
Units outstanding			76,211				2,902				99,829				12,531				61,278				3,790
Unit value		$	95.00			$	14.14			$	14.20			$	11.68			$	11.74			$	56.74
Shares			170,162				2,812				97,217				11,907				58,550				13,184
Cost		$	5,168,306			$	38,857			$	1,332,686			$	144,700			$	715,312			$	180,209

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Small Cap Index Trust Series NAV			Small Cap Opportunities Trust Series I			Small Cap Opportunities Trust Series NAV			Small Cap Stock Trust Series I			Small Cap Stock Trust Series NAV			Small Cap Value Trust Series I
Total Assets
Investments at fair value		$	3,670,430			$	131,908			$	1,495,081			$	53,769			$	2,958,852			$	25,580
Units outstanding			80,849				2,235				51,283				832				38,485				802
Unit value		$	45.40			$	59.02			$	29.15			$	64.63			$	76.88			$	31.90
Shares			224,766				5,027				57,415				4,511				243,127				1,740
Cost		$	3,060,006			$	143,729			$	1,397,560			$	40,597			$	2,308,230			$	30,621

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Small Cap Value Trust Series NAV			Small Company Value Trust Series I			Small Company Value Trust Series NAV			Strategic Income Opportunities Trust Series I			Strategic Income Opportunities Trust Series NAV			Total Bond Market Series Trust NAV
Total Assets
Investments at fair value		$	2,253,159			$	105,617			$	945,299			$	240,583			$	2,439,382			$	1,372,145
Units outstanding			25,052				1,592				24,850				7,250				98,841				47,152
Unit value		$	89.94			$	66.34			$	38.04			$	33.18			$	24.68			$	29.10
Shares			154,009				10,011				90,200				16,661				169,519				126,000
Cost		$	2,645,511			$	123,921			$	1,156,379			$	227,031			$	2,272,589			$	1,322,794

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF ASSETS AND LIABILITIES

December 31, 2020

		Total Stock Market Index Trust Series I			Total Stock Market Index Trust Series NAV			Ultra Short Term Bond Trust Series I			Ultra Short Term Bond Trust Series NAV
Total Assets
Investments at fair value		$	260,523			$	8,829,054			$	608,847			$	571,471
Units outstanding			5,443				55,233				56,453				52,676
Unit value		$	47.86			$	159.85			$	10.79			$	10.85
Shares			9,921				336,345				53,128				49,823
Cost		$	220,035			$	6,960,676			$	616,610			$	576,902

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
S TATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

			500 Index Fund Series NAV			Active Bond Trust Series I			Active Bond Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	591,613			$	453,990			$	14,228			$	12,529			$	56,050			$	47,033
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			591,613				453,990				14,228				12,529				56,050				47,033
Realized gains (losses) on investments:
Capital gain distributions received			608,800				385,287				-				-				-				-
Net realized gain (loss)			1,070,157				529,094				1,519				(1,227	)			5,417				(2,058	)
Realized gains (losses)			1,678,957				914,381				1,519				(1,227	)			5,417				(2,058	)
Unrealized appreciation (depreciation) during the period			3,505,922				5,234,999				23,894				28,355				89,524				95,585
Net increase (decrease) in net assets from operations			5,776,492				6,603,370				39,641				39,657				150,991				140,560
Changes from principal transactions:
Purchase payments			1,577,177				1,347,148				12,360				17,365				80,509				110,623
Transfers between sub-accounts and the company			2,291,965				1,072,216				9,712				(4,208	)			112,990				166,004
Transfers on general account policy loans			54,799				130,181				(102	)			16				(2,967	)			(113	)
Withdrawals			(749,465	)			(200,644	)			(36,225	)			(5,002	)			1				136
Annual contract fee			(1,195,512	)			(1,084,482	)			(16,474	)			(17,140	)			(79,474	)			(71,613	)
Net increase (decrease) in net assets from principal transactions			1,978,964				1,264,419				(30,729	)			(8,969	)			111,059				205,037
Total increase (decrease) in net assets			7,755,456				7,867,789				8,912				30,688				262,050				345,597
Net assets at beginning of period			28,644,033				20,776,244				464,686				433,998				1,749,959				1,404,362
Net assets at end of period		$	36,399,489			$	28,644,033			$	473,598			$	464,686			$	2,012,009			$	1,749,959

		2020			2019			2020			2019			2020			2019
Units, beginning of period			399,694				381,044				17,915				18,280				20,643				18,106
Units issued			73,363				51,013				1,133				740				3,498				3,591
Units redeemed			(44,515	)			(32,363	)			(2,265	)			(1,105	)			(2,313	)			(1,054	)
Units, end of period			428,542				399,694				16,783				17,915				21,828				20,643

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		American Asset Allocation Trust Series I			American Global Growth Trust Series I			American Growth Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	100,891			$	99,637			$	554			$	4,166			$	4,535			$	34,629
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			100,891				99,637				554				4,166				4,535				34,629
Realized gains (losses) on investments:
Capital gain distributions received			872,685				733,735				68,333				63,969				724,890				733,362
Net realized gain (loss)			(134,451	)			(35,267	)			12,785				5,799				11,033				(47,746	)
Realized gains (losses)			738,234				698,468				81,118				69,768				735,923				685,616
Unrealized appreciation (depreciation) during the period			(6	)			432,132				142,287				97,759				1,586,879				352,269
Net increase (decrease) in net assets from operations			839,119				1,230,237				223,959				171,693				2,327,337				1,072,514
Changes from principal transactions:
Purchase payments			562,585				575,588				59,931				55,971				293,365				284,829
Transfers between sub-accounts and the company			(605,197	)			708,190				29,788				91,186				(86,767	)			15,601
Transfers on general account policy loans			(26,411	)			(5,988	)			-				(108	)			(23,635	)			(24,504	)
Withdrawals			(63,514	)			(628	)			(17,685	)			(15,072	)			(101,284	)			(70,495	)
Annual contract fee			(388,792	)			(367,792	)			(37,179	)			(31,545	)			(167,565	)			(145,357	)
Net increase (decrease) in net assets from principal transactions			(521,329	)			909,370				34,855				100,432				(85,886	)			60,074
Total increase (decrease) in net assets			317,790				2,139,607				258,814				272,125				2,241,451				1,132,588
Net assets at beginning of period			7,730,993				5,591,386				725,088				452,963				4,610,547				3,477,959
Net assets at end of period		$	8,048,783			$	7,730,993			$	983,902			$	725,088			$	6,851,998			$	4,610,547

		2020			2019			2020			2019			2020			2019
Units, beginning of period			346,830				302,960				28,896				24,318				105,461				103,247
Units issued			28,246				57,666				5,316				6,581				9,073				16,453
Units redeemed			(52,732	)			(13,796	)			(4,040	)			(2,003	)			(10,919	)			(14,239	)
Units, end of period			322,344				346,830				30,172				28,896				103,615				105,461

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		American Growth-Income Trust Series I			American International Trust Series I			Blue Chip Growth Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	55,057			$	56,361			$	11,021			$	27,009			$	-			$	-
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			55,057				56,361				11,021				27,009				-				-
Realized gains (losses) on investments:
Capital gain distributions received			534,708				429,142				135,154				196,841				181,933				162,049
Net realized gain (loss)			(59,963	)			(417	)			6,737				36,169				1,532				(14,017	)
Realized gains (losses)			474,745				428,725				141,891				233,010				183,465				148,032
Unrealized appreciation (depreciation) during the period			(14,710	)			308,252				280,242				282,858				194,967				122,238
Net increase (decrease) in net assets from operations			515,092				793,338				433,154				542,877				378,432				270,270
Changes from principal transactions:
Purchase payments			238,281				247,455				153,273				172,930				21,887				20,200
Transfers between sub-accounts and the company			166,141				24,379				8,554				(92,121	)			(20,565	)			(90,582	)
Transfers on general account policy loans			(24,305	)			16,298				(10,781	)			21,310				3,046				29,673
Withdrawals			(148,726	)			(17,664	)			(26,584	)			(24,477	)			(579	)			(239	)
Annual contract fee			(162,991	)			(158,675	)			(92,402	)			(89,775	)			(34,306	)			(31,879	)
Net increase (decrease) in net assets from principal transactions			68,400				111,793				32,060				(12,133	)			(30,517	)			(72,827	)
Total increase (decrease) in net assets			583,492				905,131				465,214				530,744				347,915				197,443
Net assets at beginning of period			3,925,057				3,019,926				2,988,085				2,457,341				1,127,241				929,798
Net assets at end of period		$	4,508,549			$	3,925,057			$	3,453,299			$	2,988,085			$	1,475,156			$	1,127,241

		2020			2019			2020			2019			2020			2019
Units, beginning of period			105,038				101,136				114,343				115,142				23,420				25,074
Units issued			12,452				8,673				11,993				10,712				429				1,019
Units redeemed			(10,128	)			(4,771	)			(9,709	)			(11,511	)			(1,029	)			(2,673	)
Units, end of period			107,362				105,038				116,627				114,343				22,820				23,420

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Blue Chip Growth Trust Series NAV			Capital Appreciation Trust Series I			Capital Appreciation Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	-			$	982			$	-			$	170			$	-			$	963
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			-				982				-				170				-				963
Realized gains (losses) on investments:
Capital gain distributions received			2,307,265				1,780,063				67,934				314,593				322,589				1,486,707
Net realized gain (loss)			207,630				153,483				(93,375	)			(15,323	)			(373,628	)			(67,134	)
Realized gains (losses)			2,514,895				1,933,546				(25,441	)			299,270				(51,039	)			1,419,573
Unrealized appreciation (depreciation) during the period			2,336,837				1,057,405				314,094				(168,986	)			1,411,441				(806,798	)
Net increase (decrease) in net assets from operations			4,851,732				2,991,933				288,653				130,454				1,360,402				613,738
Changes from principal transactions:
Purchase payments			1,197,467				1,154,120				24,872				16,538				137,386				135,504
Transfers between sub-accounts and the company			(78,610	)			300,342				66,320				(694	)			53,201				(12,166	)
Transfers on general account policy loans			18,686				(39,403	)			(39	)			(757	)			(2,861	)			(860	)
Withdrawals			(419,166	)			(47,836	)			(36,521	)			(2,404	)			(70,985	)			(8,992	)
Annual contract fee			(462,436	)			(384,131	)			(30,506	)			(26,259	)			(99,566	)			(84,492	)
Net increase (decrease) in net assets from principal transactions			255,941				983,092				24,126				(13,576	)			17,175				28,994
Total increase (decrease) in net assets			5,107,673				3,975,025				312,779				116,878				1,377,577				642,732
Net assets at beginning of period			13,528,435				9,553,410				517,710				400,832				2,499,879				1,857,147
Net assets at end of period		$	18,636,108			$	13,528,435			$	830,489			$	517,710			$	3,877,456			$	2,499,879

		2020			2019			2020			2019			2020			2019
Units, beginning of period			54,659				50,112				10,530				10,835				51,707				51,042
Units issued			6,344				8,362				1,419				296				6,293				3,586
Units redeemed			(4,980	)			(3,815	)			(1,124	)			(601	)			(6,685	)			(2,921	)
Units, end of period			56,023				54,659				10,825				10,530				51,315				51,707

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Capital Appreciation Value Trust Series NAV			Core Bond Trust Series I			Core Bond Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	105,688			$	117,580			$	12,918			$	13,578			$	112,100			$	103,971
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			105,688				117,580				12,918				13,578				112,100				103,971
Realized gains (losses) on investments:
Capital gain distributions received			785,368				488,612				3				(2	)			1				(1	)
Net realized gain (loss)			35,649				10,662				1,675				274				29,278				(3,191	)
Realized gains (losses)			821,017				499,274				1,678				272				29,279				(3,192	)
Unrealized appreciation (depreciation) during the period			612,582				989,270				30,727				35,543				240,100				209,565
Net increase (decrease) in net assets from operations			1,539,287				1,606,124				45,323				49,393				381,479				310,344
Changes from principal transactions:
Purchase payments			622,503				580,110				11,055				12,414				226,986				241,208
Transfers between sub-accounts and the company			(36,204	)			977,397				6,191				(109,390	)			224,117				858,432
Transfers on general account policy loans			(647	)			(8,523	)			(785	)			(1,167	)			164,538				133,102
Withdrawals			(48,260	)			(95,099	)			(21,439	)			(5,036	)			(191,623	)			(57,885	)
Annual contract fee			(512,856	)			(439,170	)			(16,258	)			(18,426	)			(198,991	)			(182,587	)
Net increase (decrease) in net assets from principal transactions			24,536				1,014,715				(21,236	)			(121,605	)			225,027				992,270
Total increase (decrease) in net assets			1,563,823				2,620,839				24,087				(72,212	)			606,506				1,302,614
Net assets at beginning of period			8,947,613				6,326,774				531,148				603,360				4,311,787				3,009,173
Net assets at end of period		$	10,511,436			$	8,947,613			$	555,235			$	531,148			$	4,918,293			$	4,311,787

		2020			2019			2020			2019			2020			2019
Units, beginning of period			311,325				273,927				22,857				28,126				230,707				174,431
Units issued			29,487				57,063				783				482				51,832				74,821
Units redeemed			(29,326	)			(19,665	)			(1,643	)			(5,751	)			(40,655	)			(18,545	)
Units, end of period			311,486				311,325				21,997				22,857				241,884				230,707

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Disciplined Value International Trust Series I			Disciplined Value International Trust Series NAV			Emerging Markets Value Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	6,541			$	9,116			$	41,322			$	55,931			$	1,973			$	2,857
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			6,541				9,116				41,322				55,931				1,973				2,857
Realized gains (losses) on investments:
Capital gain distributions received			(2	)			(6	)			3				4				-				-
Net realized gain (loss)			(2,291	)			1,860				(33,249	)			(3,526	)			(6,919	)			(55	)
Realized gains (losses)			(2,293	)			1,854				(33,246	)			(3,522	)			(6,919	)			(55	)
Unrealized appreciation (depreciation) during the period			9,837				26,361				68,573				169,014				5,651				6,722
Net increase (decrease) in net assets from operations			14,085				37,331				76,649				221,423				705				9,524
Changes from principal transactions:
Purchase payments			14,249				13,793				86,489				108,253				1,324				1,396
Transfers between sub-accounts and the company			4,731				(34,257	)			26,405				70,386				(8,370	)			4,861
Transfers on general account policy loans			763				786				1,196				1,267				(296	)			(276	)
Withdrawals			77				(2,588	)			(54,595	)			374				(353	)			20
Annual contract fee			(8,994	)			(10,332	)			(58,726	)			(63,625	)			(1,074	)			(1,481	)
Net increase (decrease) in net assets from principal transactions			10,826				(32,598	)			769				116,655				(8,769	)			4,520
Total increase (decrease) in net assets			24,911				4,733				77,418				338,078				(8,064	)			14,044
Net assets at beginning of period			324,853				320,120				2,050,924				1,712,846				97,519				83,475
Net assets at end of period		$	349,764			$	324,853			$	2,128,342			$	2,050,924			$	89,455			$	97,519

		2020			2019			2020			2019			2020			2019
Units, beginning of period			11,726				12,979				114,451				107,442				5,692				5,405
Units issued			883				606				13,237				11,580				781				381
Units redeemed			(385	)			(1,859	)			(12,681	)			(4,571	)			(1,431	)			(94	)
Units, end of period			12,224				11,726				115,007				114,451				5,042				5,692

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Emerging Markets Value Trust Series NAV			Equity Income Trust Series I			Equity Income Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	33,186			$	44,027			$	19,740			$	13,175			$	148,165			$	93,783
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			33,186				44,027				19,740				13,175				148,165				93,783
Realized gains (losses) on investments:
Capital gain distributions received			(2	)			(1	)			51,051				52,305				377,052				334,725
Net realized gain (loss)			(603	)			(6,116	)			(14,569	)			(23,953	)			(120,427	)			(68,087	)
Realized gains (losses)			(605	)			(6,117	)			36,482				28,352				256,625				266,638
Unrealized appreciation (depreciation) during the period			56,313				100,148				(48,041	)			93,857				(321,734	)			582,697
Net increase (decrease) in net assets from operations			88,894				138,058				8,181				135,384				83,056				943,118
Changes from principal transactions:
Purchase payments			131,797				126,450				23,666				61,219				233,808				181,235
Transfers between sub-accounts and the company			26,853				5,898				22,900				69,535				69,315				796,612
Transfers on general account policy loans			(2,177	)			45,794				(5,199	)			15,702				(22,674	)			57,098
Withdrawals			(25,395	)			(9,691	)			120				(435	)			(46,141	)			(49,349	)
Annual contract fee			(62,078	)			(64,691	)			(35,600	)			(35,520	)			(176,111	)			(138,503	)
Net increase (decrease) in net assets from principal transactions			69,000				103,760				5,887				110,501				58,197				847,093
Total increase (decrease) in net assets			157,894				241,818				14,068				245,885				141,253				1,790,211
Net assets at beginning of period			1,446,257				1,204,439				737,488				491,603				5,371,022				3,580,811
Net assets at end of period		$	1,604,151			$	1,446,257			$	751,556			$	737,488			$	5,512,275			$	5,371,022

		2020			2019			2020			2019			2020			2019
Units, beginning of period			104,941				96,913				18,005				15,163				79,149				66,733
Units issued			23,230				16,580				1,211				4,854				6,351				23,505
Units redeemed			(15,951	)			(8,552	)			(1,053	)			(2,012	)			(5,082	)			(11,089	)
Units, end of period			112,220				104,941				18,163				18,005				80,418				79,149

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Financial Industries Trust Series I			Financial Industries Trust Series NAV			Fundamental All Cap Core Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	1,779			$	5,409			$	12,809			$	36,345			$	10			$	10
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			1,779				5,409				12,809				36,345				10				10
Realized gains (losses) on investments:
Capital gain distributions received			12,582				7,015				87,476				47,243				81				172
Net realized gain (loss)			(381	)			1,196				(15,000	)			12,616				206				(161	)
Realized gains (losses)			12,201				8,211				72,476				59,859				287				11
Unrealized appreciation (depreciation) during the period			(11,231	)			19,607				(50,733	)			124,799				441				640
Net increase (decrease) in net assets from operations			2,749				33,227				34,552				221,003				738				661
Changes from principal transactions:
Purchase payments			310				38,914				70,822				76,015				2,138				2,138
Transfers between sub-accounts and the company			1,484				(24,003	)			22,230				(61,952	)			(1	)			(4	)
Transfers on general account policy loans			3				8,513				(751	)			54,034				(13	)			(18	)
Withdrawals			(446	)			89				(9,475	)			(2,408	)			3				4
Annual contract fee			(2,953	)			(3,506	)			(48,240	)			(50,804	)			(2,160	)			(1,927	)
Net increase (decrease) in net assets from principal transactions			(1,602	)			20,007				34,586				14,885				(33	)			193
Total increase (decrease) in net assets			1,147				53,234				69,138				235,888				705				854
Net assets at beginning of period			149,155				95,921				957,272				721,384				2,508				1,654
Net assets at end of period		$	150,302			$	149,155			$	1,026,410			$	957,272			$	3,213			$	2,508

		2020			2019			2020			2019			2020			2019
Units, beginning of period			4,177				3,541				22,226				22,060				40				36
Units issued			42				1,496				3,756				4,438				35				39
Units redeemed			(99	)			(860	)			(2,689	)			(4,272	)			(34	)			(35	)
Units, end of period			4,120				4,177				23,293				22,226				41				40

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Fundamental All Cap Core Trust Series NAV			Fundamental Large Cap Value Trust Series I			Fundamental Large Cap Value Trust Series
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	4,504			$	4,476			$	8,821			$	8,966			$	33,128			$	32,901
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			4,504				4,476				8,821				8,966				33,128				32,901
Realized gains (losses) on investments:
Capital gain distributions received			32,274				68,983				15,972				13,100				57,473				43,697
Net realized gain (loss)			31,238				5,040				4,609				27,580				32,596				38,655
Realized gains (losses)			63,512				74,023				20,581				40,680				90,069				82,352
Unrealized appreciation (depreciation) during the period			223,471				181,279				74,530				181,644				243,771				674,759
Net increase (decrease) in net assets from operations			291,487				259,778				103,932				231,290				366,968				790,012
Changes from principal transactions:
Purchase payments			65,203				50,424				25,788				63,428				154,161				142,237
Transfers between sub-accounts and the company			127,248				41,441				9,738				(111,744	)			11,037				(41,866	)
Transfers on general account policy loans			(3,079	)			247				291				17,857				(71	)			347
Withdrawals			(135,298	)			(213	)			188				(13,491	)			(28,015	)			(31,467	)
Annual contract fee			(53,002	)			(46,098	)			(23,722	)			(24,376	)			(95,307	)			(90,869	)
Net increase (decrease) in net assets from principal transactions			1,072				45,801				12,283				(68,326	)			41,805				(21,618	)
Total increase (decrease) in net assets			292,559				305,579				116,215				162,964				408,773				768,394
Net assets at beginning of period			998,716				693,137				815,005				652,041				2,964,998				2,196,604
Net assets at end of period		$	1,291,275			$	998,716			$	931,220			$	815,005			$	3,373,771			$	2,964,998

		2020			2019			2020			2019			2020			2019
Units, beginning of period			26,971				25,565				19,929				21,660				102,700				103,453
Units issued			5,521				2,537				1,013				2,086				7,563				5,568
Units redeemed			(5,028	)			(1,131	)			(604	)			(3,817	)			(5,934	)			(6,321	)
Units, end of period			27,464				26,971				20,338				19,929				104,329				102,700

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Global Trust Series I			Global Trust Series NAV			Health Sciences Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	1,055			$	1,772			$	15,822			$	26,562			$	-			$	-
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			1,055				1,772				15,822				26,562				-				-
Realized gains (losses) on investments:
Capital gain distributions received			739				2,833				10,644				43,790				32,432				29,182
Net realized gain (loss)			(1,300	)			(125	)			(13,891	)			(4,808	)			3,819				(22,390	)
Realized gains (losses)			(561	)			2,708				(3,247	)			38,982				36,251				6,792
Unrealized appreciation (depreciation) during the period			4,127				7,126				61,449				114,874				39,510				69,099
Net increase (decrease) in net assets from operations			4,621				11,606				74,024				180,418				75,761				75,891
Changes from principal transactions:
Purchase payments			1,885				1,885				88,139				108,834				2,118				2,553
Transfers between sub-accounts and the company			(3,670	)			3,180				1,149				(22,390	)			(5,250	)			(118,218	)
Transfers on general account policy loans			4,141				4,236				(3,290	)			(1,304	)			(1,341	)			3,544
Withdrawals			40				(131	)			(49,950	)			(91,353	)			(1,309	)			(3,610	)
Annual contract fee			(3,832	)			(3,647	)			(56,095	)			(63,696	)			(11,443	)			(13,720	)
Net increase (decrease) in net assets from principal transactions			(1,436	)			5,523				(20,047	)			(69,909	)			(17,225	)			(129,451	)
Total increase (decrease) in net assets			3,185				17,129				53,977				110,509				58,536				(53,560	)
Net assets at beginning of period			86,233				69,104				1,255,418				1,144,909				288,998				342,558
Net assets at end of period		$	89,418			$	86,233			$	1,309,395			$	1,255,418			$	347,534			$	288,998

		2020			2019			2020			2019			2020			2019
Units, beginning of period			3,777				3,513				60,071				63,581				2,514				3,834
Units issued			285				419				4,834				12,690				20				121
Units redeemed			(388	)			(155	)			(6,190	)			(16,200	)			(157	)			(1,441	)
Units, end of period			3,674				3,777				58,715				60,071				2,377				2,514

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Health Sciences Trust Series NAV			High Yield Trust Series I			High Yield Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	-			$	-			$	19,082			$	17,227			$	218,914			$	187,129
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			-				-				19,082				17,227				218,914				187,129
Realized gains (losses) on investments:
Capital gain distributions received			412,010				228,802				-				-				(2	)			(11	)
Net realized gain (loss)			(2,607	)			(93,798	)			(4,165	)			(11,692	)			(33,179	)			(41,389	)
Realized gains (losses)			409,403				135,004				(4,165	)			(11,692	)			(33,181	)			(41,400	)
Unrealized appreciation (depreciation) during the period			566,306				635,511				2,383				42,833				7,044				330,261
Net increase (decrease) in net assets from operations			975,709				770,515				17,300				48,368				192,777				475,990
Changes from principal transactions:
Purchase payments			229,453				235,014				9,159				8,952				83,721				136,801
Transfers between sub-accounts and the company			190,687				122,862				4,124				(60,927	)			(3,945	)			39,698
Transfers on general account policy loans			14,765				(9,569	)			(1,331	)			(2,454	)			(7,252	)			(562	)
Withdrawals			(171,894	)			(35,634	)			(5,811	)			(3,030	)			(63,512	)			(23,830	)
Annual contract fee			(213,175	)			(190,014	)			(7,015	)			(8,752	)			(67,299	)			(71,013	)
Net increase (decrease) in net assets from principal transactions			49,836				122,659				(874	)			(66,211	)			(58,287	)			81,094
Total increase (decrease) in net assets			1,025,545				893,174				16,426				(17,843	)			134,490				557,084
Net assets at beginning of period			3,524,680				2,631,506				305,949				323,792				3,502,513				2,945,429
Net assets at end of period		$	4,550,225			$	3,524,680			$	322,375			$	305,949			$	3,637,003			$	3,502,513

		2020			2019			2020			2019			2020			2019
Units, beginning of period			39,249				37,703				10,655				13,044				128,389				125,229
Units issued			4,639				5,540				515				328				7,723				13,094
Units redeemed			(4,074	)			(3,994	)			(560	)			(2,717	)			(10,064	)			(9,934	)
Units, end of period			39,814				39,249				10,610				10,655				126,048				128,389

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		International Equity Index Series I			International Equity Index Series NAV			International Small Company Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	5,359			$	4,769			$	148,700			$	102,790			$	544			$	655
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			5,359				4,769				148,700				102,790				544				655
Realized gains (losses) on investments:
Capital gain distributions received			2,107				(4	)			57,366				5				898				1,312
Net realized gain (loss)			2,500				467				25,567				14,492				98				781
Realized gains (losses)			4,607				463				82,933				14,497				996				2,093
Unrealized appreciation (depreciation) during the period			12,491				30,518				605,419				619,549				844				3,278
Net increase (decrease) in net assets from operations			22,457				35,750				837,052				736,836				2,384				6,026
Changes from principal transactions:
Purchase payments			4,595				3,636				241,073				204,542				1,334				1,834
Transfers between sub-accounts and the company			4,766				22,381				1,109,285				785,563				(1,144	)			(5,581	)
Transfers on general account policy loans			(2,696	)			8,784				(9,878	)			39,034				1,022				(4,514	)
Withdrawals			(11,312	)			79				(80,114	)			(13,331	)			4				4
Annual contract fee			(5,393	)			(4,451	)			(157,742	)			(131,250	)			(1,646	)			(1,681	)
Net increase (decrease) in net assets from principal transactions			(10,040	)			30,429				1,102,624				884,558				(430	)			(9,938	)
Total increase (decrease) in net assets			12,417				66,179				1,939,676				1,621,394				1,954				(3,912	)
Net assets at beginning of period			225,874				159,695				4,875,106				3,253,712				27,354				31,266
Net assets at end of period		$	238,291			$	225,874			$	6,814,782			$	4,875,106			$	29,308			$	27,354

		2020			2019			2020			2019			2020			2019
Units, beginning of period			14,950				12,829				82,078				66,525				1,362				1,909
Units issued			554				2,362				30,260				20,864				131				121
Units redeemed			(1,249	)			(241	)			(8,748	)			(5,311	)			(146	)			(668	)
Units, end of period			14,255				14,950				103,590				82,078				1,347				1,362

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		International Small Company Trust Series NAV			Investment Quality Bond Trust Series I			Investment Quality Bond Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	31,061			$	32,080			$	4,285			$	4,477			$	13,428			$	13,655
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			31,061				32,080				4,285				4,477				13,428				13,655
Realized gains (losses) on investments:
Capital gain distributions received			50,111				57,539				101				-				312				-
Net realized gain (loss)			5,529				11,155				1,181				(140	)			1,394				(858	)
Realized gains (losses)			55,640				68,694				1,282				(140	)			1,706				(858	)
Unrealized appreciation (depreciation) during the period			61,427				177,382				10,429				13,297				34,694				30,460
Net increase (decrease) in net assets from operations			148,128				278,156				15,996				17,634				49,828				43,257
Changes from principal transactions:
Purchase payments			65,001				75,221				8,599				8,857				36,580				39,745
Transfers between sub-accounts and the company			13,209				34,450				9,647				(42,136	)			23,768				50,152
Transfers on general account policy loans			(3,814	)			2,480				83				105				157,697				(3,107	)
Withdrawals			(9,800	)			(4,891	)			(12,031	)			(5,407	)			(154,341	)			(7	)
Annual contract fee			(45,322	)			(44,904	)			(6,275	)			(6,515	)			(24,429	)			(22,925	)
Net increase (decrease) in net assets from principal transactions			19,274				62,356				23				(45,096	)			39,275				63,858
Total increase (decrease) in net assets			167,402				340,512				16,019				(27,462	)			89,103				107,115
Net assets at beginning of period			1,522,232				1,181,720				164,777				192,239				541,689				434,574
Net assets at end of period		$	1,689,634			$	1,522,232			$	180,796			$	164,777			$	630,792			$	541,689

		2020			2019			2020			2019			2020			2019
Units, beginning of period			75,393				71,816				6,085				7,764				28,789				25,256
Units issued			9,673				8,092				656				324				14,998				4,955
Units redeemed			(7,876	)			(4,515	)			(637	)			(2,003	)			(13,158	)			(1,422	)
Units, end of period			77,190				75,393				6,104				6,085				30,629				28,789

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Lifestyle Aggressive Portfolio Series NAV			Lifestyle Balanced Portfolio Series NAV			Lifestyle Conservative Portfolio Series NAV
			2020				2019				2020				2019				2020				2019
Income:
Dividend distributions received		$	36,494			$	24,883			$	95,056			$	68,629			$	5,931			$	4,433
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			36,494				24,883				95,056				68,629				5,931				4,433
Realized gains (losses) on investments:
Capital gain distributions received			123,072				21,756				126,356				93,476				4,324				3,716
Net realized gain (loss)			3,697				1,398				29,288				7,008				2,394				(788	)
Realized gains (losses)			126,769				23,154				155,644				100,484				6,718				2,928
Unrealized appreciation (depreciation) during the period			73,234				90,429				196,988				310,747				9,468				14,909
Net increase (decrease) in net assets from operations			236,497				138,466				447,688				479,860				22,117				22,270
Changes from principal transactions:
Purchase payments			2,990				3,152				370,102				331,140				17,857				11,880
Transfers between sub-accounts and the company			1,177				1,269,164				15,006				573,015				(12,317	)			32,562
Transfers on general account policy loans			-				-				(19,432	)			6,456				-				(37,826	)
Withdrawals			(31	)			48				(73,654	)			(8,855	)			(4	)			(1	)
Annual contract fee			(33,306	)			(15,240	)			(310,667	)			(265,996	)			(16,076	)			(14,280	)
Net increase (decrease) in net assets from principal transactions			(29,170	)			1,257,124				(18,645	)			635,760				(10,540	)			(7,665	)
Total increase (decrease) in net assets			207,327				1,395,590				429,043				1,115,620				11,577				14,605
Net assets at beginning of period			1,718,405				322,815				3,547,641				2,432,021				202,836				188,231
Net assets at end of period		$	1,925,732			$	1,718,405			$	3,976,684			$	3,547,641			$	214,413			$	202,836

		2020			2019			2020			2019			2020			2019
Units, beginning of period			104,431				24,947				245,885				198,716				15,512				16,198
Units issued			237				80,532				16,495				57,943				2,803				3,312
Units redeemed			(2,108	)			(1,048	)			(17,773	)			(10,774	)			(3,516	)			(3,998	)
Units, end of period			102,560				104,431				244,607				245,885				14,799				15,512

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Lifestyle Growth Portfolio Series NAV			Lifestyle Moderate Portfolio Series NAV			M Capital Appreciation
			2020				2019				2020				2019				2020				2019
Income:
Dividend distributions received		$	568,273			$	384,304			$	44,869			$	30,333			$	-			$	2,080
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			568,273				384,304				44,869				30,333				-				2,080
Realized gains (losses) on investments:
Capital gain distributions received			1,208,561				897,753				51,574				33,211				16,411				52,655
Net realized gain (loss)			77,251				64,219				4,887				2,933				(48,102	)			(8,337	)
Realized gains (losses)			1,285,812				961,972				56,461				36,144				(31,691	)			44,318
Unrealized appreciation (depreciation) during the period			1,144,188				2,263,994				92,134				126,849				152,245				106,612
Net increase (decrease) in net assets from operations			2,998,273				3,610,270				193,464				193,326				120,554				153,010
Changes from principal transactions:
Purchase payments			1,656,701				1,515,611				148,284				111,446				24,434				42,991
Transfers between sub-accounts and the company			289,489				1,760,618				44,167				236,056				(22,167	)			(2,602	)
Transfers on general account policy loans			(27,642	)			(40,487	)			601				(24	)			(44	)			(426	)
Withdrawals			(164,586	)			(174,182	)			(1,915	)			7				(84,147	)			108
Annual contract fee			(1,232,239	)			(1,107,528	)			(126,803	)			(107,085	)			(24,147	)			(26,287	)
Net increase (decrease) in net assets from principal transactions			521,723				1,954,032				64,334				240,400				(106,071	)			13,784
Total increase (decrease) in net assets			3,519,996				5,564,302				257,798				433,726				14,483				166,794
Net assets at beginning of period			21,573,145				16,008,843				1,536,225				1,102,499				685,999				519,205
Net assets at end of period		$	25,093,141			$	21,573,145			$	1,794,023			$	1,536,225			$	700,482			$	685,999

		2020			2019			2020			2019			2020			2019
Units, beginning of period			1,403,896				1,266,011				110,070				91,588				5,416				5,282
Units issued			95,195				196,753				11,010				24,771				972				554
Units redeemed			(62,048	)			(58,868	)			(6,538	)			(6,289	)			(1,691	)			(420	)
Units, end of period			1,437,043				1,403,896				114,542				110,070				4,697				5,416

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		M International Equity			M Large Cap Growth			M Large Cap Value
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	13,718			$	19,813			$	-			$	-			$	20,610			$	16,516
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			13,718				19,813				-				-				20,610				16,516
Realized gains (losses) on investments:
Capital gain distributions received			-				-				131,316				60,682				11,307				30,768
Net realized gain (loss)			(67	)			(312	)			102,703				20,182				(5,881	)			(491	)
Realized gains (losses)			(67	)			(312	)			234,019				80,864				5,426				30,277
Unrealized appreciation (depreciation) during the period			88,901				104,732				34,179				208,085				(29,427	)			123,739
Net increase (decrease) in net assets from operations			102,552				124,233				268,198				288,949				(3,391	)			170,532
Changes from principal transactions:
Purchase payments			45,085				52,629				36,298				66,992				46,557				60,119
Transfers between sub-accounts and the company			73,667				19,940				(138,354	)			(48,484	)			144,211				29,078
Transfers on general account policy loans			(44	)			(421	)			-				-				(43	)			(412	)
Withdrawals			(165	)			72				(129	)			185				(144	)			98
Annual contract fee			(22,973	)			(19,925	)			(47,362	)			(53,528	)			(32,100	)			(29,441	)
Net increase (decrease) in net assets from principal transactions			95,570				52,295				(149,547	)			(34,835	)			158,481				59,442
Total increase (decrease) in net assets			198,122				176,528				118,651				254,114				155,090				229,974
Net assets at beginning of period			755,531				579,003				1,063,822				809,708				992,389				762,415
Net assets at end of period		$	953,653			$	755,531			$	1,182,473			$	1,063,822			$	1,147,479			$	992,389

		2020			2019			2020			2019			2020			2019
Units, beginning of period			20,085				18,520				11,204				11,605				31,090				29,025
Units issued			4,495				2,362				2,105				953				7,318				3,119
Units redeemed			(1,300	)			(797	)			(3,647	)			(1,354	)			(1,285	)			(1,054	)
Units, end of period			23,280				20,085				9,662				11,204				37,123				31,090

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Managed Volatility Aggressive Portfolio Series I			Managed Volatility Aggressive Portfolio Series NAV			Managed Volatility Balanced Portfolio Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	9,595			$	8,824			$	262,631			$	249,475			$	24,470			$	25,311
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			9,595				8,824				262,631				249,475				24,470				25,311
Realized gains (losses) on investments:
Capital gain distributions received			7,535				62,532				202,687				1,733,511				64,209				152,000
Net realized gain (loss)			2,693				3,366				65,959				193,084				(14,322	)			(52,298	)
Realized gains (losses)			10,228				65,898				268,646				1,926,595				49,887				99,702
Unrealized appreciation (depreciation) during the period			(54,479	)			42,038				(1,432,787	)			1,040,846				(54,504	)			411,565
Net increase (decrease) in net assets from operations			(34,656	)			116,760				(901,510	)			3,216,916				19,853				536,578
Changes from principal transactions:
Purchase payments			37,577				53,650				1,238,556				1,283,709				13,517				13,518
Transfers between sub-accounts and the company			-				-				(430,626	)			108,245				1,282				(865	)
Transfers on general account policy loans			27				8				(17,682	)			(79,287	)			(26	)			17,318
Withdrawals			66				(89	)			(180,923	)			(249,534	)			(302,194	)			(3,927,078	)
Annual contract fee			(16,209	)			(15,689	)			(640,486	)			(641,139	)			(25,723	)			(118,374	)
Net increase (decrease) in net assets from principal transactions			21,461				37,880				(31,161	)			421,994				(313,144	)			(4,015,481	)
Total increase (decrease) in net assets			(13,195	)			154,640				(932,671	)			3,638,910				(293,291	)			(3,478,903	)
Net assets at beginning of period			694,950				540,310				18,920,540				15,281,630				1,262,736				4,741,639
Net assets at end of period		$	681,755			$	694,950			$	17,987,869			$	18,920,540			$	969,445			$	1,262,736

		2020			2019			2020			2019			2020			2019
Units, beginning of period			26,103				24,513				775,419				756,691				41,200				182,235
Units issued			1,272				2,021				56,142				61,469				405				735
Units redeemed			(489	)			(431	)			(57,185	)			(42,741	)			(10,522	)			(141,770	)
Units, end of period			26,886				26,103				774,376				775,419				31,083				41,200

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Managed Volatility Balanced Portfolio Series NAV			Managed Volatility Conservative Portfolio Series I			Managed Volatility Conservative Portfolio Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	1,130,111			$	873,410			$	2,412			$	1,838			$	245,968			$	189,434
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			1,130,111				873,410				2,412				1,838				245,968				189,434
Realized gains (losses) on investments:
Capital gain distributions received			2,306,231				1,859,776				1,100				-				109,523				5
Net realized gain (loss)			(250,109	)			(87,866	)			(635	)			(648	)			(35,085	)			(40,608	)
Realized gains (losses)			2,056,122				1,771,910				465				(648	)			74,438				(40,603	)
Unrealized appreciation (depreciation) during the period			(2,307,902	)			4,192,522				(228	)			8,125				(52,500	)			853,947
Net increase (decrease) in net assets from operations			878,331				6,837,842				2,649				9,315				267,906				1,002,778
Changes from principal transactions:
Purchase payments			3,186,947				3,366,863				-				-				185,106				249,896
Transfers between sub-accounts and the company			(14,598	)			43,134				1,177				(721	)			511,699				168,415
Transfers on general account policy loans			15,317				168,559				3,725				3,977				(6,734	)			28,562
Withdrawals			(535,820	)			(1,214,165	)			35				36				(442,924	)			(773,477	)
Annual contract fee			(2,452,967	)			(2,457,380	)			(5,569	)			(5,125	)			(352,623	)			(370,006	)
Net increase (decrease) in net assets from principal transactions			198,879				(92,989	)			(632	)			(1,833	)			(105,476	)			(696,610	)
Total increase (decrease) in net assets			1,077,210				6,744,853				2,017				7,482				162,430				306,168
Net assets at beginning of period			44,700,806				37,955,953				78,822				71,340				7,989,684				7,683,516
Net assets at end of period		$	45,778,016			$	44,700,806			$	80,839			$	78,822			$	8,152,114			$	7,989,684

		2020			2019			2020			2019			2020			2019
Units, beginning of period			1,933,830				1,937,923				2,730				2,802				388,294				423,840
Units issued			120,061				147,070				196				140				35,866				19,331
Units redeemed			(107,837	)			(151,163	)			(218	)			(212	)			(41,119	)			(54,877	)
Units, end of period			1,946,054				1,933,830				2,708				2,730				383,041				388,294

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Managed Volatility Growth Portfolio Series I			Managed Volatility Growth Portfolio Series NAV			Managed Volatility Moderate Portfolio Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	31,935			$	26,935			$	876,278			$	716,120			$	13,218			$	10,581
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			31,935				26,935				876,278				716,120				13,218				10,581
Realized gains (losses) on investments:
Capital gain distributions received			87,946				102,241				2,354,618				2,948,537				22,848				18,295
Net realized gain (loss)			(27,155	)			43,022				(139,619	)			505,320				(633	)			3,071
Realized gains (losses)			60,791				145,263				2,214,999				3,453,857				22,215				21,366
Unrealized appreciation (depreciation) during the period			(132,499	)			96,629				(3,580,988	)			2,797,030				(18,597	)			45,180
Net increase (decrease) in net assets from operations			(39,773	)			268,827				(489,711	)			6,967,007				16,836				77,127
Changes from principal transactions:
Purchase payments			84,858				86,397				3,306,466				3,551,191				6,386				2,126
Transfers between sub-accounts and the company			(88,143	)			654				(272,248	)			(1,872,762	)			10,162				-
Transfers on general account policy loans			30,037				(84,536	)			(210,694	)			1,084,791				(19,999	)			(40,009	)
Withdrawals			(25,490	)			(23,809	)			(733,722	)			(1,052,946	)			331				353
Annual contract fee			(48,216	)			(52,214	)			(2,170,701	)			(2,243,165	)			(24,410	)			(19,284	)
Net increase (decrease) in net assets from principal transactions			(46,954	)			(73,508	)			(80,899	)			(532,891	)			(27,530	)			(56,814	)
Total increase (decrease) in net assets			(86,727	)			195,319				(570,610	)			6,434,116				(10,694	)			20,313
Net assets at beginning of period			1,625,636				1,430,317				41,937,817				35,503,701				517,297				496,984
Net assets at end of period		$	1,538,909			$	1,625,636			$	41,367,207			$	41,937,817			$	506,603			$	517,297

		2020			2019			2020			2019			2020			2019
Units, beginning of period			56,907				59,861				1,776,513				1,799,921				16,964				19,022
Units issued			9,392				7,259				118,164				259,115				525				46
Units redeemed			(11,652	)			(10,213	)			(118,034	)			(282,523	)			(1,409	)			(2,104	)
Units, end of period			54,647				56,907				1,776,643				1,776,513				16,080				16,964

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Managed Volatility Moderate Portfolio Series NAV			Mid Cap Index Trust Series I			Mid Cap Index Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	330,957			$	251,984			$	8,198			$	6,220			$	62,824			$	43,340
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			330,957				251,984				8,198				6,220				62,824				43,340
Realized gains (losses) on investments:
Capital gain distributions received			553,757				425,297				54,460				46,649				405,353				297,242
Net realized gain (loss)			(80,430	)			(87,494	)			(4,683	)			155				(15,065	)			(23,415	)
Realized gains (losses)			473,327				337,803				49,777				46,804				390,288				273,827
Unrealized appreciation (depreciation) during the period			(405,960	)			1,160,457				8,618				68,098				168,580				467,202
Net increase (decrease) in net assets from operations			398,324				1,750,244				66,593				121,122				621,692				784,369
Changes from principal transactions:
Purchase payments			840,100				925,796				3,903				4,348				277,510				263,250
Transfers between sub-accounts and the company			(110,718	)			(91,953	)			6,208				(44,577	)			41,626				(118,390	)
Transfers on general account policy loans			(4,490	)			(6,184	)			16				7				(11,051	)			123,711
Withdrawals			(152,199	)			(177,833	)			(41,198	)			(3,118	)			(107,920	)			(30,601	)
Annual contract fee			(589,989	)			(619,889	)			(17,717	)			(19,076	)			(189,037	)			(188,619	)
Net increase (decrease) in net assets from principal transactions			(17,296	)			29,937				(48,788	)			(62,416	)			11,128				49,351
Total increase (decrease) in net assets			381,028				1,780,181				17,805				58,706				632,820				833,720
Net assets at beginning of period			12,114,638				10,334,457				548,253				489,547				3,904,763				3,071,043
Net assets at end of period		$	12,495,666			$	12,114,638			$	566,058			$	548,253			$	4,537,583			$	3,904,763

		2020			2019			2020			2019			2020			2019
Units, beginning of period			534,457				532,753				8,647				9,697				93,675				92,620
Units issued			32,009				38,769				269				137				15,695				17,820
Units redeemed			(32,654	)			(37,065	)			(1,030	)			(1,187	)			(13,265	)			(16,765	)
Units, end of period			533,812				534,457				7,886				8,647				96,105				93,675

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Mid Cap Stock Trust Series I			Mid Cap Stock Trust Series NAV			Mid Value Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	-			$	-			$	-			$	-			$	4,398			$	2,876
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			-				-				-				-				4,398				2,876
Realized gains (losses) on investments:
Capital gain distributions received			88,874				73,205				398,351				338,739				6,245				33,258
Net realized gain (loss)			2,728				(1,858	)			82,861				20,266				(2,439	)			(570	)
Realized gains (losses)			91,602				71,347				481,212				359,005				3,806				32,688
Unrealized appreciation (depreciation) during the period			232,351				56,909				1,028,039				261,764				18,613				8,864
Net increase (decrease) in net assets from operations			323,953				128,256				1,509,251				620,769				26,817				44,428
Changes from principal transactions:
Purchase payments			23,400				20,952				180,697				151,516				5,430				5,523
Transfers between sub-accounts and the company			(13,797	)			(674	)			(187,671	)			60,749				(1,099	)			5,455
Transfers on general account policy loans			(30	)			9,658				(154	)			(591	)			85				(462	)
Withdrawals			(2,142	)			(531	)			(101,064	)			(94,395	)			(1,976	)			37
Annual contract fee			(28,060	)			(24,774	)			(134,836	)			(113,465	)			(5,917	)			(5,966	)
Net increase (decrease) in net assets from principal transactions			(20,629	)			4,631				(243,028	)			3,814				(3,477	)			4,587
Total increase (decrease) in net assets			303,324				132,887				1,266,223				624,583				23,340				49,015
Net assets at beginning of period			503,545				370,658				2,439,067				1,814,484				273,582				224,567
Net assets at end of period		$	806,869			$	503,545			$	3,705,290			$	2,439,067			$	296,922			$	273,582

		2020			2019			2020			2019			2020			2019
Units, beginning of period			8,431				8,349				18,718				18,747				7,402				7,263
Units issued			268				486				1,395				2,404				331				342
Units redeemed			(531	)			(404	)			(2,929	)			(2,433	)			(403	)			(203	)
Units, end of period			8,168				8,431				17,184				18,718				7,330				7,402

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY
For the years ended December 31,

		Mid Value Trust Series NAV			Money Market Trust Series I			Money-Market Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	21,087			$	14,775			$	6,606			$	41,313			$	33,350			$	111,370
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			21,087				14,775				6,606				41,313				33,350				111,370
Realized gains (losses) on investments:
Capital gain distributions received			29,134				162,455				-				-				2				1
Net realized gain (loss)			(82,447	)			(20,715	)			-				-				-				-
Realized gains (losses)			(53,313	)			141,740				-				-				2				1
Unrealized appreciation (depreciation) during the period			153,379				59,219				(1	)			(1	)			1				-
Net increase (decrease) in net assets from operations			121,153				215,734				6,605				41,312				33,353				111,371
Changes from principal transactions:
Purchase payments			84,681				90,221				11,444				27,188				3,487,668				13,086,236
Transfers between sub-accounts and the company			(16,913	)			(899	)			3,532				1,617				(7,372,295	)			(7,817,350	)
Transfers on general account policy loans			(75	)			1,077				(5,307	)			(6,637	)			(3,396	)			17,500
Withdrawals			(54,272	)			(18,744	)			(16,239	)			(4,748	)			(1,311,091	)			234,402
Annual contract fee			(57,402	)			(59,441	)			(60,980	)			(77,310	)			(352,963	)			(397,236	)
Net increase (decrease) in net assets from principal transactions			(43,981	)			12,214				(67,550	)			(59,890	)			(5,552,077	)			5,123,552
Total increase (decrease) in net assets			77,172				227,948				(60,945	)			(18,578	)			(5,518,724	)			5,234,923
Net assets at beginning of period			1,329,385				1,101,437				2,145,153				2,163,731				10,179,028				4,944,105
Net assets at end of period		$	1,406,557			$	1,329,385			$	2,084,208			$	2,145,153			$	4,660,304			$	10,179,028

		2020			2019			2020			2019			2020			2019
Units, beginning of period			23,361				23,127				152,943				157,256				975,555				482,975
Units issued			2,621				2,278				957				1,363				663,497				1,268,971
Units redeemed			(3,455	)			(2,044	)			(5,763	)			(5,676	)			(1,194,164	)			(776,391	)
Units, end of period			22,527				23,361				148,137				152,943				444,888				975,555

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Opportunistic Fixed Income Trust Series I			Opportunistic Fixed Income Trust Series NAV			PIMCO All Asset
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	6,452		$	13,120			$	47,027		$	69,889			$	23,339		$	12,725
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			6,452				13,120				47,027				69,889				23,339				12,725
Realized gains (losses) on investments:
Capital gain distributions received			-				-				-				4				(1	)			-
Net realized gain (loss)			195				(5,441	)			(2,100	)			(3,234	)			(2,053	)			310
Realized gains (losses)			195				(5,441	)			(2,100	)			(3,230	)			(2,054	)			310
Unrealized appreciation (depreciation) during the period			14,628				4,691				107,170				1,550				20,279				38,088
Net increase (decrease) in net assets from operations			21,275				12,370				152,097				68,209				41,564				51,123
Changes from principal transactions:
Purchase payments			1,834				1,834				76,595				77,630				40,500				44,303
Transfers between sub-accounts and the company			74				(52,564	)			(40,408	)			(21,630	)			4,786				(13,553	)
Transfers on general account policy loans			(7	)			(126	)			539				1,397				(7,771	)			28,442
Withdrawals			91				(7,095	)			(12,833	)			(14,208	)			(5,364	)			(810	)
Annual contract fee			(2,841	)			(4,303	)			(39,664	)			(41,108	)			(11,509	)			(12,899	)
Net increase (decrease) in net assets from principal transactions			(849	)			(62,254	)			(15,771	)			2,081				20,642				45,483
Total increase (decrease) in net assets			20,426				(49,884	)			136,326				70,290				62,206				96,606
Net assets at beginning of period			156,382				206,266				1,137,304				1,067,014				526,495				429,889
Net assets at end of period		$	176,808			$	156,382			$	1,273,630			$	1,137,304			$	588,701			$	526,495

		2020			2019			2020			2019			2020			2019
Units, beginning of period			6,425				9,016				32,644				32,577				27,331				24,870
Units issued			165				130				3,516				4,412				2,148				4,645
Units redeemed			(206	)			(2,721	)			(4,065	)			(4,345	)			(1,113	)			(2,184	)
Units, end of period			6,384				6,425				32,095				32,644				28,366				27,331

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Real Estate Securities Trust Series I			Real Estate Securities Trust Series NAV			Science & Technology Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	3,259			$	4,075			$	37,373			$	38,706			$	-			$	440
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			3,259				4,075				37,373				38,706				-				440
Realized gains (losses) on investments:
Capital gain distributions received			19,397				1,550				217,185				14,434				47,162				68,399
Net realized gain (loss)			1,052				8,811				32,650				78,715				4,979				10,384
Realized gains (losses)			20,449				10,361				249,835				93,149				52,141				78,783
Unrealized appreciation (depreciation) during the period			(34,033	)			33,332				(383,555	)			307,686				155,014				36,916
Net increase (decrease) in net assets from operations			(10,325	)			47,768				(96,347	)			439,541				207,155				116,139
Changes from principal transactions:
Purchase payments			7,840				11,863				99,774				101,211				10,154				8,627
Transfers between sub-accounts and the company			1,015				(26,724	)			67,184				(42,631	)			(1,935	)			(42,092	)
Transfers on general account policy loans			(518	)			(1,484	)			(11,825	)			33,773				(261	)			228
Withdrawals			(508	)			(6,704	)			(41,092	)			(46,534	)			(3,763	)			(741	)
Annual contract fee			(10,608	)			(12,821	)			(67,143	)			(74,442	)			(30,092	)			(26,202	)
Net increase (decrease) in net assets from principal transactions			(2,779	)			(35,870	)			46,898				(28,623	)			(25,897	)			(60,180	)
Total increase (decrease) in net assets			(13,104	)			11,898				(49,449	)			410,918				181,258				55,959
Net assets at beginning of period			178,676				166,778				1,915,727				1,504,809				377,165				321,206
Net assets at end of period		$	165,572			$	178,676			$	1,866,278			$	1,915,727			$	558,423			$	377,165

		2020			2019			2020			2019			2020			2019
Units, beginning of period			2,444				2,952				9,440				9,600				10,458				12,296
Units issued			115				139				1,058				922				247				176
Units redeemed			(159	)			(647	)			(758	)			(1,082	)			(872	)			(2,014	)
Units, end of period			2,400				2,444				9,740				9,440				9,833				10,458

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Science & Technology Trust Series NAV			Select Bond Trust Series I			Select Bond Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	-			$	7,229			$	1,209			$	610			$	42,748			$	34,441
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			-				7,229				1,209				610				42,748				34,441
Realized gains (losses) on investments:
Capital gain distributions received			599,973				717,015				-				-				1				(1	)
Net realized gain (loss)			173,604				70,712				52				-				5,492				(454	)
Realized gains (losses)			773,577				787,727				52				-				5,493				(455	)
Unrealized appreciation (depreciation) during the period			1,908,105				462,623				1,834				1,321				70,945				74,528
Net increase (decrease) in net assets from operations			2,681,682				1,257,579				3,095				1,931				119,186				108,514
Changes from principal transactions:
Purchase payments			262,705				247,908				883				879				63,646				60,456
Transfers between sub-accounts and the company			(60,442	)			331,469				14,226				-				36,120				34,030
Transfers on general account policy loans			44,282				(35,257	)			-				-				(367	)			(511	)
Withdrawals			(174,531	)			(44,559	)			-				-				(60,467	)			(21,766	)
Annual contract fee			(276,628	)			(226,631	)			(929	)			(630	)			(55,772	)			(55,560	)
Net increase (decrease) in net assets from principal transactions			(204,614	)			272,930				14,180				249				(16,840	)			16,649
Total increase (decrease) in net assets			2,477,068				1,530,509				17,275				2,180				102,346				125,163
Net assets at beginning of period			4,763,319				3,232,810				23,756				21,576				1,315,070				1,189,907
Net assets at end of period		$	7,240,387			$	4,763,319			$	41,031			$	23,756			$	1,417,416			$	1,315,070

		2020			2019			2020			2019			2020			2019
Units, beginning of period			79,005				74,042				1,833				1,814				101,083				99,701
Units issued			5,877				11,772				1,135				68				10,127				9,754
Units redeemed			(8,671	)			(6,809	)			(66	)			(49	)			(11,381	)			(8,372	)
Units, end of period			76,211				79,005				2,902				1,833				99,829				101,083

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Short Term Government Income Trust Series			Short Term Government Income Trust Series NAV			Small Cap Index Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	2,519		$	2,863			$	12,548		$	10,576			$	2,471		$	1,717
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			2,519				2,863				12,548				10,576				2,471				1,717
Realized gains (losses) on investments:
Capital gain distributions received			(1	)			-				1				-				12,827				16,026
Net realized gain (loss)			187				(3,993	)			(207	)			(1,417	)			1,177				610
Realized gains (losses)			186				(3,993	)			(206	)			(1,417	)			14,004				16,636
Unrealized appreciation (depreciation) during the period			2,546				9,894				11,613				11,740				19,456				18,911
Net increase (decrease) in net assets from operations			5,251				8,764				23,955				20,899				35,931				37,264
Changes from principal transactions:
Purchase payments			3,998				7,233				31,555				32,277				3,348				3,798
Transfers between sub-accounts and the company			(22	)			(57,336	)			94,277				4,529				45				2,968
Transfers on general account policy loans			125				100				(1,941	)			(1,004	)			23				14
Withdrawals			42				(113,949	)			(11,002	)			(10,991	)			(5,324	)			25
Annual contract fee			(10,888	)			(17,741	)			(36,549	)			(37,781	)			(5,618	)			(5,498	)
Net increase (decrease) in net assets from principal transactions			(6,745	)			(181,693	)			76,340				(12,970	)			(7,526	)			1,307
Total increase (decrease) in net assets			(1,494	)			(172,929	)			100,295				7,929				28,405				38,571
Net assets at beginning of period			147,836				320,765				619,285				611,356				186,624				148,053
Net assets at end of period		$	146,342			$	147,836			$	719,580			$	619,285			$	215,029			$	186,624

		2020			2019			2020			2019			2020			2019
Units, beginning of period			13,114				29,416				54,660				55,814				3,923				3,892
Units issued			357				660				30,086				2,930				134				121
Units redeemed			(940	)			(16,962	)			(23,468	)			(4,084	)			(267	)			(90	)
Units, end of period			12,531				13,114				61,278				54,660				3,790				3,923

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Small Cap Index Trust Series NAV			Small Cap Opportunities Trust Series I			Small Cap Opportunities Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	42,162			$	23,065			$	792			$	546			$	9,240			$	4,008
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			42,162				23,065				792				546				9,240				4,008
Realized gains (losses) on investments:
Capital gain distributions received			211,856				203,014				6,545				11,585				71,591				74,219
Net realized gain (loss)			(5,177	)			(9,093	)			(5,906	)			(8,124	)			(57,728	)			(13,999	)
Realized gains (losses)			206,679				193,921				639				3,461				13,863				60,220
Unrealized appreciation (depreciation) during the period			510,229				266,369				9,592				24,089				201,670				128,105
Net increase (decrease) in net assets from operations			759,070				483,355				11,023				28,096				224,773				192,333
Changes from principal transactions:
Purchase payments			153,185				138,772				5,227				5,369				51,309				53,743
Transfers between sub-accounts and the company			506,568				(92,965	)			3				(19,069	)			301,396				48,813
Transfers on general account policy loans			(10,819	)			107,995				210				35				(2,720	)			(1,925	)
Withdrawals			(46,381	)			(7,072	)			(6,956	)			-				(34,675	)			(8,519	)
Annual contract fee			(127,004	)			(118,591	)			(4,546	)			(5,529	)			(30,694	)			(29,749	)
Net increase (decrease) in net assets from principal transactions			475,549				28,139				(6,062	)			(19,194	)			284,616				62,363
Total increase (decrease) in net assets			1,234,619				511,494				4,961				8,902				509,389				254,696
Net assets at beginning of period			2,435,811				1,924,317				126,947				118,045				985,692				730,996
Net assets at end of period		$	3,670,430			$	2,435,811			$	131,908			$	126,947			$	1,495,081			$	985,692

		2020			2019			2020			2019			2020			2019
Units, beginning of period			64,021				63,256				2,364				2,759				37,165				34,617
Units issued			24,688				13,396				110				97				20,664				5,519
Units redeemed			(7,860	)			(12,631	)			(239	)			(492	)			(6,546	)			(2,971	)
Units, end of period			80,849				64,021				2,235				2,364				51,283				37,165

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Small Cap Stock Trust Series I			Small Cap Stock Trust Series NAV			Small Cap Value Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	-			$	-			$	-			$	-			$	232			$	340
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			-				-				-				-				232				340
Realized gains (losses) on investments:
Capital gain distributions received			5,439				11,893				271,724				482,488				2,573				4,917
Net realized gain (loss)			790				44				(34,278	)			(17,656	)			(389	)			(7,897	)
Realized gains (losses)			6,229				11,937				237,446				464,832				2,184				(2,980	)
Unrealized appreciation (depreciation) during the period			13,146				350				756,507				20,733				(4,540	)			16,159
Net increase (decrease) in net assets from operations			19,375				12,287				993,953				485,565				(2,124	)			13,519
Changes from principal transactions:
Purchase payments			659				849				147,076				140,199				-				-
Transfers between sub-accounts and the company			(9,347	)			(989	)			31,241				186,511				-				(44,622	)
Transfers on general account policy loans			-				-				(3,379	)			(3,416	)			-				-
Withdrawals			(49	)			8				(36,636	)			(19,539	)			7				(2,868	)
Annual contract fee			(614	)			(876	)			(99,261	)			(84,930	)			(939	)			(2,184	)
Net increase (decrease) in net assets from principal transactions			(9,351	)			(1,008	)			39,041				218,825				(932	)			(49,674	)
Total increase (decrease) in net assets			10,024				11,279				1,032,994				704,390				(3,056	)			(36,155	)
Net assets at beginning of period			43,745				32,466				1,925,858				1,221,468				28,636				64,791
Net assets at end of period		$	53,769			$	43,745			$	2,958,852			$	1,925,858			$	25,580			$	28,636

		2020			2019			2020			2019			2020			2019
Units, beginning of period			1,026				1,051				37,980				33,266				838				2,399
Units issued			14				22				3,694				7,089				-				-
Units redeemed			(208	)			(47	)			(3,189	)			(2,375	)			(36	)			(1,561	)
Units, end of period			832				1,026				38,485				37,980				802				838

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Small Cap Value Trust Series NAV			Small Company Value Trust Series I			Small Company Value Trust Series NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	21,546			$	12,812			$	265			$	806			$	2,682			$	7,390
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			21,546				12,812				265				806				2,682				7,390
Realized gains (losses) on investments:
Capital gain distributions received			228,416				140,290				6,076				45,215				52,826				390,469
Net realized gain (loss)			(92,690	)			(94,908	)			(15,008	)			(1,976	)			(72,646	)			(53,323	)
Realized gains (losses)			135,726				45,382				(8,932	)			43,239				(19,820	)			337,146
Unrealized appreciation (depreciation) during the period			(248,140	)			412,282				17,831				(23,737	)			111,767				(169,039	)
Net increase (decrease) in net assets from operations			(90,868	)			470,476				9,164				20,308				94,629				175,497
Changes from principal transactions:
Purchase payments			113,482				103,018				4,669				4,384				42,574				47,652
Transfers between sub-accounts and the company			137,834				(117,895	)			643				(23	)			12,313				29,681
Transfers on general account policy loans			(2,075	)			2,110				407				618				-				(200	)
Withdrawals			(21,027	)			(11,562	)			(5,240	)			(477	)			(12,811	)			(59,724	)
Annual contract fee			(68,044	)			(74,487	)			(4,164	)			(4,523	)			(31,748	)			(34,085	)
Net increase (decrease) in net assets from principal transactions			160,170				(98,816	)			(3,685	)			(21	)			10,328				(16,676	)
Total increase (decrease) in net assets			69,302				371,660				5,479				20,287				104,957				158,821
Net assets at beginning of period			2,183,857				1,812,197				100,138				79,851				840,342				681,521
Net assets at end of period		$	2,253,159			$	2,183,857			$	105,617			$	100,138			$	945,299			$	840,342

		2020			2019			2020			2019			2020			2019
Units, beginning of period			22,659				23,808				1,649				1,651				24,135				24,594
Units issued			4,598				1,719				202				71				2,758				2,204
Units redeemed			(2,205	)			(2,868	)			(259	)			(73	)			(2,043	)			(2,663	)
Units, end of period			25,052				22,659				1,592				1,649				24,850				24,135

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Strategic Income Opportunities Trust Series I			Strategic Income Opportunities Trust Series NAV			Total Bond Market Series Trust NAV
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	3,758			$	5,828			$	40,151			$	61,531			$	30,386			$	20,450
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			3,758				5,828				40,151				61,531				30,386				20,450
Realized gains (losses) on investments:
Capital gain distributions received			1				-				(1	)			(1	)			(5	)			3
Net realized gain (loss)			45				(32	)			205				(1,300	)			4,655				(1,986	)
Realized gains (losses)			46				(32	)			204				(1,301	)			4,650				(1,983	)
Unrealized appreciation (depreciation) during the period			14,596				13,521				149,808				151,383				36,686				48,503
Net increase (decrease) in net assets from operations			18,400				19,317				190,163				211,613				71,722				66,970
Changes from principal transactions:
Purchase payments			5,955				5,549				143,781				167,393				49,927				58,992
Transfers between sub-accounts and the company			4,163				625				34,054				113,350				418,447				56,353
Transfers on general account policy loans			3,465				38,826				25,914				28,150				3,427				44,336
Withdrawals			35				(2,416	)			(87,145	)			(42,215	)			(14,463	)			(14,634	)
Annual contract fee			(10,492	)			(10,082	)			(95,745	)			(94,407	)			(56,087	)			(49,979	)
Net increase (decrease) in net assets from principal transactions			3,126				32,502				20,859				172,271				401,251				95,068
Total increase (decrease) in net assets			21,526				51,819				211,022				383,884				472,973				162,038
Net assets at beginning of period			219,057				167,238				2,228,360				1,844,476				899,172				737,134
Net assets at end of period		$	240,583			$	219,057			$	2,439,382			$	2,228,360			$	1,372,145			$	899,172

		2020			2019			2020			2019			2020			2019
Units, beginning of period			7,168				6,070				98,053				90,088				33,180				29,458
Units issued			461				1,500				11,936				14,745				17,796				7,114
Units redeemed			(379	)			(402	)			(11,148	)			(6,780	)			(3,824	)			(3,392	)
Units, end of period			7,250				7,168				98,841				98,053				47,152				33,180

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Total Stock Market Index Trust Series I			Total Stock Market Index Trust Series NAV			Ultra Short Term Bond Trust Series I
		2020			2019			2020			2019			2020			2019
Income:
Dividend distributions received		$	4,462			$	4,273			$	136,618			$	84,277			$	11,539			$	8,376
Expenses:
Mortality and expense risk and administrative charges			-				-				-				-				-				-
Net investment income (loss)			4,462				4,273				136,618				84,277				11,539				8,376
Realized gains (losses) on investments:
Capital gain distributions received			22,255				20,825				663,900				343,847				-				-
Net realized gain (loss)			9,133				7,055				140,375				109,705				(142	)			(173	)
Realized gains (losses)			31,388				27,880				804,275				453,552				(142	)			(173	)
Unrealized appreciation (depreciation) during the period			14,064				35,905				736,994				748,325				(2,389	)			(4,766	)
Net increase (decrease) in net assets from operations			49,914				68,058				1,677,887				1,286,154				9,008				3,437
Changes from principal transactions:
Purchase payments			2,328				2,367				289,005				285,151				-				-
Transfers between sub-accounts and the company			6,135				(70,844	)			1,521,129				151,735				-				613,202
Transfers on general account policy loans			(783	)			24,424				(7,769	)			(24,918	)			-				-
Withdrawals			(43,754	)			35				(202,077	)			(35,546	)			-				(2,517	)
Annual contract fee			(10,485	)			(12,093	)			(204,121	)			(173,962	)			(28,674	)			(7,409	)
Net increase (decrease) in net assets from principal transactions			(46,559	)			(56,111	)			1,396,167				202,460				(28,674	)			603,276
Total increase (decrease) in net assets			3,355				11,947				3,074,054				1,488,614				(19,666	)			606,713
Net assets at beginning of period			257,168				245,221				5,755,000				4,266,386				628,513				21,800
Net assets at end of period		$	260,523			$	257,168			$	8,829,054			$	5,755,000			$	608,847			$	628,513

		2020			2019			2020			2019			2020			2019
Units, beginning of period			6,526				8,066				43,744				42,060				59,132				2,115
Units issued			252				814				15,058				4,752				-				59,796
Units redeemed			(1,335	)			(2,354	)			(3,569	)			(3,068	)			(2,679	)			(2,779	)
Units, end of period			5,443				6,526				55,233				43,744				56,453				59,132

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY

For the years ended December 31,

		Ultra Short Term Bond Trust Series NAV
		2020			2019
Income:
Dividend distributions received		$	10,253			$	9,060
Expenses:
Mortality and expense risk and administrative charges			-				-
Net investment income (loss)			10,253				9,060
Realized gains (losses) on investments:
Capital gain distributions received			-				-
Net realized gain (loss)			(189	)			(267	)
Realized gains (losses)			(189	)			(267	)
Unrealized appreciation (depreciation) during the period			(2,473	)			4,016
Net increase (decrease) in net assets from operations			7,591				12,809
Changes from principal transactions:
Purchase payments			28,390				29,626
Transfers between sub-accounts and the company			61,918				121,480
Transfers on general account policy loans			(44	)			24,643
Withdrawals			17				(1	)
Annual contract fee			(20,036	)			(16,203	)
Net increase (decrease) in net assets from principal transactions			70,245				159,545
Total increase (decrease) in net assets			77,836				172,354
Net assets at beginning of period			493,635				321,281
Net assets at end of period		$	571,471			$	493,635

		2020			2019
Units, beginning of period			46,238				31,020
Units issued			19,190				17,841
Units redeemed			(12,752	)			(2,623	)
Units, end of period			52,676				46,238

See accompanying notes.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS

December 31, 2020

1. Organization

John Hancock Life Insurance Company of New York Separate Account B (the 'Account') is a separate account established by John Hancock Life Insurance Company of New York (the 'Company'). The Account operates as a Unit Investment Trust under the Investment Company Act of 1940, as amended (the 'Act') and is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board ('FASB') Accounting Standards Codification ('ASC') Topic 946 Financial Services - Investment Companies. The Account consists of 89 active sub-accounts which are exclusively invested in a corresponding portfolio of the John Hancock Variable Insurance Trust (the 'Trust'), and 5 active sub-accounts that are invested in portfolios of other Non-affiliated Trusts (the 'Non-affiliated Trusts'). The Trust and Non-affiliated Trusts are registered under the Act as an open-ended management investment company, commonly known as a mutual fund, which does not transact with the general public. The Account is a funding vehicle for the allocation of net premiums under single premium variable life and variable universal life insurance contracts (the 'Contracts') issued by the Company.

The Company is a wholly owned subsidiary of John Hancock Life Insurance Company (U.S.A.) ('JHUSA'), which in turn is an indirect, wholly owned subsidiary of the Manufacturers Life Insurance Company which is an indirect, wholly owned subsidiary of Manulife Financial Corporation (''MFC''), a Canadian based publicly traded life insurance company. MFC and its subsidiaries are known collectively as Manulife Financial.

The Company is required to maintain assets in the Account with a total fair value of at least equal to the reserves and other liabilities relating to the variable benefits under all Contracts participating in the Account. These assets may not be charged with liabilities which arise from any other business the Company conducts. However, all obligations under the Contracts are general corporate obligations of the Company.

In addition to the Account, certain contract owners may also allocate funds to the fixed account, which is part of the Company's general account. Because of exemptive and exclusionary provisions, interests in the fixed account have not been registered under the Securities Act of 1933, and the Company's general account has not been registered as an investment company under the Investment Company Act of 1940. Net interfund transfers include transfers between separate and general accounts.

Each sub-account holds shares of a particular series ('Portfolio') of a registered investment company. Sub-accounts that invest in Portfolios of the Trust may offer 2 classes of units to fund Contracts issued by the Company. These classes, Series I and Series NAV, represent an interest in the same Trust Portfolio, but in different classes of that Portfolio. Series I and Series NAV shares of the Trust Portfolio differ in the level of 12b-1 fees and other expenses assessed against the Portfolio's assets.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS (CONTINUED)

December 31, 2020

2.	Significant Accounting Policies

Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from reported results using those estimates.

The Company's results and operations have been and may continue to be adversely impacted by the COVID-19 pandemic and the recent economic downturn. The adverse effects include but are not limited to significant volatility in equity markets and decline in interest rates, increase in credit risk, strain on commodity markets, foreign currency exchange rate volatility, increases in insurance claims, persistency and redemptions, and disruption of business operations. The breadth and depth of these events and how long they will continue have introduced additional uncertainty around estimates used in determining the carrying value of certain assets and liabilities included in these financial statements.

Valuation of Investments

Investments made in the Portfolios of the Trust, and of the Non-affiliated Trusts, are valued at fair value based on the reported net asset values of such Portfolios. Investment transactions are recorded on the trade date. Income from dividends, and gains from realized gain distributions are recorded on the ex-dividend date. Realized gains and losses on the sales of investments are computed on a first-in, first-out basis.

Amounts Receivable/Payable

Receivables/Payables from/to Portfolios/the Company are due to unsettled contract transactions (net of asset-based charges) and/or subsequent/preceding purchases/sales of the respective Portfolios' shares. The amounts are due from/to either the respective Portfolio and/or the Company for the benefit of contract owners. There are no unsettled policy transactions at December 31, 2020.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS

December 31, 2020

3.Federal Income Taxes

The Account does not file separate tax returns. The taxable income of the Account is consolidated with that of the Company within the consolidated federal tax return. Any tax contingencies arising from the taxable income generated by the Account is the responsibility of the Company and the Company holds any and all tax contingencies on its financial statements. The Company's consolidated federal tax return for the years 2014 and 2015 are currently under examination by the Internal Revenue Service. The years from 2015 are also open for examination by the internal revenue service. The Account is not a party to the consolidated tax sharing agreement thus no amount of income taxes or tax contingencies are passed through to the Account. The legal form of the Account is not taxable in any state or foreign jurisdictions.

The income taxes topic of the FASB ASC establishes a minimum threshold for financial statement recognition of the benefit of positions taken, or expected to be taken, in filing tax returns (including whether the Account is taxable in certain jurisdictions). The topic requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether tax positions are 'more-likely-than-not' of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold would be recorded as tax expense or benefit.

The Account complies with the provisions of FASB ASC Topic 740, Income Taxes. As of December 31, 2020, the Account did not have a liability for any uncertain tax positions. The Account recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statements of Operations and Changes in Contract Owners' Equity.

4.Transactions with Affiliates

The Company has an administrative services agreement with Manulife Financial, whereby Manulife Financial or its designee, with the consent of the Company, performs certain services on behalf of the Company necessary for the operation of the Account. John Hancock Investment Management Services, LLC ('JHIMS'), a Delaware limited liability company controlled by MFC, serves as investment adviser for the Trust.

John Hancock Distributors, LLC, a registered broker-dealer and wholly owned subsidiary of JHUSA, acts as the principle underwriter of the Contracts pursuant to a distribution agreement with the Company. Contracts are sold by registered representatives of either John Hancock Distributors, LLC or other broker-dealers having distribution agreements with John Hancock Distributors, LLC.

Certain officers of the Account are officers and directors of JHUSA or the Trust.

Contract charges, as described in Note 9, are paid to the Company.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS (CONTINUED)

December 31, 2020

5.Fair Value Measurements

ASC 820 'Fair Value Measurements and Disclosures' provides a single definition of fair value for accounting purposes, establishes a consistent framework for measuring fair value, and expands disclosure requirements about fair value measurements. ASC 820 defines fair value as the value that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. An exit value is not a forced liquidation or distressed sale.

Following ASC 820 guidance, the Account has categorized its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Account's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

●	Level 1 - Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Account has the ability to access at the measurement date.

●	Level 2 - Fair value measurements using inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.

●	Level 3 - Fair value measurements using significant non market observable inputs.

All of the Account's sub-accounts' investments in a Portfolio of the Trust were valued at the reported net asset value of the Portfolio and categorized as Level 1 as of December 31, 2020. The following table presents the Account's assets that are measured at fair value on a recurring basis by fair value hierarchy level under ASC 820, as of December 31, 2020:

		Level 1			Level 2			Level 3			Total
Mutual Funds
Affiliated		$	360,995,490				-				-				360,995,490
NonAffiliated		$	4,572,788				-				-				4,572,788
Total		$	365,568,278				-				-				365,568,278

Assets owned by the Account are primarily open-ended mutual fund investments issued by the Trust. These are classified within Level 1, as fair values of the underlying funds are based upon reported net asset values ('NAV'), which represent the values at which each sub-account can redeem its investments.

Changes in valuation techniques may result in transfer in or out of an assigned level within the disclosure hierarchy. Transfers between investment levels may occur as the availability of a price source or data used in an investment's valuation changes. Transfers between investment levels are recognized at the beginning of the reporting period. There have been no transfers between any level of fair value measurements during the period ended December 31, 2020.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS (CONTINUED)

December 31, 2020

6.Purchases and Sales of Investments

The cost of purchases including reinvestment of dividend distributions and proceeds from the sales of investments in the Portfolios of the Trust and Non-affiliated Trusts during 2020 were as follows:

Sub-Account		Purchases			Sales
500 Index Fund Series NAV		$	6,291,096			$	3,111,721
Active Bond Trust Series I			45,504				62,006
Active Bond Trust Series NAV			368,737				201,628
American Asset Allocation Trust Series I			1,605,373				1,153,127
American Global Growth Trust Series I			216,714				112,972
American Growth Trust Series I			1,155,500				511,960
American Growth-Income Trust Series I			1,008,422				350,259
American International Trust Series I			414,091				235,856
Blue Chip Growth Trust Series I			206,030				54,615
Blue Chip Growth Trust Series NAV			3,954,031				1,390,825
Capital Appreciation Trust Series I			164,642				72,583
Capital Appreciation Trust Series NAV			724,769				385,006
Capital Appreciation Value Trust Series I			0				621
Capital Appreciation Value Trust Series NAV			1,753,328				837,737
Core Bond Trust Series I			32,295				40,609
Core Bond Trust Series NAV			1,117,197				780,071
Disciplined Value International Trust Series I			26,937				9,572
Disciplined Value International Trust Series NAV			244,463				202,369
Emerging Markets Value Trust Series I			12,798				19,595
Emerging Markets Value Trust Series NAV			294,789				192,605
Equity Income Trust Series I			113,787				37,107
Equity Income Trust Series NAV			885,076				301,662
Financial Industries Trust Series I			15,722				2,964
Financial Industries Trust Series NAV			237,215				102,345
Fundamental All Cap Core Trust Series I			2,229				2,172
Fundamental All Cap Core Trust Series NAV			226,313				188,465
Fundamental Large Cap Value Trust Series I			60,636				23,560
Fundamental Large Cap Value Trust Series NAV			288,868				156,460
Global Trust Series I			7,945				7,588
Global Trust Series NAV			118,761				112,340
Health Sciences Trust Series I			34,266				19,060
Health Sciences Trust Series NAV			846,760				384,914
High Yield Trust Series I			33,721				15,512
High Yield Trust Series NAV			419,898				259,273
International Equity Index Series I			15,375				17,947
International Equity Index Series NAV			1,797,091				488,397
International Small Company Trust Series I			3,749				2,737
International Small Company Trust Series NAV			241,515				141,069
Investment Quality Bond Trust Series I			22,830				18,420
Investment Quality Bond Trust Series NAV			297,588				244,573
Lifestyle Aggressive Portfolio Series NAV			163,425				33,027
Lifestyle Balanced Portfolio Series NAV			465,386				262,617
Lifestyle Conservative Portfolio Series NAV			48,677				48,962
Lifestyle Growth Portfolio Series NAV			3,244,353				945,795
Lifestyle Moderate Portfolio Series NAV			253,475				92,698
M Capital Appreciation			110,369				200,031
M International Equity			156,297				47,009
M Large Cap Growth			355,652				373,884
M Large Cap Value			226,789				36,390

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B

NOTES TO FINANCIAL STATEMENTS (CONTINUED)

December 31, 2020

6.Purchases and Sales of Investments (continued):

Sub-Account		Purchases			Sales
Managed Volatility Aggressive Portfolio Series I		$	50,012			$	11,422
Managed Volatility Aggressive Portfolio Series NAV			1,643,274				1,209,117
Managed Volatility Balanced Portfolio Series I			100,878				325,343
Managed Volatility Balanced Portfolio Series NAV			5,990,004				2,354,782
Managed Volatility Conservative Portfolio Series I			9,111				6,231
Managed Volatility Conservative Portfolio Series NAV			1,088,231				838,214
Managed Volatility Growth Portfolio Series I			368,741				295,815
Managed Volatility Growth Portfolio Series NAV			5,728,593				2,578,597
Managed Volatility Moderate Portfolio Series I			50,824				42,289
Managed Volatility Moderate Portfolio Series NAV			1,587,245				719,827
Mid Cap Index Trust Series I			77,402				63,531
Mid Cap Index Trust Series NAV			998,168				518,862
Mid Cap Stock Trust Series I			106,910				38,666
Mid Cap Stock Trust Series NAV			616,547				461,223
Mid Value Trust Series I			21,218				14,054
Mid Value Trust Series NAV			180,701				174,458
Money Market Trust Series I			20,060				81,005
Money-Market Trust Series NAV			6,968,167				12,486,891
Opportunistic Fixed Income Trust Series I			10,888				5,285
Opportunistic Fixed Income Trust Series NAV			177,934				146,679
PIMCO All Asset			64,387				20,407
Real Estate Securities Trust Series I			30,006				10,129
Real Estate Securities Trust Series NAV			434,312				132,856
Science & Technology Trust Series I			56,862				35,598
Science & Technology Trust Series NAV			1,006,022				610,661
Select Bond Trust Series I			16,292				903
Select Bond Trust Series NAV			180,172				154,262
Short Term Government Income Trust Series I			6,667				10,894
Short Term Government Income Trust Series NAV			363,250				274,360
Small Cap Index Trust Series I			19,843				12,070
Small Cap Index Trust Series NAV			1,016,018				286,452
Small Cap Opportunities Trust Series I			12,227				10,953
Small Cap Opportunities Trust Series NAV			512,754				147,307
Small Cap Stock Trust Series I			6,093				10,006
Small Cap Stock Trust Series NAV			474,862				164,095
Small Cap Value Trust Series I			2,805				931
Small Cap Value Trust Series NAV			577,086				166,956
Small Company Value Trust Series I			17,302				14,647
Small Company Value Trust Series NAV			133,049				67,213
Strategic Income Opportunities Trust Series I			18,390				11,505
Strategic Income Opportunities Trust Series NAV			312,243				251,234
Total Bond Market Series Trust NAV			540,354				108,723
Total Stock Market Index Trust Series I			38,066				57,908
Total Stock Market Index Trust Series NAV			2,696,804				500,120
Ultra Short Term Bond Trust Series I			11,539				28,674
Ultra Short Term Bond Trust Series NAV			217,018				136,519

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7. Unit Values

A summary of unit values and units outstanding for variable life contracts and the expense and income ratios, excluding expenses of the underlying Portfolios, were as follows:

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
500 Index Fund Series NAV(*)		2020		429		$ 86.62 to $ 54.15		$ 36,399		0.00 % to 0.00 %		1.97 %		18.14 % to 18.14 %
		2019		400		73.32 to 45.84		28,644		0.00 to 0.00		1.81		31.16 to 31.16
		2018		381		55.90 to 34.95		20,776		0.00 to 0.00		1.42		-4.64 to -4.65
		2017		369		58.62 to 36.65		21,067		0.00 to 0.00		1.81		21.54 to 21.54
		2016		360		48.23 to 30.16		16,841		0.00 to 0.00		2.20		11.64 to 11.64
Active Bond Trust Series I(*)		2020		17		28.22 to 28.22		474		0.00 to 0.00		2.99		8.79 to 8.79
		2019		18		25.94 to 25.94		465		0.00 to 0.00		2.77		9.26 to 9.26
		2018		18		23.74 to 23.74		434		0.00 to 0.00		3.20		-0.60 to -0.60
		2017		18		23.89 to 23.89		435		0.00 to 0.00		4.01		4.84 to 4.84
		2016		13		22.78 to 22.78		287		0.00 to 0.00		3.29		4.34 to 4.34
Active Bond Trust Series NAV(*)		2020		22		92.17 to 92.17		2,012		0.00 to 0.00		3.08		8.73 to 8.73
		2019		21		84.77 to 84.77		1,750		0.00 to 0.00		2.91		9.29 to 9.29
		2018		18		77.56 to 77.56		1,404		0.00 to 0.00		3.38		-0.55 to -0.55
		2017		16		77.99 to 77.99		1,282		0.00 to 0.00		3.59		4.89 to 4.89
		2016		14		74.36 to 74.36		1,077		0.00 to 0.00		3.76		4.50 to 4.50
American Asset Allocation Trust Series I(*)		2020		322		24.97 to 24.97		8,049		0.00 to 0.00		1.40		12.02 to 12.02
		2019		347		22.29 to 22.29		7,731		0.00 to 0.00		1.50		20.78 to 20.78
		2018		303		18.46 to 18.46		5,591		0.00 to 0.00		1.85		-4.91 to -4.91
		2017		259		19.41 to 19.41		5,030		0.00 to 0.00		1.33		15.79 to 15.79
		2016		185		16.76 to 16.76		3,107		0.00 to 0.00		1.48		8.99 to 8.99
American Global Growth Trust Series I(*)		2020		30		32.61 to 32.61		984		0.00 to 0.00		0.07		29.96 to 29.96
		2019		29		25.09 to 25.09		725		0.00 to 0.00		0.68		34.71 to 34.71
		2018		24		18.63 to 18.63		453		0.00 to 0.00		0.73		-9.37 to -9.37
		2017		18		20.55 to 20.55		374		0.00 to 0.00		0.27		30.92 to 30.92
		2016		17		15.70 to 15.70		267		0.00 to 0.00		1.08		0.29 to 0.29
American Growth Trust Series I(*)		2020		104		92.82 to 61.65		6,852		0.00 to 0.00		0.09		51.52 to 51.52
		2019		105		61.26 to 40.69		4,611		0.00 to 0.00		0.85		30.30 to 30.30
		2018		103		47.01 to 31.23		3,478		0.00 to 0.00		0.39		-0.66 to -0.66
		2017		101		47.32 to 31.43		3,441		0.00 to 0.00		0.37		27.87 to 27.86
		2016		102		37.01 to 24.58		2,672		0.00 to 0.00		0.41		9.08 to 9.07
American Growth-Income Trust Series I(*)		2020		107		56.83 to 38.08		4,509		0.00 to 0.00		1.43		13.11 to 13.11
		2019		105		50.25 to 33.66		3,925		0.00 to 0.00		1.59		25.70 to 25.70
		2018		101		39.97 to 26.78		3,020		0.00 to 0.00		1.51		-2.18 to -2.18
		2017		95		40.87 to 27.38		2,932		0.00 to 0.00		1.10		22.03 to 22.03
		2016		95		33.49 to 22.44		2,394		0.00 to 0.00		1.60		11.10 to 11.10
American International Trust Series I(*)		2020		117		50.02 to 28.41		3,453		0.00 to 0.00		0.39		13.56 to 13.55
		2019		114		44.04 to 25.02		2,988		0.00 to 0.00		1.00		22.40 to 22.40
		2018		115		35.98 to 20.44		2,457		0.00 to 0.00		2.91		-13.46 to -13.46
		2017		94		41.58 to 23.62		2,325		0.00 to 0.00		0.99		31.65 to 31.65
		2016		83		31.58 to 17.94		1,603		0.00 to 0.00		1.00		3.12 to 3.12
Blue Chip Growth Trust Series I(*)		2020		23		64.62 to 64.62		1,475		0.00 to 0.00		0.00		34.30 to 34.30
		2019		23		48.11 to 48.11		1,127		0.00 to 0.00		0.00		29.79 to 29.79
		2018		25		37.07 to 37.07		930		0.00 to 0.00		0.02		1.97 to 1.97
		2017		25		36.35 to 36.35		902		0.00 to 0.00		0.07		36.28 to 36.28
		2016		27		26.67 to 26.67		722		0.00 to 0.00		0.01		0.81 to 0.81
Blue Chip Growth Trust Series NAV(*)		2020		56		332.65 to 332.65		18,636		0.00 to 0.00		0.00		34.40 to 34.40
		2019		55		247.50 to 247.50		13,528		0.00 to 0.00		0.01		29.83 to 29.83
		2018		50		190.64 to 190.64		9,553		0.00 to 0.00		0.06		2.03 to 2.03
		2017		44		186.84 to 186.84		8,271		0.00 to 0.00		0.11		36.34 to 36.34
		2016		52		137.04 to 137.04		7,175		0.00 to 0.00		0.06		0.85 to 0.85
Capital Appreciation Trust Series I(*)		2020		11		76.72 to 76.72		830		0.00 to 0.00		0.00		56.04 to 56.04
		2019		11		49.17 to 49.17		518		0.00 to 0.00		0.04		32.89 to 32.89
		2018		11		37.00 to 37.00		401		0.00 to 0.00		0.27		-0.80 to -0.80
		2017		11		37.30 to 37.30		417		0.00 to 0.00		0.06		36.53 to 36.53
		2016		12		27.32 to 27.32		323		0.00 to 0.00		0.00		-1.08 to -1.08
Capital Appreciation Trust Series NAV(*)		2020		51		75.55 to 75.55		3,877		0.00 to 0.00		0.00		56.29 to 56.29
		2019		52		48.34 to 48.34		2,500		0.00 to 0.00		0.04		32.88 to 32.88
		2018		51		36.38 to 36.38		1,857		0.00 to 0.00		0.37		-0.72 to -0.72
		2017		34		36.64 to 36.64		1,239		0.00 to 0.00		0.11		36.51 to 36.51
		2016		124		26.84 to 26.84		3,318		0.00 to 0.00		0.01		-1.00 to -1.00
Capital Appreciation Value Trust Series NAV(*)		2020		311		33.74 to 33.74		10,511		0.00 to 0.00		1.15		17.41 to 17.41
		2019		311		28.74 to 28.74		8,948		0.00 to 0.00		1.54		24.44 to 24.44
		2018		274		23.09 to 23.09		6,327		0.00 to 0.00		2.34		0.45 to 0.45
		2017		235		22.99 to 22.99		5,394		0.00 to 0.00		1.46		15.13 to 15.13
		2016		149		19.97 to 19.97		2,966		0.00 to 0.00		1.66		8.19 to 8.19

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Core Bond Trust Series I(*)		2020		22		$ 25.24 to $ 25.24		$ 555		0.00 % to 0.00 %		2.34 %		8.62 % to 8.62 %
		2019		23		23.23 to 23.23		531		0.00 to 0.00		2.25		8.32 to 8.32
		2018		28		21.45 to 21.45		603		0.00 to 0.00		2.47		-0.59 to -0.59
		2017		29		21.58 to 21.58		619		0.00 to 0.00		2.02		3.40 to 3.40
		2016		31		20.87 to 20.87		651		0.00 to 0.00		1.89		2.74 to 2.74
Core Bond Trust Series NAV(*)		2020		242		20.33 to 20.33		4,918		0.00 to 0.00		2.43		8.79 to 8.79
		2019		231		18.69 to 18.69		4,312		0.00 to 0.00		2.62		8.33 to 8.33
		2018		174		17.25 to 17.25		3,009		0.00 to 0.00		2.65		-0.54 to -0.54
		2017		161		17.35 to 17.35		2,790		0.00 to 0.00		2.26		3.47 to 3.47
		2016		141		16.76 to 16.76		2,357		0.00 to 0.00		2.12		2.73 to 2.73
Disciplined Value International Trust Series I(*)		2020		12		28.61 to 28.61		350		0.00 to 0.00		2.23		3.28 to 3.28
		2019		12		27.71 to 27.71		325		0.00 to 0.00		2.73		12.33 to 12.33
		2018		13		24.66 to 24.66		320		0.00 to 0.00		2.51		-15.03 to -15.03
		2017		13		29.03 to 29.03		371		0.00 to 0.00		1.87		17.14 to 17.14
		2016		13		24.78 to 24.78		318		0.00 to 0.00		2.67		12.24 to 12.24
Disciplined Value International Trust Series NAV(*)		2020		115		18.50 to 18.50		2,128		0.00 to 0.00		2.29		3.27 to 3.27
		2019		114		17.92 to 17.92		2,051		0.00 to 0.00		2.99		12.40 to 12.40
		2018		107		15.94 to 15.94		1,713		0.00 to 0.00		2.61		-14.96 to -14.96
		2017		98		18.75 to 18.75		1,835		0.00 to 0.00		1.91		17.25 to 17.25
		2016		100		15.99 to 15.99		1,596		0.00 to 0.00		4.13		12.20 to 12.20
Emerging Markets Value Trust Series I(*)		2020		5		17.74 to 17.74		89		0.00 to 0.00		2.51		3.56 to 3.56
		2019		6		17.13 to 17.13		98		0.00 to 0.00		3.24		10.94 to 10.94
		2018		5		15.44 to 15.44		83		0.00 to 0.00		2.58		-13.59 to -13.59
		2017		5		17.87 to 17.87		94		0.00 to 0.00		2.15		32.69 to 32.69
		2016		4		13.47 to 13.47		49		0.00 to 0.00		5.49		18.00 to 18.00
Emerging Markets Value Trust Series NAV(*)		2020		112		14.29 to 14.29		1,604		0.00 to 0.00		2.62		3.72 to 3.72
		2019		105		13.78 to 13.78		1,446		0.00 to 0.00		3.36		10.90 to 10.90
		2018		97		12.43 to 12.43		1,204		0.00 to 0.00		2.70		-13.48 to -13.48
		2017		94		14.36 to 14.36		1,348		0.00 to 0.00		1.53		32.67 to 32.67
		2016		69		10.83 to 10.83		746		0.00 to 0.00		2.52		18.09 to 18.09
Equity Income Trust Series I(*)		2020		18		41.37 to 41.37		752		0.00 to 0.00		3.08		1.02 to 1.02
		2019		18		40.96 to 40.96		737		0.00 to 0.00		2.24		26.34 to 26.34
		2018		15		32.42 to 32.42		492		0.00 to 0.00		1.87		-9.58 to -9.58
		2017		16		35.85 to 35.85		568		0.00 to 0.00		2.26		16.28 to 16.28
		2016		17		30.83 to 30.83		518		0.00 to 0.00		2.24		19.12 to 19.12
Equity Income Trust Series NAV(*)		2020		80		68.54 to 68.54		5,512		0.00 to 0.00		3.16		1.01 to 1.01
		2019		79		67.86 to 67.86		5,371		0.00 to 0.00		2.38		26.47 to 26.47
		2018		67		53.66 to 53.66		3,581		0.00 to 0.00		1.93		-9.52 to -9.52
		2017		70		59.30 to 59.30		4,144		0.00 to 0.00		1.83		16.28 to 16.28
		2016		103		51.00 to 51.00		5,239		0.00 to 0.00		2.32		19.18 to 19.18
Financial Industries Trust Series I(*)		2020		4		36.49 to 36.49		150		0.00 to 0.00		1.39		2.17 to 2.17
		2019		4		35.71 to 35.71		149		0.00 to 0.00		4.47		31.79 to 31.79
		2018		4		27.10 to 27.10		96		0.00 to 0.00		1.16		-14.49 to -14.49
		2017		4		31.69 to 31.69		116		0.00 to 0.00		1.10		15.29 to 15.29
		2016		4		27.49 to 27.49		104		0.00 to 0.00		1.28		19.37 to 19.37
Financial Industries Trust Series NAV(*)		2020		23		44.06 to 44.06		1,026		0.00 to 0.00		1.49		2.31 to 2.31
		2019		22		43.07 to 43.07		957		0.00 to 0.00		4.46		31.71 to 31.71
		2018		22		32.70 to 32.70		721		0.00 to 0.00		1.19		-14.38 to -14.38
		2017		22		38.19 to 38.19		842		0.00 to 0.00		0.82		15.29 to 15.29
		2016		16		33.13 to 33.13		540		0.00 to 0.00		1.54		19.47 to 19.47
Fundamental All Cap Core Trust Series I(*)		2020		0		78.90 to 78.90		3		0.00 to 0.00		0.38		26.88 to 26.88
		2019		0		62.18 to 62.18		3		0.00 to 0.00		0.46		36.45 to 36.45
		2018		0		45.57 to 45.57		2		0.00 to 0.00		0.44		-13.16 to -13.16
		2017		0		52.48 to 52.48		1		0.00 to 0.00		0.82		27.70 to 27.70
		2016		0		41.10 to 41.10		1		0.00 to 0.00		0.61		8.34 to 8.34
Fundamental All Cap Core Trust Series NAV(*)		2020		27		47.02 to 47.02		1,291		0.00 to 0.00		0.43		26.97 to 26.97
		2019		27		37.03 to 37.03		999		0.00 to 0.00		0.51		36.58 to 36.58
		2018		26		27.11 to 27.11		693		0.00 to 0.00		0.46		-13.16 to -13.16
		2017		30		31.22 to 31.22		924		0.00 to 0.00		0.84		27.77 to 27.77
		2016		26		24.44 to 24.44		623		0.00 to 0.00		0.73		8.40 to 8.40
Fundamental Large Cap Value Trust Series I(*)		2020		20		45.79 to 45.79		931		0.00 to 0.00		1.13		11.96 to 11.96
		2019		20		40.90 to 40.90		815		0.00 to 0.00		1.14		35.85 to 35.85
		2018		22		30.10 to 30.10		652		0.00 to 0.00		1.12		-17.03 to -17.03
		2017		22		36.28 to 36.28		806		0.00 to 0.00		1.57		17.43 to 17.43
		2016		25		30.90 to 30.90		765		0.00 to 0.00		2.06		10.17 to 10.17

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Fundamental Large Cap Value Trust Series NAV(*)		2020		104		$ 32.34 to $ 32.34		$ 3,374		0.00 % to 0.00 %		1.18 %		12.01 % to 12.01 %
		2019		103		28.87 to 28.87		2,965		0.00 to 0.00		1.24		35.97 to 35.97
		2018		103		21.23 to 21.23		2,197		0.00 to 0.00		1.19		-17.03 to -17.03
		2017		100		25.59 to 25.59		2,556		0.00 to 0.00		1.68		17.54 to 17.54
		2016		109		21.77 to 21.77		2,375		0.00 to 0.00		2.34		10.21 to 10.21
Global Trust Series I(*)		2020		4		24.34 to 24.34		89		0.00 to 0.00		1.36		6.60 to 6.60
		2019		4		22.83 to 22.83		86		0.00 to 0.00		2.32		16.05 to 16.05
		2018		4		19.68 to 19.68		69		0.00 to 0.00		1.68		-14.49 to -14.49
		2017		5		23.01 to 23.01		106		0.00 to 0.00		1.93		18.88 to 18.88
		2016		5		19.36 to 19.36		104		0.00 to 0.00		4.15		9.47 to 9.47
Global Trust Series NAV(*)		2020		59		22.30 to 22.30		1,309		0.00 to 0.00		1.38		6.71 to 6.71
		2019		60		20.90 to 20.90		1,255		0.00 to 0.00		2.21		16.06 to 16.06
		2018		64		18.01 to 18.01		1,145		0.00 to 0.00		1.87		-14.42 to -14.42
		2017		65		21.04 to 21.04		1,361		0.00 to 0.00		1.97		18.90 to 18.90
		2016		66		17.70 to 17.70		1,168		0.00 to 0.00		4.69		9.46 to 9.46
Health Sciences Trust Series I(*)		2020		2		146.19 to 146.19		348		0.00 to 0.00		0.00		27.17 to 27.17
		2019		3		114.96 to 114.96		289		0.00 to 0.00		0.00		28.68 to 28.68
		2018		4		89.34 to 89.34		343		0.00 to 0.00		0.00		0.69 to 0.69
		2017		4		88.73 to 88.73		356		0.00 to 0.00		0.00		27.51 to 27.51
		2016		5		69.59 to 69.59		330		0.00 to 0.00		0.07		-10.57 to -10.57
Health Sciences Trust Series NAV(*)		2020		40		114.29 to 114.29		4,550		0.00 to 0.00		0.00		27.26 to 27.26
		2019		39		89.80 to 89.80		3,525		0.00 to 0.00		0.00		28.67 to 28.67
		2018		38		69.79 to 69.79		2,632		0.00 to 0.00		0.00		0.76 to 0.76
		2017		33		69.27 to 69.27		2,316		0.00 to 0.00		0.00		27.61 to 27.61
		2016		40		54.28 to 54.28		2,180		0.00 to 0.00		0.10		-10.54 to -10.54
High Yield Trust Series I(*)		2020		11		30.37 to 30.37		322		0.00 to 0.00		6.45		5.81 to 5.81
		2019		11		28.70 to 28.70		306		0.00 to 0.00		5.07		15.67 to 15.67
		2018		13		24.81 to 24.81		324		0.00 to 0.00		6.06		-3.01 to -3.01
		2017		13		25.58 to 25.58		338		0.00 to 0.00		5.53		7.50 to 7.50
		2016		13		23.80 to 23.80		313		0.00 to 0.00		7.09		16.27 to 16.27
High Yield Trust Series NAV(*)		2020		126		28.85 to 28.85		3,637		0.00 to 0.00		6.58		5.77 to 5.77
		2019		128		27.28 to 27.28		3,503		0.00 to 0.00		5.69		15.99 to 15.99
		2018		125		23.52 to 23.52		2,945		0.00 to 0.00		6.88		-3.02 to -3.02
		2017		107		24.25 to 24.25		2,587		0.00 to 0.00		5.39		7.46 to 7.46
		2016		132		22.57 to 22.57		2,982		0.00 to 0.00		8.21		16.56 to 16.56
International Equity Index Series I(*)		2020		14		16.72 to 16.72		238		0.00 to 0.00		2.57		10.64 to 10.64
		2019		15		15.11 to 15.11		226		0.00 to 0.00		2.57		21.37 to 21.37
		2018		13		12.45 to 12.45		160		0.00 to 0.00		2.21		-14.10 to -14.10
		2017		15		14.49 to 14.49		223		0.00 to 0.00		2.06		27.30 to 27.30
		2016		19		11.39 to 11.39		217		0.00 to 0.00		2.75		4.45 to 4.45
International Equity Index Series NAV(*)		2020		104		65.78 to 65.78		6,815		0.00 to 0.00		2.82		10.76 to 10.76
		2019		82		59.39 to 59.39		4,875		0.00 to 0.00		2.70		21.44 to 21.44
		2018		67		48.91 to 48.91		3,254		0.00 to 0.00		2.45		-14.10 to -14.10
		2017		61		56.94 to 56.94		3,482		0.00 to 0.00		1.66		27.45 to 27.45
		2016		135		44.68 to 44.68		6,025		0.00 to 0.00		2.68		4.43 to 4.43
International Small Company Trust Series I(*)		2020		1		21.76 to 21.76		29		0.00 to 0.00		2.19		8.37 to 8.37
		2019		1		20.08 to 20.08		27		0.00 to 0.00		2.12		22.60 to 22.60
		2018		2		16.38 to 16.38		31		0.00 to 0.00		1.26		-20.10 to -20.10
		2017		2		20.50 to 20.50		40		0.00 to 0.00		0.99		29.45 to 29.45
		2016		5		15.83 to 15.83		82		0.00 to 0.00		1.86		4.90 to 4.90
International Small Company Trust Series NAV(*)		2020		77		21.89 to 21.89		1,690		0.00 to 0.00		2.22		8.41 to 8.41
		2019		75		20.19 to 20.19		1,522		0.00 to 0.00		2.36		22.71 to 22.71
		2018		72		16.45 to 16.45		1,182		0.00 to 0.00		1.26		-20.07 to -20.07
		2017		67		20.59 to 20.59		1,376		0.00 to 0.00		1.43		29.59 to 29.59
		2016		69		15.89 to 15.89		1,100		0.00 to 0.00		2.05		4.95 to 4.95
Investment Quality Bond Trust Series I(*)		2020		6		29.61 to 29.61		181		0.00 to 0.00		2.35		9.37 to 9.37
		2019		6		27.07 to 27.07		165		0.00 to 0.00		2.30		9.37 to 9.37
		2018		8		24.75 to 24.75		192		0.00 to 0.00		2.73		-0.81 to -0.81
		2017		8		24.95 to 24.95		199		0.00 to 0.00		2.22		4.60 to 4.60
		2016		13		23.86 to 23.86		307		0.00 to 0.00		2.39		4.29 to 4.29
Investment Quality Bond Trust Series NAV(*)		2020		31		20.59 to 20.59		631		0.00 to 0.00		2.34		9.45 to 9.45
		2019		29		18.81 to 18.81		542		0.00 to 0.00		2.74		9.35 to 9.35
		2018		25		17.20 to 17.20		435		0.00 to 0.00		2.89		-0.67 to -0.67
		2017		35		17.32 to 17.32		612		0.00 to 0.00		2.80		4.67 to 4.67
		2016		32		16.55 to 16.55		521		0.00 to 0.00		2.49		4.26 to 4.26

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Lifestyle Aggressive Portfolio Series NAV(*)		2020		103		$ 18.78 to $ 18.78		$ 1,926		0.00 % to 0.00 %		2.23 %		14.11 % to 14.11 %
		2019		104		16.45 to 16.45		1,718		0.00 to 0.00		4.86		27.16 to 27.16
		2018		25		12.94 to 12.94		323		0.00 to 0.00		2.43		-8.87 to -8.87
		2017		15		14.20 to 14.20		213		0.00 to 0.00		1.76		21.85 to 21.85
		2016		14		11.65 to 11.65		161		0.00 to 0.00		11.95		9.59 to 9.59
Lifestyle Balanced Portfolio Series NAV(*)		2020		245		16.26 to 16.26		3,977		0.00 to 0.00		2.64		12.68 to 12.68
		2019		246		14.43 to 14.43		3,548		0.00 to 0.00		2.26		17.89 to 17.89
		2018		199		12.24 to 12.24		2,432		0.00 to 0.00		2.64		-3.29 to -4.39
		2017		154		12.80 to 12.80		1,971		0.00 to 0.00		2.73		12.38 to 12.38
		2016		101		11.39 to 11.39		1,148		0.00 to 0.00		3.27		6.17 to 6.17
Lifestyle Conservative Portfolio Series NAV(*)		2020		15		14.49 to 14.49		214		0.00 to 0.00		2.81		10.81 to 10.81
		2019		16		13.08 to 13.08		203		0.00 to 0.00		2.31		12.52 to 12.52
		2018		16		11.62 to 11.62		188		0.00 to 0.00		3.58		-1.92 to -1.92
		2017		9		11.85 to 11.85		108		0.00 to 0.00		2.72		7.01 to 7.01
		2016		8		11.07 to 11.07		88		0.00 to 0.00		3.10		4.36 to 4.36
Lifestyle Growth Portfolio Series NAV(*)		2020		1,437		17.46 to 17.46		25,093		0.00 to 0.00		2.60		13.64 to 13.64
		2019		1,404		15.37 to 15.37		21,573		0.00 to 0.00		2.01		21.52 to 21.52
		2018		1,266		12.64 to 12.64		16,009		0.00 to 0.00		2.34		-6.07 to -6.07
		2017		1,181		13.46 to 13.46		15,902		0.00 to 0.00		4.06		16.20 to 16.20
		2016		410		11.59 to 11.59		4,748		0.00 to 0.00		5.87		7.22 to 1.99
Lifestyle Moderate Portfolio Series NAV(*)		2020		115		15.66 to 15.66		1,794		0.00 to 0.00		2.76		12.22 to 12.22
		2019		110		13.96 to 13.96		1,536		0.00 to 0.00		2.25		15.95 to 15.95
		2018		92		12.04 to 12.04		1,102		0.00 to 0.00		2.81		-2.24 to -3.53
		2017		75		12.48 to 12.48		932		0.00 to 0.00		2.59		10.56 to 10.56
		2016		63		11.29 to 11.29		708		0.00 to 0.00		3.12		5.54 to 5.54
M Capital Appreciation		2020		5		149.12 to 149.12		700		0.00 to 0.00		0.00		17.73 to 17.73
		2019		5		126.67 to 126.67		686		0.00 to 0.00		0.33		28.85 to 28.85
		2018		5		98.31 to 98.31		519		0.00 to 0.00		0.32		-14.15 to -14.15
		2017		5		114.51 to 114.51		552		0.00 to 0.00		0.00		19.02 to 19.02
		2016		4		96.21 to 96.21		384		0.00 to 0.00		0.00		21.06 to 21.06
M International Equity		2020		23		40.96 to 40.96		954		0.00 to 0.00		1.79		8.90 to 8.90
		2019		20		37.62 to 37.62		756		0.00 to 0.00		2.96		20.32 to 20.32
		2018		19		31.26 to 31.26		579		0.00 to 0.00		1.61		-20.57 to -20.57
		2017		15		39.36 to 39.36		595		0.00 to 0.00		1.63		24.05 to 24.05
		2016		16		31.73 to 31.73		515		0.00 to 0.00		1.39		-0.05 to -0.05
M Large Cap Growth		2020		10		122.39 to 122.39		1,182		0.00 to 0.00		0.00		28.89 to 28.89
		2019		11		94.95 to 94.95		1,064		0.00 to 0.00		0.00		36.09 to 36.09
		2018		12		69.77 to 69.77		810		0.00 to 0.00		0.00		-4.95 to -4.95
		2017		11		73.41 to 73.41		803		0.00 to 0.00		0.00		38.97 to 38.97
		2016		14		52.82 to 52.82		717		0.00 to 0.00		0.00		-2.32 to -2.32
M Large Cap Value		2020		37		30.91 to 30.91		1,147		0.00 to 0.00		2.14		-3.16 to -3.16
		2019		31		31.92 to 31.92		992		0.00 to 0.00		1.84		21.51 to 21.51
		2018		29		26.27 to 26.27		762		0.00 to 0.00		1.55		-12.07 to -12.07
		2017		26		29.87 to 29.87		771		0.00 to 0.00		1.60		14.99 to 14.99
		2016		23		25.98 to 25.98		598		0.00 to 0.00		1.78		9.64 to 9.64
Managed Volatility Aggressive Portfolio Series I(*)		2020		27		25.36 to 25.36		682		0.00 to 0.00		1.54		-4.76 to -4.76
		2019		26		26.62 to 26.62		695		0.00 to 0.00		1.41		20.78 to 20.78
		2018		25		22.04 to 22.04		540		0.00 to 0.00		2.05		-8.46 to -8.46
		2017		24		24.08 to 24.08		580		0.00 to 0.00		1.83		22.81 to 22.81
		2016		23		19.61 to 19.61		454		0.00 to 0.00		1.76		1.95 to 1.95
Managed Volatility Aggressive Portfolio Series NAV(*)		2020		774		23.23 to 23.23		17,988		0.00 to 0.00		1.57		-4.80 to -4.80
		2019		775		24.40 to 24.40		18,921		0.00 to 0.00		1.45		20.82 to 20.82
		2018		757		20.19 to 20.19		15,282		0.00 to 0.00		2.12		-8.32 to -8.32
		2017		731		22.03 to 22.03		16,094		0.00 to 0.00		1.88		22.88 to 22.88
		2016		700		17.93 to 17.93		12,546		0.00 to 0.00		1.77		1.89 to 1.89
Managed Volatility Balanced Portfolio Series I(*)		2020		31		31.25 to 31.25		969		0.00 to 0.00		2.07		1.81 to 1.81
		2019		41		30.69 to 30.69		1,263		0.00 to 0.00		0.80		17.92 to 17.92
		2018		182		26.03 to 26.03		4,742		0.00 to 0.00		2.27		-4.89 to -4.89
		2017		194		27.37 to 27.37		5,310		0.00 to 0.00		2.19		14.14 to 14.14
		2016		206		23.98 to 23.98		4,948		0.00 to 0.00		2.10		4.80 to 4.80
Managed Volatility Balanced Portfolio Series NAV(*)		2020		1,946		23.52 to 23.52		45,778		0.00 to 0.00		2.66		1.77 to 1.77
		2019		1,934		23.11 to 23.11		44,701		0.00 to 0.00		2.09		18.02 to 18.02
		2018		1,938		19.58 to 19.58		37,956		0.00 to 0.00		2.39		-4.82 to -4.82
		2017		1,959		20.58 to 20.58		40,305		0.00 to 0.00		2.30		14.15 to 14.15
		2016		1,973		18.02 to 18.02		35,568		0.00 to 0.00		2.21		4.91 to 4.91

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Managed Volatility Conservative Portfolio Series I(*)		2020		3		$ 29.86 to $ 29.86		$ 81		0.00 % to 0.00 %		3.19 %		3.39 % to 3.39 %
		2019		3		28.88 to 28.88		79		0.00 to 0.00		2.46		13.37 to 13.37
		2018		3		25.47 to 25.47		71		0.00 to 0.00		2.74		-2.18 to -2.18
		2017		3		26.04 to 26.04		71		0.00 to 0.00		2.64		7.81 to 7.81
		2016		3		24.15 to 24.15		64		0.00 to 0.00		2.06		4.58 to 4.58
Managed Volatility Conservative Portfolio Series NAV(*)		2020		383		21.28 to 21.28		8,152		0.00 to 0.00		3.03		3.43 to 3.43
		2019		388		20.58 to 20.58		7,990		0.00 to 0.00		2.39		13.51 to 13.51
		2018		424		18.13 to 18.13		7,684		0.00 to 0.00		2.01		-2.21 to -2.21
		2017		1,035		18.54 to 18.54		19,180		0.00 to 0.00		8.37		7.94 to 7.94
		2016		186		17.17 to 17.17		3,186		0.00 to 0.00		2.55		4.53 to 4.53
Managed Volatility Growth Portfolio Series I(*)		2020		55		28.17 to 28.17		1,539		0.00 to 0.00		2.25		-1.42 to -1.42
		2019		57		28.57 to 28.57		1,626		0.00 to 0.00		1.83		19.56 to 19.56
		2018		60		23.90 to 23.90		1,430		0.00 to 0.00		1.91		-6.54 to -6.54
		2017		79		25.57 to 25.57		2,029		0.00 to 0.00		1.91		18.59 to 18.59
		2016		94		21.56 to 21.56		2,018		0.00 to 0.00		1.77		3.34 to 3.34
Managed Volatility Growth Portfolio Series NAV(*)		2020		1,777		23.28 to 23.28		41,367		0.00 to 0.00		2.27		-1.37 to -1.37
		2019		1,777		23.61 to 23.61		41,938		0.00 to 0.00		1.82		19.68 to 19.68
		2018		1,800		19.72 to 19.72		35,504		0.00 to 0.00		2.24		-6.56 to -6.56
		2017		1,797		21.11 to 21.11		37,922		0.00 to 0.00		2.08		18.71 to 18.71
		2016		1,902		17.78 to 17.78		33,819		0.00 to 0.00		1.98		3.38 to 3.38
Managed Volatility Moderate Portfolio Series I(*)		2020		16		31.51 to 31.51		507		0.00 to 0.00		2.75		3.31 to 3.31
		2019		17		30.50 to 30.50		517		0.00 to 0.00		2.11		16.72 to 16.72
		2018		19		26.13 to 26.13		497		0.00 to 0.00		1.76		-3.99 to -3.99
		2017		30		27.22 to 27.22		828		0.00 to 0.00		2.30		11.88 to 11.88
		2016		33		24.33 to 24.33		810		0.00 to 0.00		2.07		5.29 to 5.29
Managed Volatility Moderate Portfolio Series NAV(*)		2020		534		23.41 to 23.41		12,496		0.00 to 0.00		2.84		3.28 to 3.28
		2019		534		22.67 to 22.67		12,115		0.00 to 0.00		2.21		16.85 to 16.85
		2018		533		19.40 to 19.40		10,334		0.00 to 0.00		2.52		-3.93 to -3.93
		2017		525		20.19 to 20.19		10,593		0.00 to 0.00		2.71		12.02 to 12.02
		2016		462		18.03 to 18.03		8,336		0.00 to 0.00		2.31		5.25 to 5.25
Mid Cap Index Trust Series I(*)		2020		8		71.78 to 71.78		566		0.00 to 0.00		1.66		13.22 to 13.22
		2019		9		63.41 to 63.41		548		0.00 to 0.00		1.13		25.59 to 25.59
		2018		10		50.49 to 50.49		490		0.00 to 0.00		1.11		-11.46 to -11.46
		2017		10		57.02 to 57.02		580		0.00 to 0.00		0.58		15.81 to 15.81
		2016		8		49.24 to 49.24		370		0.00 to 0.00		1.26		20.11 to 20.11
Mid Cap Index Trust Series NAV(*)		2020		96		47.21 to 47.21		4,538		0.00 to 0.00		1.71		13.27 to 13.27
		2019		94		41.68 to 41.68		3,905		0.00 to 0.00		1.22		25.72 to 25.72
		2018		93		33.16 to 33.16		3,071		0.00 to 0.00		1.18		-11.45 to -11.45
		2017		92		37.45 to 37.45		3,448		0.00 to 0.00		0.50		15.86 to 15.86
		2016		99		32.32 to 32.32		3,184		0.00 to 0.00		1.22		20.17 to 20.17
Mid Cap Stock Trust Series I(*)		2020		8		98.79 to 98.79		807		0.00 to 0.00		0.00		65.39 to 65.39
		2019		8		59.73 to 59.73		504		0.00 to 0.00		0.00		34.53 to 34.53
		2018		8		44.40 to 44.40		371		0.00 to 0.00		0.00		-1.56 to -1.56
		2017		8		45.10 to 45.10		364		0.00 to 0.00		0.00		28.54 to 28.54
		2016		8		35.09 to 35.09		287		0.00 to 0.00		0.00		0.59 to 0.59
Mid Cap Stock Trust Series NAV(*)		2020		17		215.62 to 215.62		3,705		0.00 to 0.00		0.00		65.47 to 65.47
		2019		19		130.31 to 130.31		2,439		0.00 to 0.00		0.00		34.64 to 34.64
		2018		19		96.79 to 96.79		1,814		0.00 to 0.00		0.00		-1.54 to -1.54
		2017		17		98.30 to 98.30		1,637		0.00 to 0.00		0.00		28.66 to 28.66
		2016		16		76.41 to 76.41		1,249		0.00 to 0.00		0.00		0.58 to 0.58
Mid Value Trust Series I(*)		2020		7		40.50 to 40.50		297		0.00 to 0.00		1.74		9.60 to 9.60
		2019		7		36.95 to 36.95		274		0.00 to 0.00		1.14		19.54 to 19.54
		2018		7		30.91 to 30.91		225		0.00 to 0.00		0.75		-10.84 to -10.84
		2017		8		34.67 to 34.67		276		0.00 to 0.00		0.98		11.43 to 11.43
		2016		8		31.12 to 31.12		264		0.00 to 0.00		1.09		24.02 to 24.02
Mid Value Trust Series NAV(*)		2020		23		62.43 to 62.43		1,407		0.00 to 0.00		1.77		9.72 to 9.72
		2019		23		56.90 to 56.90		1,329		0.00 to 0.00		1.21		19.49 to 19.49
		2018		23		47.62 to 47.62		1,101		0.00 to 0.00		0.84		-10.68 to -10.68
		2017		23		53.32 to 53.32		1,238		0.00 to 0.00		1.15		11.46 to 11.46
		2016		19		47.84 to 47.84		885		0.00 to 0.00		1.26		24.09 to 24.09
Money Market Trust Series I(*)		2020		148		14.06 to 14.06		2,084		0.00 to 0.00		0.31		0.30 to 0.30
		2019		153		14.02 to 14.02		2,145		0.00 to 0.00		1.92		1.92 to 1.92
		2018		157		13.75 to 13.75		2,164		0.00 to 0.00		1.53		1.53 to 1.53
		2017		164		13.55 to 13.55		2,225		0.00 to 0.00		0.59		0.60 to 0.60
		2016		165		13.46 to 13.46		2,218		0.00 to 0.00		0.07		0.04 to 0.04

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Money -Market Trust Series NAV(*)		2020		445		$ 10.46 to $ 10.46		$ 4,660		0.00 % to 0.00 %		0.49 %		0.33 % to 0.33 %
		2019		976		10.43 to 10.43		10,179		0.00 to 0.00		1.94		1.97 to 1.97
		2018		483		10.23 to 10.23		4,944		0.00 to 0.00		1.58		1.60 to 1.60
		2017		542		10.07 to 10.07		5,459		0.00 to 0.00		0.65		0.61 to 0.61
		2016		488		10.00 to 10.00		4,882		0.00 to 0.00		0.15		0.05 to 0.05
Opportunistic Fixed Income Trust Series I(*)		2020		6		27.69 to 27.69		177		0.00 to 0.00		3.95		13.80 to 13.80
		2019		6		24.33 to 24.33		156		0.00 to 0.00		6.69		6.38 to 6.38
		2018		9		22.87 to 22.87		206		0.00 to 0.00		2.56		-1.90 to -1.90
		2017		11		23.32 to 23.32		245		0.00 to 0.00		2.21		8.75 to 8.75
		2016		11		21.44 to 21.44		230		0.00 to 0.00		0.00		3.05 to 3.05
Opportunistic Fixed Income Trust Series NAV(*)		2020		32		39.68 to 39.68		1,274		0.00 to 0.00		4.03		13.90 to 13.90
		2019		33		34.84 to 34.84		1,137		0.00 to 0.00		6.36		6.37 to 6.37
		2018		33		32.75 to 32.75		1,067		0.00 to 0.00		2.64		-1.74 to -1.74
		2017		52		33.33 to 33.33		1,734		0.00 to 0.00		2.68		8.71 to 8.71
		2016		31		30.66 to 30.66		953		0.00 to 0.00		0.00		3.15 to 3.15
PIMCO All Asset		2020		28		29.30 to 20.76		589		0.00 to 0.00		4.65		7.74 to 7.74
		2019		27		27.19 to 19.26		526		0.00 to 0.00		2.65		11.44 to 11.44
		2018		25		24.40 to 17.29		430		0.00 to 0.00		2.94		-5.59 to -5.59
		2017		24		25.85 to 18.31		445		0.00 to 0.00		3.20		13.19 to 13.19
		2016		95		22.84 to 16.18		1,534		0.00 to 0.00		2.15		12.59 to 12.59
Real Estate Securities Trust Series I(*)		2020		2		68.95 to 68.95		166		0.00 to 0.00		2.08		-5.64 to -5.64
		2019		2		73.08 to 73.08		179		0.00 to 0.00		2.18		29.40 to 29.40
		2018		3		56.47 to 56.47		167		0.00 to 0.00		1.48		-3.46 to -3.46
		2017		4		58.50 to 58.50		257		0.00 to 0.00		0.22		6.24 to 6.24
		2016		13		55.06 to 55.06		714		0.00 to 0.00		3.72		6.92 to 6.92
Real Estate Securities Trust Series NAV(*)		2020		10		191.60 to 191.60		1,866		0.00 to 0.00		2.17		-5.58 to -5.58
		2019		9		202.92 to 202.92		1,916		0.00 to 0.00		2.16		29.47 to 29.47
		2018		10		156.74 to 156.74		1,505		0.00 to 0.00		1.71		-3.43 to -3.43
		2017		10		162.30 to 162.30		1,658		0.00 to 0.00		0.44		6.26 to 6.26
		2016		15		152.74 to 152.74		2,363		0.00 to 0.00		3.46		6.96 to 6.96
Science & Technology Trust Series I(*)		2020		10		56.77 to 56.77		558		0.00 to 0.00		0.00		57.46 to 57.46
		2019		10		36.05 to 36.05		377		0.00 to 0.00		0.12		38.06 to 38.06
		2018		12		26.11 to 26.11		321		0.00 to 0.00		0.00		-0.61 to -0.61
		2017		14		26.27 to 26.27		356		0.00 to 0.00		0.05		41.13 to 41.13
		2016		14		18.62 to 18.62		263		0.00 to 0.00		0.00		8.38 to 8.38
Science & Technology Trust Series NAV(*)		2020		76		95.00 to 95.00		7,240		0.00 to 0.00		0.00		57.58 to 57.58
		2019		79		60.29 to 60.29		4,763		0.00 to 0.00		0.18		38.09 to 38.09
		2018		74		43.66 to 43.66		3,233		0.00 to 0.00		0.00		-0.57 to -0.57
		2017		49		43.91 to 43.91		2,141		0.00 to 0.00		0.09		41.21 to 41.21
		2016		40		31.10 to 31.10		1,238		0.00 to 0.00		0.00		8.41 to 8.41
Select Bond Trust Series I(*)		2020		3		14.14 to 14.14		41		0.00 to 0.00		3.39		9.08 to 9.08
		2019		2		12.96 to 12.96		24		0.00 to 0.00		2.67		8.94 to 8.94
		2018		2		11.90 to 11.90		22		0.00 to 0.00		2.80		-0.43 to -0.43
		2017		2		11.95 to 11.95		22		0.00 to 0.00		2.48		3.67 to 3.67
		2016		2		11.52 to 11.52		21		0.00 to 0.00		1.85		3.06 to 3.06
Select Bond Trust Series NAV(*)		2020		100		14.20 to 14.20		1,417		0.00 to 0.00		3.12		9.13 to 9.13
		2019		101		13.01 to 13.01		1,315		0.00 to 0.00		2.71		9.01 to 9.01
		2018		100		11.94 to 11.94		1,190		0.00 to 0.00		2.84		-0.38 to -0.38
		2017		100		11.98 to 11.98		1,198		0.00 to 0.00		2.85		3.65 to 3.65
		2016		98		11.56 to 11.56		1,137		0.00 to 0.00		3.93		3.19 to 3.19
Short Term Government Income Trust Series I(*)		2020		13		11.68 to 11.68		146		0.00 to 0.00		1.70		3.60 to 3.60
		2019		13		11.27 to 11.27		148		0.00 to 0.00		1.18		3.39 to 3.39
		2018		29		10.90 to 10.90		321		0.00 to 0.00		2.07		0.84 to 0.84
		2017		30		10.81 to 10.81		328		0.00 to 0.00		1.35		0.57 to 0.57
		2016		35		10.75 to 10.75		373		0.00 to 0.00		1.72		0.57 to 0.57
Short Term Government Income Trust Series NAV(*)		2020		61		11.74 to 11.74		720		0.00 to 0.00		1.76		3.65 to 3.65
		2019		55		11.33 to 11.33		619		0.00 to 0.00		1.71		3.44 to 3.44
		2018		56		10.95 to 10.95		611		0.00 to 0.00		1.91		0.89 to 0.89
		2017		46		10.86 to 10.86		497		0.00 to 0.00		1.42		0.62 to 0.62
		2016		48		10.79 to 10.79		515		0.00 to 0.00		1.44		0.63 to 0.63
Small Cap Index Trust Series I(*)		2020		4		56.74 to 56.74		215		0.00 to 0.00		1.44		19.29 to 19.29
		2019		4		47.57 to 47.57		187		0.00 to 0.00		1.00		25.05 to 25.05
		2018		4		38.04 to 38.04		148		0.00 to 0.00		0.93		-11.42 to -11.42
		2017		4		42.95 to 42.95		169		0.00 to 0.00		0.45		14.39 to 14.39
		2016		4		37.55 to 37.55		151		0.00 to 0.00		1.23		20.98 to 20.98

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Small Cap Index Trust Series NAV(*)		2020		81		$ 45.40 to $ 45.40		$ 3,670		0.00 % to 0.00 %		1.61 %		19.32 % to 19.32 %
		2019		64		38.05 to 38.05		2,436		0.00 to 0.00		1.04		25.07 to 25.07
		2018		63		30.42 to 30.42		1,924		0.00 to 0.00		1.00		-11.31 to -11.31
		2017		63		34.30 to 34.30		2,174		0.00 to 0.00		0.50		14.43 to 14.43
		2016		80		29.98 to 29.98		2,384		0.00 to 0.00		1.16		21.02 to 21.02
Small Cap Opportunities Trust Series I(*)		2020		2		59.02 to 59.02		132		0.00 to 0.00		0.73		9.88 to 9.88
		2019		2		53.71 to 53.71		127		0.00 to 0.00		0.41		25.54 to 25.54
		2018		3		42.79 to 42.79		118		0.00 to 0.00		0.42		-13.84 to -13.84
		2017		3		49.66 to 49.66		139		0.00 to 0.00		0.42		11.07 to 11.07
		2016		3		44.71 to 44.71		126		0.00 to 0.00		0.45		19.47 to 19.47
Small Cap Opportunities Trust Series NAV(*)		2020		51		29.15 to 29.15		1,495		0.00 to 0.00		0.86		9.93 to 9.93
		2019		37		26.52 to 26.52		986		0.00 to 0.00		0.46		25.60 to 25.60
		2018		35		21.11 to 21.11		731		0.00 to 0.00		0.47		-13.81 to -13.81
		2017		35		24.50 to 24.50		847		0.00 to 0.00		0.46		11.18 to 11.18
		2016		34		22.03 to 22.03		759		0.00 to 0.00		0.60		19.51 to 19.51
Small Cap Stock Trust Series I(*)		2020		1		64.63 to 64.63		54		0.00 to 0.00		0.00		51.55 to 51.55
		2019		1		42.64 to 42.64		44		0.00 to 0.00		0.00		38.02 to 38.02
		2018		1		30.90 to 30.90		32		0.00 to 0.00		0.00		-5.19 to -5.19
		2017		1		32.59 to 32.59		36		0.00 to 0.00		0.00		26.46 to 26.46
		2016		1		25.77 to 25.77		18		0.00 to 0.00		0.00		2.29 to 2.29
Small Cap Stock Trust Series NAV(*)		2020		38		76.89 to 76.89		2,959		0.00 to 0.00		0.00		51.62 to 51.62
		2019		38		50.71 to 50.71		1,926		0.00 to 0.00		0.00		38.10 to 38.10
		2018		33		36.72 to 36.72		1,221		0.00 to 0.00		0.00		-5.22 to -5.22
		2017		35		38.74 to 38.74		1,352		0.00 to 0.00		0.00		26.70 to 26.70
		2016		32		30.58 to 30.58		968		0.00 to 0.00		0.00		2.27 to 2.27
Small Cap Value Trust Series I(*)		2020		1		31.89 to 31.89		26		0.00 to 0.00		1.07		-6.70 to -6.70
		2019		1		34.18 to 34.18		29		0.00 to 0.00		0.54		26.52 to 26.52
		2018		2		27.01 to 27.01		65		0.00 to 0.00		0.60		-12.50 to -12.50
		2017		3		30.87 to 30.87		98		0.00 to 0.00		0.96		3.73 to 3.73
		2016		3		29.76 to 29.76		96		0.00 to 0.00		0.66		22.67 to 22.67
Small Cap Value Trust Series NAV(*)		2020		25		89.94 to 89.94		2,253		0.00 to 0.00		1.20		-6.68 to -6.68
		2019		23		96.38 to 96.38		2,184		0.00 to 0.00		0.64		26.62 to 26.62
		2018		24		76.12 to 76.12		1,812		0.00 to 0.00		0.76		-12.45 to -12.45
		2017		19		86.94 to 86.94		1,681		0.00 to 0.00		0.71		3.79 to 3.79
		2016		17		83.77 to 83.77		1,425		0.00 to 0.00		0.79		22.68 to 22.68
Small Company Value Trust Series I(*)		2020		2		66.41 to 66.41		106		0.00 to 0.00		0.30		9.25 to 9.25
		2019		2		60.79 to 60.79		100		0.00 to 0.00		0.87		25.53 to 25.53
		2018		2		48.43 to 48.43		80		0.00 to 0.00		0.37		-12.94 to -12.94
		2017		2		55.63 to 55.63		111		0.00 to 0.00		0.24		11.49 to 11.49
		2016		4		49.89 to 49.89		199		0.00 to 0.00		0.76		32.32 to 32.32
Small Company Value Trust Series NAV(*)		2020		25		38.04 to 38.04		945		0.00 to 0.00		0.35		9.25 to 9.25
		2019		24		34.82 to 34.82		840		0.00 to 0.00		0.94		25.65 to 25.65
		2018		25		27.71 to 27.71		682		0.00 to 0.00		0.34		-12.93 to -12.93
		2017		47		31.83 to 31.83		1,497		0.00 to 0.00		0.25		11.58 to 11.58
		2016		49		28.53 to 28.53		1,391		0.00 to 0.00		0.86		32.33 to 32.33
Strategic Income Opportunities Trust Series I(*)		2020		7		33.19 to 33.19		241		0.00 to 0.00		1.72		8.59 to 8.59
		2019		7		30.56 to 30.56		219		0.00 to 0.00		2.99		10.91 to 10.91
		2018		6		27.56 to 27.56		167		0.00 to 0.00		3.86		-5.03 to -5.03
		2017		6		29.02 to 29.02		176		0.00 to 0.00		3.28		5.59 to 5.59
		2016		5		27.48 to 27.48		144		0.00 to 0.00		2.24		5.12 to 5.12
Strategic Income Opportunities Trust Series NAV(*)		2020		99		24.69 to 24.69		2,439		0.00 to 0.00		1.77		8.61 to 8.61
		2019		98		22.73 to 22.73		2,228		0.00 to 0.00		2.93		11.00 to 11.00
		2018		90		20.48 to 20.48		1,844		0.00 to 0.00		3.89		-5.00 to -5.00
		2017		88		21.56 to 21.56		1,890		0.00 to 0.00		3.22		5.66 to 5.66
		2016		86		20.40 to 20.40		1,752		0.00 to 0.00		2.54		5.19 to 5.19
Total Bond Market Series Trust NAV(*)		2020		47		29.10 to 29.10		1,372		0.00 to 0.00		2.62		7.38 to 7.38
		2019		33		27.10 to 27.10		899		0.00 to 0.00		2.41		8.30 to 8.30
		2018		29		25.02 to 25.02		737		0.00 to 0.00		2.72		-0.24 to -0.24
		2017		31		25.08 to 25.08		776		0.00 to 0.00		2.96		3.34 to 3.34
		2016		30		24.27 to 24.27		717		0.00 to 0.00		2.80		2.45 to 2.45
Total Stock Market Index Trust Series I(*)		2020		5		47.86 to 47.86		261		0.00 to 0.00		1.80		21.44 to 21.44
		2019		7		39.41 to 39.41		257		0.00 to 0.00		1.53		29.63 to 29.63
		2018		8		30.40 to 30.40		245		0.00 to 0.00		1.01		-5.70 to -5.70
		2017		13		32.24 to 32.24		418		0.00 to 0.00		1.61		20.59 to 20.59
		2016		6		26.73 to 26.73		154		0.00 to 0.00		1.53		12.38 to 12.38

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7.Unit Values (continued):

		At December 31,		For the years and periods ended December 31,
Sub-account		Year		Units (000s)		Unit Fair Value Highest to Lowest (a)		Assets (000s)		Expense Ratio Highest to Lowest (b)		Investment Income Ratio (c)		Total Return Highest to Lowest (d)
Total Stock Market Index Trust Series NAV(*)		2020		55		$ 159.85 to $ 159.85		$ 8,829		0.00 % to 0.00 %		2.00 %		21.50 % to 21.50 %
		2019		44		131.56 to 131.56		5,755		0.00 to 0.00		1.66		29.70 to 29.70
		2018		42		101.44 to 101.44		4,266		0.00 to 0.00		1.25		-5.66 to -5.66
		2017		42		107.52 to 107.52		4,550		0.00 to 0.00		1.44		20.65 to 20.65
		2016		40		89.11 to 89.11		3,541		0.00 to 0.00		1.58		12.38 to 12.38
Ultra Short Term Bond Trust Series I(*)		2020		56		10.78 to 10.78		609		0.00 to 0.00		1.86		1.46 to 1.46
		2019		59		10.63 to 10.63		629		0.00 to 0.00		5.31		3.12 to 3.12
		2018		2		10.31 to 10.31		22		0.00 to 0.00		1.67		1.40 to 1.40
		2017		2		10.17 to 10.17		24		0.00 to 0.00		1.60		0.66 to 0.66
		2016		2		10.10 to 10.10		24		0.00 to 0.00		1.92		0.52 to 0.52
Ultra Short Term Bond Trust Series NAV(*)		2020		53		10.85 to 10.85		571		0.00 to 0.00		2.01		1.62 to 1.62
		2019		46		10.68 to 10.68		494		0.00 to 0.00		2.07		3.08 to 3.08
		2018		31		10.36 to 10.36		321		0.00 to 0.00		1.74		1.53 to 1.53
		2017		33		10.20 to 10.20		341		0.00 to 0.00		1.74		0.62 to 0.62
		2016		28		10.14 to 10.14		288		0.00 to 0.00		1.37		0.67 to 0.67

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

7. Unit Values (continued):

(*) Sub-account that invests in affiliated Trust.

(a) As the unit fair value is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract unit values are not within the ranges presented.

(b) These ratios represent the annualized contract expenses of the separate account, consisting primarily of the items known as 'Revenue from underlying fund (12b-1, STA, Other)' and 'Revenue from Sub-account' (formerly referred to as the administrative maintenance charges and sales and service fees (AMC and SSF)). The ratios include only those expenses that result in a direct reduction to unit value s. Charges made directly to unitholder accounts through the redemption of units and expenses of the underlying fund are excluded.

(c) These ratios represent the distributions from net investment income received by the sub-account from the underlying Portfolio, net of management fees assessed by the portfolio manager, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that are assessed against policyholder accounts either through the reductions in the unit values or the redemptions of units. The recognition of investment income by the sub-account is affected by the timing of the declaration of dividends by the underlying Portfolio in which the sub-accounts invest.

(d) These ratios, represent the total return for the periods indicated, including changes in the value of the underlying Portfolio, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options indicated in footnote 1 with a date notation, if any, denote the effective date of that investment option in the variable account. The total return is calculated for the period indicated or from the effective date through the end of the reporting period. For closed sub-accounts, the total return is calculated from the beginning of the reporting period to the date the sub-account closed. As the total return is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract total returns are not within the ranges presented.

JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK SEPARATE ACCOUNT B
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
December 31, 2020

8. Diversification Requirements

The Internal Revenue Service has issued regulations under Section 817(h) of the Internal Revenue Code ('the Code'). Under the provisions of Section 817(h) of the Code, a Contract will not be treated as a variable life contract for federal tax purposes for any period for which the investments of the Account on which the contract is based are not adequately diversified. The Code provides that the 'adequately diversified' requirement may be met if the underlying investments satisfy either a statutory safe harbor test or diversification requirement set forth in regulations issued by the Secretary of the Treasury. The Company believes that the Account satisfies the current requirements of the regulations, and the Account will continue to meet such requirements.

9. Contract Charges

The Company deducts certain charges from gross premiums before placing the remaining net premiums in the sub-account. In the event of a surrender by the contract holder, surrender charges may be levied by the Company against the contract value at the time of termination to cover sales and administrative expenses associated with underwriting and issuing the Contract. Additionally, each month a deduction consisting of an administrative charge, a charge for cost of insurance, and charges for supplementary benefits is deducted from the contract value. Contract charges are paid through the redemption of sub -accounts and are reflected as terminations.